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Abstract
Nanoparticle probes can unlock the potential for multimodal biomedical imaging
(in vivo and in vitro) with enhanced spatial resolution and penetration depth
and targeted visualization of complex organisms. This thesis demonstrates
synthesis and characterization of magnetic upconversion Gd2O3 nanoparticles
that can serve as bimodal probes for optical imaging in near infrared (NIR)
biomedical window, where minimal tissue autofluorescence is expected, as well
as magnetic resonance imaging. More specifically, Gd2O3:Yb
3+,Tm3+ and
Gd2O3:Yb
3+,Er3+ nanoparticles are synthesized using urea-based homogeneous
precipitation method (UHP) as well as Y2O3:Yb
3+/Er3+ micro and nanoparti-
cles using conventional combustion and thermal synthesis methods. The mor-
phological and compositional properties of nanoparticles as well as their pho-
tonic and magnetic responses are systematically analyzed to understand the role
of synthesis methods and initial synthesis materials including the concentrations
of Tm and Er dopants and urea solution on the properties of the synthesized
particles. The upconversion nanoparticles synthesized using UHP method are
spherical and monodisperse with a size distribution in the range of 60 to 150 nm
and controllable dopant concentration through manipulation of initial synthe-
sis chemistry. When excited with 975 nm NIR radiation, Gd2O3:Yb
3+,Tm3+
nanoparticles show a pure near infrared emission centered at around 810 nm (i.e.,
NIR-to-NIR upconversion) in NIR biological window with potential for high
depth optical imaging while Er3+ doped particles emit light mainly in visible
red centred at around 661 nm. The photoluminescence and transient optical de-
cay measurements demonstrate distinctly different energy transfer mechanisms
for Er and Tm doped samples. While these measurements signify a dominant
role for Yb3+ dopants in strong upconversion emission of Tm3+ samples with
a double exponential decay behaviour, they show less important role of Yb3+
in Er3+ samples with a single exponential decay. Systematic magnetic charac-
terization demonstrate strong paramagnetic behaviour for the optically active
upconversion nanoparticles, demonstrating their potential for bimodal optical
and magnetic resonant imaging.
ii
Chapter 1
Introduction
1.1 Opportunities for Molecular Imaging in
Nanomedicine
Molecular imaging is the ability to visualize biological, physiological and patho-
logical processes by non-invasive acquisition of quantitative temporal images of
a target of interest (often enhanced by using targeted nanoparticles) in a cul-
ture medium (in vitro) or living conditions (in vivo) [20]. Although conventional
medical imaging methods provide anatomical information that is important to
diagnosis, surgical guidance, and treatment monitoring, they suffer from lack of
sensitivity and specificity to specific target areas, resulting in wrong diagnosis,
high percentage of false positives or negatives and limited success in early detec-
tion. Recent advances in genomics, proteomics, biotechnology, nanomedicine,
molecular biology and biochemistry have resulted in the opportunity to signif-
icantly enrich conventional anatomical images with targeted functional molec-
1
ular imaging of tissues and cells. These advances provide a pathway for much-
needed improved sensitivity and specificity and have been investigated for sev-
eral conventional modalities such as X-ray imaging, magnetic resonant imag-
ing (MRI), computed tomography (CT), positron emission tomography (PET),
single-photon emission computed tomography (SPECT), Ultrasound (US), pho-
toacoustic imaging and optical imaging, which will be summarized in more de-
tails in part 1.2 of this thesis[21, 22, 31]. Advantages of molecular imaging are
independent of the modality and include early non-invasive detection of diseased
tissues and cells, functional monitoring of therapeutic effects on cells in patient
or animal models, improving the ability to investigate cell processes and inter-
actions in vivo, targeted drug delivery for more effective treatments with less
adverse effects, and whole-body safe molecular imaging.
Synthetic nanoparticles play a critical role in enabling targeted molecular
imaging in the field of “nanomedicine”; although since almost all interactions
that occur in human biology is at nanoscale, one can easily argue that all
medicine is “nanomedicine”. Figure 1.1 illustrates the size of biological elements
is in micro/nano scale, signifying the role of nanoparticles and nanostructures
for interactions in medical and biological processes. Nanomedicine is defined as
the application of novel synthetic nanostructures for improving our ability to
diagnose and treat diseases [32].
New applications of nanotechnology in medicine are being introduced every
day, which have the potential to revolutionize the medical and pharmaceutical
sciences. Examples of these applications include: (i) Nanoparticles are used
2
10810710610510410310210110-1
Tennis 
BallA Period
Cancer
CellBacteriaVirusAntibodyGlucoseWater
Nanometer
LiposomeDendrimerGold 
Nanoshell
Quantum
Dot
Fullerene
Figure 1.1: Schematic diagram for comparison of the size of synthetic nanopar-
ticles and other familiar building blocks of human biology [1].
as targeted detection agents, as targeted carriers of therapeutic materials and
drugs, and targeted contrasts agents in tissues. The small size of these particles
allow their transfer through biological barriers such as blood brain barriers. (ii)
The ability to acquire quantitative information from biological and physiolog-
ical processes in vitro or in vivo can dramatically enhance our understanding
about the these complex system of processes involved in healthy and diseased
tissues and organisms. (iii) Engineered nanostructures can be used in targeted
regenerative medicine, tissue engineering and wound healing. (iv) There is a
significant potential to enhance specificity and reduce delay in diagnosis by
transferring our paraclinical abilities to small, affordable and mobile electronic
chips that can be used in remote areas even by amateur users. (v) The ability
to perform complex biological experiments on small scale and with improved
3
resolution has an overreaching potential for cost saving in research and develop-
ment for a more efficient pharmaceutical industry. (vi) All these advantages can
play a revolutionary role in medicine in future to change the “one-size-fits-all”
approach in medicine toward more patient-specific methods known as “person-
alized medicine” [33].
1.2 Molecular Imaging Modalities
Classification of the modalities of molecular imaging methods are based on en-
ergy and modality of the (externally excited or self emitting) imaging agent or
probe used for detection of a target of interest. Table 1.1 summarizes these
modalities and common probes, as well as their advantages and disadvantages.
Currently, molecular imaging is mostly performed using nuclear imaging such
as PET or SPECT. Optical and US imaging methods are real-time, inexpensive
and safe, but these methods need advances in technological aspects of nanopar-
ticles probes, detectors and instrumentations. Considering the imperfections of
each modality in providing resolution, specificity and sensitivity, an efficient and
practical molecular imaging may be achieved by using more than one modality
(i.e., multimodality) for one investigation.
Nuclear imaging (e.g., PET and SPECT) is the most popular molecular
imaging modality currently used in clinical applications. Gamma-ray emitting
particles circulate in body generate the required contrast when aggregate on
the desired target with no need for an external excitation source and unlim-
4
ited penetration depth. Extremely sensitive imaging has been demonstrated by
PET/SPECT for detection of radionuclides with concentration as small as 10−11
moles/L, equivalent to detection of a single cell by only two to three labelled
antibody molecules [34]. Nuclear imaging modalities have been combined with
CT or MRI for multimodal imaging, so as to have anatomical and molecular
information simultaneously with functional images provided by PET/SPECT.
SPECT has been also merged with some treatments methods such as radiother-
apy for guided treatments. Nuclear modality suffers from disadvantages such
as: (1) limited spatial resolution (1 mm) which is determined by the resolution
of detector and imaging system, (2) poor anatomical resolution, (3) exposure
of tissues to radiation, particularly with potential for high radiation damage to
kidneys because of the pharmacokinetics, (4) long acquisition time (minutes to
hours), and (5) the required direct or indirect access to a cyclotron facility for
PET [22].
Magnetic resonant imaging and spectroscopy (MRI and MRS) are widely
used in clinical imaging in view of their high spatial resolution. The resolution
of MRI is dependent on the strength of the magnetic field; a 3 T magnetic
source commonly used in most MRI centres provides a millimeter resolution. A
more powerful magnetic sources such as 5-8 T improve the resolution of MRI
for smaller samples by increasing the signal to noise ratio [35], as an example
using a 8 T MRI enable imaging with resolution of less than 100 µm from brain
tissue in vitro [36]. Other factors determining spatial and contrast resolution
of MRI include imaging sequence and signal sampling rate [22]. In addition to
having a high resolution, MRI has a deep tissue penetration depth, no exposure
5
to radiation, possibility of whole body imaging and excellent soft-tissue con-
trast. One of the most important drawbacks of MRI, especially for molecular
imaging application, is its low sensitivity. The detection limit of gadolinium
in MRI is 10−5 moles/L, while detection limit is 10−11 for PET/SPECT and
10−8 in optical imaging [37]. This low sensitivity also leads to slow data ac-
quisition (approximately an hour for a good quality image). New technologies
like chemical exchange saturation transfer (CEST) and paramagnetic chemical
exchange saturation transfer (PARA-CEST) are expected to enhance the sen-
sitivity of MRI [38, 39]. Another important drawback of MRI for molecular
imaging is the cost and availability of MRI systems. Magnetic nanoparticles
have the potential for playing a critical role in addressing these drawbacks for
magnetic modality in molecular imaging as discussed in Section 1.4 of this thesis.
Historically, a major turning point in medical imaging has been the invention
of X-ray and its usage in computed tomography (CT) scan for clinical diagnosis
applications. Unlike X-ray imaging, in CT scan the source rotates around the
sample to provide a 3 dimensional (3D) replication of the sample. Advantages
of CT scan includes high spatial resolution (1-2 mm) [40], high penetration
depth, possibility for whole body imaging, fast data acquisition and high qual-
ity anatomical data. Disadvantages of CT scans are exposure to high level of
X-ray radiation, low sensitivity, poor soft tissue contrast and resolution and
being moderately expensive. Due to the presence of these disadvantages and
lack of proper imaging probes, application of CT in molecular imaging is very
limited at the moment. The effective resolution of an X-ray image is limited by
the hardware, object size and object geometry and can be improved by using
6
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flat panel detectors and gold nanoparticles as contrast agents [41].
Two other modalities, which can be named as the safest amongst other
modalities, are optical and ultrasound (US). Optical modality will be described
in the next section. Ultrasound is one of the safest methods in medical imaging
as it uses propagation of low intensity ultrasonic waves. Advantages of US imag-
ing include high spatial resolution, low cost, non-ionizing radiation, real-time
imaging and high sensitivity. However, for ultrasound, whole body scans are
not possible and the quality of the imaging is highly dependent on the experi-
ence of the operator. The resolution of ultrasound imaging is dependent on the
frequency (usually 5-15 MHz) [42]. Nanoparticles have not been able to play
an important role for improving performance for this modality, since for detect-
ing particles with the size in the range of less than 1000 nm, frequency of the
ultrasound wave must increase to more than 30 MHz with a tissue penetration
depth of a few millimeters [22]. The application of US for molecular imaging
is just limited to detecting intravascular targets by using microbubbles, usually
more than 5 µm in diameter, as the imaging contrast.
1.3 Optical Modality
It is possible to argue that the first experience of molecular imaging was per-
formed in the field of histology and pathology by using simple haematoxylin
and eosin (H&E) staining in light microscopy, which has revolutionized medical
pathology and is still one of the main methods used. H&E enables detection of
8
molecules inside tissue cultures according to their affinity to these two dyes. The
capabilities in optical microscopy have improved radically by novel approaches
in biotechnology and optical instrumentation such as indirect labelling using
antibodies, availability of monoclonal antibodies, antibody fragments, enzyme
tracers, confocal scanning laser microscopy and two-photon microscopy. These
techniques combined with new advances in optical nanoparticles revive the role
of optical modality for in vitro and in vivo imaging. An example for this re-
vival is the possibility to view specific targets in living cells at high spatial and
temporal resolution (sub-micrometer, microseconds) and to track them for days
without any significant damage to the cells [22].
Optical imaging is a versatile, non-invasive imaging method, where quanti-
tative contrast can be generated through modulation of intensity, wavelength,
polarization, coherence, interferences, lifetime and nonlinear effects. Advantages
of optical modality include: (1) non-ionizing radiation, (2) fast data acquisition
(minutes), (3) possibility of real-time imaging, (4) relatively high spatial resolu-
tion, (5) miniaturization for internal use on endoscopes, (6) highly quantitative
and sensitive (as low as 10−8 moles/L) and (7) possibility of multimodality by
simultaneous optical and for example MRI. In spite of all these advantages, op-
tical imaging suffers from some draw backs such as limited penetration depth
(1 cm), difficulty in performing whole-body scans, and low signal-to-noise ratio
by virtue of autofluorescence. In addition, optical microscopy has; drawbacks
including short focal lengths that narrows the application to samples smaller
than a few millimetres and toxicity of most conventional dyes and agents that
do pass the required pharmacokinetics for in vivo imaging [23].
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1.3.1 Fundamentals of the Interactions of Light with Cells
and Tissues
Biological samples and tissues contain a mixture of different biomolecules and
cells with size ranging from submicron to over 20 µm. While the fundamentals
for interaction of light with biological samples are similar to those with other
bulk material, some critical differences are present that we will explain in this
section. In general, as conceptually illustrated in Figure 1.2, an incident light
beam undergoes four phenomena when travelling through material interfaces
including reflection, refraction, scattering and absorption. As shown, Snell’s
law governs the refraction by
n sin θ = n′ sin θ′, (1.1)
where n and n′ denote refractive indices for the two mediums, describing the
change in the speed of light travelling through the medium c = c0/n, where
c0 is the speed of light in vacuum. The refractive index of individual tissue
constituents varies from 1.33 for water to 1.55 for fat and concentrated protein
solutions [43], resulting in an overall refractive index of around 1.4 typically
used for biological tissues [44].
Reflection is mainly defined by three factors including refractive index of
the medium of interest, polarization of light and the angle of incidence. In
bioimaging applications, as the excitation sources are often collimated non-
polarized lasers, the effect of polarization is limited. The effect of angle of
10
Figure 1.2: Propagation of light from one medium with refractive index n to
another one with refractive index of n′ (n < n′).
incidence on reflection is linear and the greater the angle of incidence the larger
the reflection from the surface. Therefore, maximum light penetration achieved
when the light beam is perpendicular to the tissue. In propagation from air
(n ≈ 1) to a tissue with a refractive index of n′, the reflectance R, defined as
the intensity of reflected to the incident light, is given by
R =
(
n′ − 1
n′ + 1
)2
. (1.2)
The absorption and scattering phenomena are discussed in more details in the
following.
Absorption Absorption is the transfer of energy from the incident radiation
to the propagation medium. If a collimated beam of light of intensity I0 and
wavelength of λ propagates through a non-scattering medium with width x,
intensity of the emerging light is given by
I = I0e
−µa(λ)x, (1.3)
11
where µa(λ) is the absorption coefficient of the medium. The absorption coef-
ficient is the number of absorption events happened per unit of length of the
medium and its reciprocal is the distance in which the intensity falls to 1/e of
the original intensity. It is also possible to say that for an absorbing material
dissolved in a non-absorbing medium the absorption coefficient is proportional
to the concentration c of the solution or
µa = αc, (1.4)
where α is a constant known as specific absorption coefficient that defines the
amount of absorption by a unit absorption concentration per unit length of
beam penetration.
In a biological sample absorption occurs in a number of different individ-
ual chromophores with different absorption coefficients. In this case, the total
absorption coefficient B(λ) is expressed as the sum of the multiplication of con-
centration of each chromophore cn with its specific absorption coefficient αn
or
B(λ) =
∑
n
αn(λ)cn. (1.5)
Absorption in tissues can cause many photophysical and photochemical pro-
cesses which could be classified to two major groups; radiative and nonradia-
tive processes. An important example of radiative process is autofluorescence
that will be described in Section 1.3.3 of this thesis. Examples of nonradia-
tive processes include: (i) thermal effects such as protein denaturation and
water vaporization, (ii) photochemical processes like photorearrangement and
12
photoaddition, and (iii) photoablation that means direct breaking of cellular
structures usually caused by high energy UV radiation [7].
Scattering As illustrated in Figure 1.2, scattering is the optical phenomenon
that changes the direction of radiation within a medium described by a scatter-
ing coefficient µs. In the case of collimated beam scattering coefficient is given
by
I = I0e
−µsx, (1.6)
where I is the intensity of the non-scattered light after passing thorough a non-
absorbing medium with the width of x. The main difference between absorption
and scattering is that scattering leads to propagation of photons in different
directions. Thus, if the medium is absorbing, the increased travelling distance
of photons caused by scattering must be included through a differential path
length factor DPFx. In general DPF is a function of the scattering coefficient
µs, the anisotropy of the scattering medium, the absorption of the medium and
the geometry of the medium. Therefore, the attenuation of the scattered light
can be described using the modified version of absorption equation as
I = I0e
−µa(λ)DPFx+G, (1.7)
where G represents losses due to the geometry of the medium.
The anisotropy of the scattered beam is defined by anisotropy factor g
which is the mean cosine of the scattering angle θ′′ (shown in Figure 1.2). The
anisotropy factor is given by
13
g =
∫
4pi
d(cos θ′′) cos θ′′dθ′′, (1.8)
and depends on morphology, size and refractive index mismatches of the scat-
tering centers. Depending on the medium, if g = 0 then scattering is isotropic,
if g = 1 the scattering is completely forward and if g = −1 the light is back
scattered. The isotropy factor in biological samples varies between 0.69 and
0.99 [45] and therefore it is mainly in a forward scattering mechanism. By con-
sidering the effect of isotropy on scattering, the reduced scattering coefficient
µ′s is given by
µ′s = µs(1− g), (1.9)
where the reciprocal of µ′s is the distance that a collimated light has a 1/e prob-
ability of an isotropic scattering event.
The most important kind of scattering in bioimaging is referred to as elastic
scattering, which describes a scattering where the incident and scattered photons
are of the same frequency. There are two different kind of elastic scattering
including Rayleigh scattering and Mie scattering. Rayleigh scattering is caused
by particles smaller than the wavelength of light and depends on wavelength of
light with the factor of λ−4, and therefore is significantly higher for blue than
for near infrared. Mie scattering happen with particles of size comparable to
the wavelength of light, it is less wavelength dependent (λ−x with 0.4≤ x≤ 0.5)
[7].
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1.3.2 Optical Properties of Bulk Tissues
All the optical properties discussed in previous sections have been discussed
with the assumption that a medium is, for example, only absorbing light, while
in reality the optical property of a tissue is a mixture of different phenomena
interacting with light. Therefore, the total intensity attenuation in a tissue
sample is given by:
Iz = I0e
−(µa+µ′s)z, (1.10)
where z is the measurement depth in the tissue. An important term arising
from this equation is the optical penetration depth δ, defined as the distance
that light can travel in a tissue by which the intensity of light drops to a fraction
1/e(∼ 0.37) of the original intensity of the beam. Equation (1.10) shows that
the penetration depth δ is equal to 1µa+µ′s
. Therefore the optical penetration
depth is mainly dependent on the type of tissue, concentration of cellular con-
stituents, vascularity of the tissue, and wavelength of the incident light.
Measured optical properties of different tissue samples published in litera-
ture are summarized in Table [45, 46, 47, 48, 49, 50]. The measured values of
absorption and scattering coefficient is an average value in a constant condition,
while in reality tissues are alive and dynamic materials and therefore the optical
properties are changing by conditions such as the amount of blood pumping into
the tissue, the oxygenation of the blood and the presence of tissue chromophores
and fluorophores. Note that the refractive index for all the tissues is assumed
to be between water and lipid (n≈ 1.4).
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Water is one of the most abundant constituents of tissues, therefore signif-
icantly contributing to their optical properties. Although water absorbs light
in infra red region (> 1.3µ m), but as illustrated in Figure 1.3, the absorption
coefficient of water over the wavelength range of 660 to 920 changes from 0.0005
to 0.008 mm−1, and it is 0.0022 mm−1 at 800 nm. Note that the water con-
centration of tissues usually remains unchanged, and therefore, water can be
treated as a constant absorber [51].
Figure 1.3: Absorption spectrum of water in red and near infrared region .
The most abundant chemical species in cells and tissues are proteins mainly
built from amino acids. Amino acids have strong absorption in ultra violet
(UV) region of the spectrum but proteins have absorption in other spectral re-
gion as well owing to their structural bondings . Proteins may also contain a
chromophore, which provide a strong absorption, an important example being
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hemoglobin. Hemoglobin is located in red blood cells (RBC) and is responsi-
ble for delivery of oxygen through our body. Deoxy-hemoglobin attaches to an
oxygen molecule in our lung to become oxy-hemoglobin and therefore the ratio
of this oxy-hemoglobin to total hemoglobin is a measure of blood oxygenation.
Figure 1.4 depicts the absorption spectra of oxy- and deoxy-hemoglobin in red
and near infrared (NIR) region. Although hemoglobin has absorption peaks
around 280 nm, 420 nm, 540 nm and 580 nm the absorption coefficient of both
oxy- and deoxy- hemoglobin decreases dramatically in red and NIR region [2].
The absorption spectra of melanin, skin pigment, covers almost all the visible
region but decreases dramatically as wavelength increases.
Figure 1.4: The absorption spectra of oxy- and deoxy-hemoglobin in red and
NIR region [2].
17
1.3.3 Autofluorescence and Effect of Near Infrared Spec-
trum
One of the possible outcomes of light absorption in tissues is the occurrence of
photochemical processes. Several cellular constituents fluoresce when excited
by light or by transfer of chemical energy from other constituents in their prox-
imity. Figure 1.5 illustrates the absorption and emission spectra of important
endogenous fluorophores responsible for autofluorescence observed from typical
tissue samples.
Figure 1.5: The absorption (a) and emission (b) spectra of important tissue
fluorophores responsible for autofluorescence in aqueous solution. [3]
Although clinical fluorescence microscopes employ autofluorescence, this phe-
nomena is detrimental to the signal to noise ratio (SNR), quality and resolution
of optical molecular imaging. As depicted in Figure 1.5, the absorption spectra
of important fluorophores are in the wavelength range of less than 500 nm and
their emission spectra are located in blue to green region. The typical autofluo-
rescence emission and absorption spectra signifies the underlying interest in low
energy red or NIR spectra for optical imaging in view of minimum autofluores-
cence intensity, leading to increased SNR and image quality [52].
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1.3.4 Near Infrared Optical Imaging
Figure 1.6: NIR biological window (650-900 nm) provides the maximum pene-
tration depth in tissues for optical imaging [4] .
Despite all the advantages mentioned, the major drawbacks of optical molec-
ular imaging are limited penetration depth due to absorption and scattering of
excitation signal, tissue autofluorescence that suppresses SNR and image qual-
ity, and cellular phototoxicity and photodamage in exposure to ultraviolet (UV)
or other high energy excitation sources. Light absorbance, scattering and aut-
ofluorescence is substantially dependent on excitation wavelength. The UV and
visible (Vis) spectra are strongly absorbed by the most relevant tissue chro-
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mophores (e.g., oxy- and deoxy-haemoglobin, myoglobins, lipids and melanin),
reducing the penetration depth to only a few micrometers. In contrast, red and
near infrared (NIR) spectra (650-1000 nm) have the minimum absorption and
scattering in tissues, as shown in Figure 1.6, to be referred to as NIR biological
window [4]. Theoretically, NIR radiation can go as deep as several centimeters
depending on the type of tissue. For example, ≈ 10 cm in breast tissue and
4 cm for skull/brain and muscles [53]. The use of optical nanoparticles such
as dye-doped nanoparticles, QDs and upconversion nanoparticles promise un-
paralleled improvements in NIR for optical imaging, which will be described in
more detail in Section 1.5.
1.4 Magnetic Modality
One of the most important and clinically used modalities for molecular imaging
is magnetic modality including magnetic resonance imaging (MRI) and mag-
netic resonance spectroscopy (MRS). Basically, MRI systems construct an im-
age from relaxation response of living subjects to a strong static magnetic field.
This modality provides high spatial resolution (< 1 mm), high tissue penetra-
tion depth, no exposure to ionizing radiation, possibility of whole body imaging
and excellent soft-tissue contrast [20, 21, 22]. Disadvantages of this modality
include low sensitivity, slow data acquisition and infrastructure costs. The prac-
tical usage and performance of magnetic modalities can be enhanced by using
conventional and novel contrasts and magnetic nanoparticles. In the following,
we present fundamentals of magnetism and MRI, followed by the magnetic prop-
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erties of bulk tissues and the methods that we used in this work for magnetic
characterization of nanoparticles.
1.4.1 Fundamentals of Magnetic Materials
Magnetic properties of materials arises from superposition of the magnetic mo-
ment ~µm of all electrons in the material. This moment comprises of both the
orbital magnetic moment ~µorb that is proportional to angular momentum of the
electron ~L and the spin magnetic moment ~µspin. The magnetic moment for
complete atomic shells reduces to zero as orbital and spin moments of opposite
signs cancel each other [54]. However, for some magnetic materials the unpaired
spins and orbital moments lead to a macroscale magnetic moment that can be
measured. The atomic magnetic moments of a magnetic material can align in
the direction of an external magnetic field, generating a magnetization vector
and additional magnetic field according to
B = µ0(H +M), (1.11)
where µ0 is the magnetic permeability of free space, H the strength of the
external magnetic field and the magnetization vector M is the average total
magnetic moment per unit volume. The relative magnetic permeability of the
material µr is then defined as
µr =
B
µ0H
, (1.12)
and the magnetic susceptibility as
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χ =
M
H
. (1.13)
Depending on magnetic susceptibility χ and response to an external mag-
netic field, materials are classified as diamagnetic, paramagnetic, ferromagnetic
and superparamagnetic materials, as schemactically illustrated in Figure 1.7
[5, 55, 56]. Diamagnetic materials (e.g., Si, Ge, Cu, Au, Ag, water, organic
materials and polymers) have a small, negative and temperature-independent
susceptibility (-10−6), due to the non-cooperative behaviour of orbiting elec-
trons exposed to an external magnetic field. Paramagnetic materials (e.g., O2,
Li, Mg and Mo) show a partial alignment of the magnetic moments of unpaired
electrons in the direction of the external field, resulting in a small positive
magnetization and susceptibility (10−5). The efficiency of the external field in
aligning the magnetic moments reduces by the randomizing effects of increasing
temperature, leading to a susceptibility that is inversely proportional to tem-
perature according to Curie’s law χ ∝ 1/T . Ferromagnetic materials (e.g., Fe,
Co and Ni) have large susceptibility and maintain a large magnetization in the
absence of the external field. The atomic moments exhibit strong interactions
due to electronic exchange forces, resulting in parallel or antiparallel alignment
of the moments in uniformly magnetized domains. The relationship between M
and H is highly non-linear and magnetization saturates to Msat at high field.
The magnetization vanishes for temperatures above a Curie temperature (Tc).
1.4.2 Fundamentals of Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a powerful noninvasive diagnostic tool for
visualizing soft tissues. A biological tissue is placed in a large magnetic field B0
22
MH
Diamagnetic
M
H
M
H
M
H
Paramagnetic
Ferromagnetic Superparamagnetic
Figure 1.7: Magnetic responses (M-H curves) associated with different classes
of magnetic materials: diamagnetic, paramagnetic, ferromagnetic and super-
paramagnetic materials. Dashed lines illustrates the hysteresis of ferromagnetic
materials [5].
23
to align the spin of protons of molecules in biological tissues or body [57, 24].
As shown in Figure 1.8, a pulsed radio frequency (RF) electromagnetic wave
in a plane perpendicular to B0 is used to flip the proton magnetization, which
relaxes back to its original direction with a Larmor precession frequency (ω0)
given by
ω0 = γB0. (1.14)
Here, γ is the gyromagnetic ratio of protons and is equal to 2.67×108 rad s−1T−1,
yielding a Larmor precession frequency of ω02pi = 42.57 MHz at B0 = 1 T. A RF
signal is emitted during relaxation that is detected by the MRI scanner to con-
struct an image [5, 6].
As illustrated in Figure 1.8 for the static magnetic field in z direction, the
magnitude of Mz and Mxy are given by
Mz = M(1− e
−t
τ1 ) (1.15)
and
Mxy = m sin(ω0t)e
−t
τ2 , (1.16)
respectively, where τ1 is the longitudinal (spin-lattice) relaxation time and τ2
the transverse (spin-spin) relaxation time. The time constant τ1 is related to
the energy loss from the magnetic moment to its surrounding lattice and is
related to the coupling of the proton moments to the surrounding materials.
The transverse relaxation time τ2 is relatively fast and is driven by the loss of
phase coherence in the precessing protons due to their magnetic interactions
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Figure 1.8: (A) Magnetization vectors of a sample with original moment M in
the presence of a static external magnetic field B0 and resonant magnetic field
pulse B1, perpendicular to B0. (B) When the oscillating field B1 is removed
at time 0, the in-plane magnetization Mxy rotates around z with a decreasing
amplitude while (C) Mz gradually reaches its maximum (redrawn using [5, 6])
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with each other and other fluctuating moments in the tissue. Dephasing can
also be affected by local inhomogeneities and causing the replacement of τ2 with
a shorter relaxation time τ∗2 , given by
1
τ∗2
=
1
τ2
+ γ
∆B0
2
, (1.17)
where ∆B0 is the variation in the field caused by distortions in the homogeneity
of the applied field or by local variations in the magnetic susceptibility of the
system [58].
Magnetic contrast agents are used to shorten the relaxation times of the se-
lected tissue, increasing the contrast of the surrounding tissues. These contrast
agents are classified as T1 and T2 agents employed for enhancing the contrast
for longitudinal and transverse relaxation processes, respectively. The strength
of the contrast agents is usually measured as the relaxivity Ri = 1/τi at 20
◦C
and i = 1 and 2 for longitudinal and transverse processes, respectively. The
T2 agents are mainly iron oxide nanoparticles which exhibit superparamagnetic
with magnetic susceptibility many times higher than paramagnetic nanoparti-
cles. Paramagnetic T2 agents are also available but less effective. Because the
T2 agents decrease the magnitude of the signal in order to produce contrast
they are famous as negative contrast agents that require a small r2 for being
effective. The negative nature of T2 agents causes confusion between pathologic
dark areas like bleeding or metal deposits with normal dark areas like air in
the lung. Another drawback of T2 agents is their high susceptibility causing
distortion in the image from the surrounding tissues, what is referred to as the
booming effect [59].
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T1 contrast agents are usually paramagnetic metal ions based on gadolinium
(Gd), dysprosium or manganese [60]. The magnetization strength of the agents
is dependent on the number of metal ions. An advantage of T1 agents over
T2 agents is that they produce bright signal in MRI images and therefore are
better to distinguish small changes in contrast. Magnetic nanoparticles will be
discussed in more detail in Section 1.5.3.
1.4.3 Magnetic Properties of Bulk Tissues
As mentioned in the previous section, there are two type of relaxation mech-
anisms T1 and T2 enabling a MRI system to produce signal. T2 relaxation
depends on how fast protons in a specific tissue lose their phase coherence, and
consequently, this relaxation mechanism is highly dependent on the density of
protons. A higher proton density means a faster relaxation. T1 relaxation de-
pends on the efficiency of energy transfer to the tissue, and this efficiency is
related to the vibrational frequencies and the physical composition of a specific
tissues [24]. Different tissues in the body have different compositions, and as a
result, different magnetic behaviour.
Due to the dependence on the density of protons for T2 relaxation, fluids
with low density of protons provide less dephasing and a long T2 relaxation,
whereas solid tissues have the highest density of protons and therefore produce
a short T2 signal. In the case of fat and protein rich tissues, the dephasing is at
a medium level, thus providing an intermediate T2 signal. The T1 relaxation is
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related to the efficiency of energy transfer and vibrational states of the protons.
Fluids vibrates at higher frequency therefore the energy transfer is inefficient,
resulting in a very long T1 relaxation. For fat and protein rich tissues, the
rotational frequency around the C–C bonds is near the Lamor frequency, and
consequently, energy transfer is efficient, producing a short T1 relaxation signal.
The approximate lifetime values of T1 and T2 relaxation mechanisms for some
human tissues are summarized in Table 1.2 [24].
Table 1.2: The approximate lifetime values of T1 and T2 relaxations for some
human tissues, under an external magnetic field of 1.5 T [24].
Tissue type τ2 (ms) τ1 (ms)
Adipose tissues 60–80 240–250
Whole blood (oxy-
genated)
200 1350
Cerebrospinal fluid 500–1400 2200–2400
Grey matter 100 920
White matter 90 780
Liver 40 490
Kidney 60–75 650
Muscle 50 860–900
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1.5 Nanoparticles for Molecular Imaging
1.5.1 Role of Nanoparticles in Bioimaging
As mentioned before, the requirements of an efficient and practical molecular
imaging system can be summarized as suitable modality for the imaging ap-
plication, availability of agents for targeted detection and finally availability
of targets that can facilitate better, faster and non-invasive detection of an
illness or a physio-pathological processes. Conventionally, some dyes and con-
trasts agents have been used to enhance the clarity of different imaging modal-
ities. This includes barium for X-ray imaging or 99mTc for nuclear imaging.
Nanoparticles can bring revolutionary effects as materials in nanoscale behave
differently than the bulk. The first specific feature of nanoparticles is their high
surface to volume ratio, resulting in greater functionality sites on the surface
for the same amount of material. Second, different functional substitution for
enhancing contrast and/or targeting specific molecules can be added to a single
nanoparticle for multi-target, multi-purpose and multimodal imaging. Finally,
in the area of bioimaging small nanoparticles are less hindered by biological
barriers [20, 21, 22]. Nanoparticles also suffer from some important drawbacks
such as interaction with plasma proteins, being digested by phagocytic agents
or reticuloendothelial systems, and acute or chronic toxicity.
The design criteria for practical nanoparticles that can be used in molecular
imaging are manyfold:
First, multifunctional particles in the range of 30 to 150 nm are preferred
[22], since smaller particles are filtered rapidly through kidney and larger parti-
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cles will be trapped in reticuloendothelial system (RE) including lymph nodes,
liver and spleen. Particles in this range can remain in body circulation for long
enough time in order to get accumulated in the place of interest for improved
signal to noise ratio. Larger size particles not only decrease the possibility for
targeted imaging by getting trapped in the RE system, but also intervene in
kinetics of these organs and cause serious toxicology issues. Note that surface
modification chemicals such as polyethylene glycol (PEG) or silica can prevent
or decrease the possibility of trapping in RE, and therefore, particles smaller
than 30 nm can be potentially used with surfactants, but unfortunately this
method has little effect on liver accumulation and toxicity of particles [61].
The second criterion in designing a nanoparticle for molecular imaging is the
concentration of agents required for generation of a measurable signal. This fea-
ture is completely dependent on the modality and sensitivity of imaging method
used. For example, usually one or two radionuclide molecules per particle are
enough for a measurable contrast in PET. Also each quantum dot (QD) con-
tains one exciton, while for fluorochromes doped particles; a single particle may
need up to 100 dye molecules [22].
Third criterion is the number of targeting groups that can be attached to
a single particle. This feature is important for targeting efficiency of the par-
ticle and is related to the type of target and ligands as well. One of the most
important ligands and targets with clinical application in molecular imaging is
antibody-antigen complexes. To increase the detection efficacy of a nanoparti-
cle, it must be attached to many antibodies that can bond to antigens. For an
30
efficient targeting, a 50 nm nanoparticle is tagged by at least 10 antibodies [22].
Mechanical properties of nanoparticles are the fourth important criterion.
Nanoparticles used in molecular imaging will be exposed to different biological
conditions, and as such they should be structurally and chemically stable and
not get affected by the environment. While this stability is required for the
particle to tolerate flow turbulence in blood streams, a highly stable particle
cannot be removed from the body unless by phagocytes, which means exceed-
ing toxicity level. Therefore, the ideal nanoparticle for in vivo imaging is the
one that is stable enough to remain in blood stream to reach the target and
provide signal for detection, and then disintegrates and excretes through kidney
[22].
Another important factor is the biocompatibility of the surface of a nanopar-
ticle. Almost all nanoparticles need to have surface modification after synthesis
because body considers them as foreign entities and tries to get rid of them.
The larger the particle the more likely it will be trapped in the body so they
should be covered by some inert material such as silica or polyethyleneglycol
(PEG) to be “stealth” in the body [62, 63] . Surface modification also helps to
reduce nanoparticles toxicity and improve their stability.
Several nanoparticles with different matrix materials have been used for dif-
ferent molecular imaging modalities as summarized in the following. Schematic
of some of the available nanoparticles are presented in Figure 1.1:
1. Liposomes are self-organized nanoparticles that consist of amphiphilic
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compounds which can encapsulate dyes and medical materials [64]. A
successful example of clinical applications of nanoparticles for drug deliv-
ery is the liposomal daeunorubicin that has been approved by FDA for
treatment of Kaposi sarcoma [65].
2. Metal oxide nanoparticles are used in molecular imaging as imaging agents
for MRI, but optical metal oxide particles are now being researched for
optical modality. superparamagnetic iron oxide (SPIO) [66] and Y2O3
upconversion nanoparticles [67] are examples of MRI and optical modality
agents, respectively. Since metal oxides do not have surface functionalities,
they have to be coated with functional molecules to be of use in drug
delivery applications.
3. Dendrimers are made from small building blocks for engineering nanoparti-
cles with a high control over their size, composition, shape, weight, branch-
ing length and density using lego and click chemistry. Their controlled size
and composition lead to designable biocompatibility and pharmacokinetics
[68].
4. Polymer particles have been used for conjugation of drugs and imaging
dyes, for example poly-L-glutamic acid-paclitaxel conjugates (XyotaxTM )
or cyclodextrin-camptothecin conjugate (IT-101) [69].
5. Proteins can be used as the matrix material of nanoparticles. Famous
examples of this kind of nanoparticles are albumin and gelatine nanopar-
ticles or other types of proteins which are generally referred to as “protein
cages”, which have been used for drug delivery [70].
6. Metal nanoparticles such as gold [71] and silver nanoparticles [72] have
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applications in optical imaging, while bismuth nanoparticles [73] have been
used in CT molecular imaging.
7. Viruses can be used as a scaffold for imaging agents and drug delivery
[74].
8. Carbon-based nanoparticles such as carbon nanotubes (CNT) have been
investigated for imaging and drug conjugation, but there are some impor-
tant toxicity issues for CNTs [75].
Other optical and magnetic particles will be described in the next two sec-
tions in more details.
It is important to note that the process of getting approval for using a
nanoparticle in clinical application is laborious, costly and difficult like any
other pharmaceutical product. The process consists of several steps including:
(i) Identify and validate a molecular target to be targeted by the nanoparti-
cle by using microarrays, immunostaining, blotting, genomics and proteomics.
(ii) Binding compound should be identified and tested while attached to the
particle by using in vitro experiments. (iii) Third step is the preclinical and op-
timization step where specificity, stability, off-target effects, bio-distribution and
pharmacokinetics of targeted nanoparticles is tested by in vivo animal tests. (iv)
Clinical development step, in which toxicity tests, clinical examination phase I,
II and III is performed to approve the elements checked in step 3 this time in
human. (v) FDA approval and after that finally nanoparticle can be used in
clinical applications [20].
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1.5.2 Optical Nanoparticles
There are two different types of optical imaging agents used in optical molecu-
lar imaging, namely, endogenous and exogenous contrasts. Endogenous agents
work on the basis of an enzyme-mediated process in cells and tissues to emit
the optical signal for detection. There are two important examples for endoge-
nous probes: luciferin/luciferase bioluminescence systems [76] and fluorescent
proteins such as green fluorescent protein (GFP) [77]. Important drawbacks
of fluorescent proteins are the need for genetical modification of targeted cells
and low emission wavelength (510 nm) overlapping the autoflourescent signal
of surrounding tissues. Luciferin/luciferase systems also suffer from positional
uncertainty due to inhomogeneous scattering, limited light penetration, depen-
dence on environmental parameters such as pH and temperature and the ap-
parent need for a stable expression of luciferase [23]. Other types of optical
imaging agents are exogenous contrasts such as organic fluorophores, quantum
dots (QDs) and upconversion particles, which are inserted in to the bio-system
from outside.
Conventional organic fluorescent dyes are one of the most important optical
agents with applications in clinical, paraclinical and research. Some examples of
organic fluorophores are fluorescein iso thiocyanate (FITC), carboxyfluorescein
diactatesuccinidyl ester (CFSE) and IRG-023 Cy5 [78]. These kind of optical
imaging dyes suffer from disadvantages such as rapid photo-bleaching, chemi-
cal instability and biodegradation in biological environment due to their typical
sensitivity to pH and interacting local ions. As such, these agents are not suit-
able for long term cell tracking and time-resolved detection (TRD) methods.
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These agents are usually not soluble in aqueous solutions, leading to poor in-
teractions with biomaterials and their toxicity. Conventional dyes are mainly
excited by UV-Vis light spectrum that has limited penetration depth, have low
signal to noise ratio due to auto-fluorescence, and cause photodamage to the
cells. Organic dyes are not suitable for simultaneous multicolour imaging, as
their emission are mostly overlapped with each other or overlapped with aut-
oflourescent produced by nicotinamide, flavins, collagen and elastin as shown in
Figure 1.5 (Page 18). Although the problem of autofluorescence can be curtailed
by using NIR emitting dyes such as cyanine particles, but these dyes suffer from
low quantum yield (low brightness) and poor photostability [23, 78, 79, 80]. As
a result, conventional dyes are far from an ideal candidate for optical imaging,
with attributes such as high signal to noise ratio, good photochemical stability,
absence of interfering compounds, low toxicity, rapid signal generation, high
quantum yield, high absorbance, low cost synthesis, excitation and emission in
NIR region and adequate dispersibility in a biological environment. Table 1.3
summarizes the effort for curtailing the disadvantages of conventional optical
nanoparticles including organic dye-doped nanoparticles, QDs and upconver-
sion nanoparticles [81, 25].
Organic-doped nanoparticles are one of the novel solutions to overcome prob-
lems of conventional dyes. These kind of nanoparticles usually made from silica
and sometimes from other polymers such as poly (D, L-lactic-co-glycolic acid)
(PLGA) [82]. The size of these particles is in the range of 2 to 200 nm. They
have advantages such as increased in vitro and in vivo stability, acceptable
chemical stability, low possibility of photobleaching as dyes are protected by
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Table 1.3: Comparison of novel optical nanoparticles and conventional organic
dyes [25].
Parameters Conventional
organic dyes
Organic
dye-doped
nanoparti-
cles
QDs Upconversion
nanoparti-
cles
Size - 50-500 nm 2-10 nm 50-200 nm
Autofluorescence High High High Low
Light penetra-
tion depth
Low Medium/high Medium/high High
Photodamage Medium Medium/low Medium/low Low
Photostability Low Low/medium High High
Excitation
wavelength
UV/Vis/NIR UV/Vis/NIR UV/Vis/NIR NIR
Cytotoxicity Medium Medium High Low
Synthesis cost Medium Low/medium High Low
Multicolour as-
says
NA NA Good Good
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a silica layer, increased hydrophilic properties, bright emission as each particle
include large number of dyes and diversity of silica chemistry for synthesis and
bioconjugation. The disadvantage of this kind of particles is that encapsulation
can alter fluorescent emission of the dyes [23, 25].
As another novel optical nanoparticle, quantum dots (QDs) are important
candidates for in vitro optical molecular imaging. QDs are semiconductor crys-
tals with dimensions in the range of 1 to 10 nm and luminescence properties
due to quantum confinement effects. The emission is size dependent and typi-
cally in a narrow band with 30 to 40 nm full width half maximum (FWHM),
whereas the absorption spectrum is broad from UV to NIR [25, 83]. Two main
categories of QDs are II-VI particles such as CdS, CdSe and CdTe and III-V
QDs such as GaAs, InP and InAs [23]. III-V QDs are toxic but generally less
toxic and more biocompatible than II-VI QDs, but III-V particles are difficult
to synthesise and also suffer from much lower quantum efficiency than II-VI
counterparts. In comparison to conventional organic dyes, the emission band of
QDs can be tuned over a wide range by changing the size and composition of
the particles. Examples include UV-blue emission from ZnS QDs, visible emis-
sion from CdE (E=S, Se or Te) and NIR emission from CdS/HgS/CdS, InP
and InAs QDs. In addition, QDs have a broad excitation and narrow emission
spectra. This is particularly attractive for multicolour imaging using a sin-
gle excitation source, where overlapping of emission wavelength is not desired.
QDs are resistant to photobleaching, but prone to blinking when used with-
out surface modification. Consequently, to improve photostability and reduce
toxicity of QDs, they are often covered with a surface shell, made from ZnS,
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ZnSe or GaAs. The shell can also improve water-dispersibility and resistance to
metabolic degradation. Examples of materials used for the surface include mer-
captoacetic acid, phosopholipid micelles, silica and amine modified poly(acrylic
acid). These surface modifications significantly suppress toxicity, as proven by
experiments where the cells loaded with these QDs remain alive for more than
12 days [84]. An important advantage of QDs is their large extinction coefficient
(0.5− 5× 10−6 M−1cm−1) which means that they are very bright probes [85].
QDs also have long fluorescent lifetime on the order of 20 to 50 ns, which allows
them to be distinguished from background noise for increasing imaging quality.
Finally, QDs have a high quantum yield (up to 85%) which is not affected by
protein conjugation [23].
Although QDs provide many advantages and novel NIR-emitting QDs open
a new platform for in vivo molecular imaging [86, 87], they suffer from some
important issues including toxicity and dependence on high energy excitation
sources that decreases the signal to noise ratio (SNR) due to tissue autofluores-
cence. Considering these problems upconversion nanoparticles have attracted
attention as the next generation of optical molecular imaging probes.
1.5.3 Magnetic Nanoparticles
Iron oxide nanoparticles are the first and most commonly used magnetic nanopar-
ticles used as MRI contrast. Some of the main advantages of iron oxide particles
for bio-applications include chemical stability, lack of toxicity and biodegrad-
ability. It is also important to mention that iron oxide nanoparticles have been
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through regulatory processes and could be used legally and safely in human.
Basically, iron oxide particles are superparamagnetic and classified as a T2-
relaxivity-based dark or negative contrast agents. To increase the applicability
of iron oxide particles they usually need to be covered and functionalized to
make them more biodegradable and help these particles to reach their targets
easier. Covering iron oxide particles with dextran or with carbodextran is the
most common way for surface modification of these particles [26]. Another
useful method is the encapsulation of iron nanoparticles in other nanoparti-
cle structures such as liposomes and dendrimeres [88, 89]. Superparamagnetic
iron oxide (SPIO) particles for biomedical applications exist in many forms de-
fined mostly by their hydrodynamic diameter, for example, Oral-SPIO (300 nm
– 3.5 µm), Standard-SPIO (SSPIO, 60 – 150 nm), Ultrasmall-SPIO (USPIO,
5 – 40 nm), a subset of USPIO called monocrystalline iron oxide nanoparti-
cles (MION) and MIONs with a chemically crosslinked polysachharide shell are
termed cross linked iron oxide (CLIO) [27, 28].
Another important type of magnetic nanoparticles is cobalt nanoparticle.
Cobalt nanoparticles have much higher room temperature saturation magne-
tization (1422 emu cm−3) as compared to iron oxide (395 emu cm−3), and
therefore, cobalt nanoparticles have larger effect on proton relaxation so even
ultra-small particles can be used as MRI contrast agents without sacrificing
sensitivity [29]. Like iron oxide particles, cobalt nanoparticles are also classified
as a negative contrast as they mainly affect T2 relaxation. Although cobalt is
routinely prescribed for treatment of some illnesses such as refractory anemia,
and there is connection with receiving high amount of cobalt and cardiomyopa-
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thy [90], but still there is no accurate data available on the toxicity of cobalt
nanoparticles and application of these kind of nanoparticles for MRI imaging is
dependent on the toxicology results of these particles [91].
The applicability of iron oxide nanoparticles as MRI contrasts is limited by
their physicochemical properties as the magnetisation of these particles depends
on their size and their surface chemistry. For example, it has been proven that
larger iron-oxide particles exhibit larger T2 effect [92]. To overcome this prob-
lem different spinel ferrite nanoparticles are introduced with high and tunable
magnetisation. The spinel ferrites nanoparticles are MFe2O4, where M is a +2
cation of Mn, Fe, Co or Ni. The MnFe2O4 has the highest magnetic suscep-
tibility and the strongest R2 relaxivity value of 358 mM
−1s−1 [93]. Another
reported mixture is spinel Zn0.34Fe0.66Fe2O3 with a R2 relaxivity value of 294
mM−1s−1. Another way to overcome the above-mentioned problem is the idea
of making core-shell magnetic nanoparticles such as Fe3O4:mSiO2 a superpara-
magnetic particle with a 15 nm core size and 3.4 mM−1s−1 and 245 mM−1s−1
for R1 and R2 relaxivity values, respectively [94].
The other important group of magnetic nanoparticles is the T1 contrast
agents which are usually paramagnetic metal nanoparticles based of Gd, dys-
prosium or manganese [24, 60]. The magnetisation of these nanoparticles are
directly related to the number of metal ions in their structure. In order to
reduce possible toxicity effect of heavy metals such as Gd, conventional T1 con-
trasts are built by attaching Gd ions to a chelate molecule. This problem is
greatly reduced by using novel surface modified nanoparticles. For example,
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novel Gd based nanoparticles is the Gd:C82(OH)22±2 paramagnetic nanoparti-
cles that show T1 relaxivity 10 times more than commercially avaialble contrast
Gd-DTPA [30]. A list of commercial and novel contrast agents with some of
their magnetic properties is presented in Table 1.4.
Table 1.4: Commercial and novel MRI contrast agents and some of their mag-
netic properties. [5, 26, 27, 28, 29, 30]
Name Coating materials Average size
(nm)
R2
(mM−1s−1)
R1
(mM−1s−1)
R2/R1
Feridex Dextran 80 – 150 nm 100 10 10
Resovist Carbodextran 62 151 – –
Combidex Dextran 20 – 40 53 – –
CLIO or MION Dextran 10 – 30 69 – –
Magnevist – – 4.6 4.6 1
Fe3O4 DMSA, PEG 15 218 4.6 47.4
MnFe2O4 DMSA 15 358 1.1 325.5
Gd2O3 D-glucuronic acid 100 10.9 9.9 1.1
Gd:C82(OH)22±2 – 100 – 14.1 –
1.5.4 Toxicology Issue of Nanoparticles Used in Molecular
Imaging
One of the most important issues in clinical applications of nanoparticles used
in molecular imaging is their unknown acute and chronic toxicity. Generally,
nanoparticles can interact with cells in different ways to produce toxic effects.
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Firstly, nanoparticles can produce toxic materials, ions or can generate reactive
oxygen species (ROS) when contacting cells. Secondly, the probability for de-
composition of materials is higher at nanoscale than in bulk. Thirdly, nanopar-
ticles can remain in a cell membrane or go into a cell and impair its functions.
Finally, morphology of nanoparticles can have toxic effects, for example, such
effect has been observed for carbon nanotubes (CNT) [95]. Another example
is CdTe QDs that can have different levels of toxicity dependent on their size.
While spherical particles exhibit limited or no toxicity, rod shape nanoparticles
increase cell proliferation and platelet particles are cytotoxic [96].
Important features of nanoparticles that are critical to toxicity effects are
the chemical core and surface composition of nanoparticles. For example, bare
polystyrene nanoparticles are less toxic than when they are covered with car-
boxylic acid (-COOH) groups [96]. The crystal phase and structure are also
important for toxicity. For example, anatase phase TiO2 is hundred times more
toxic than rutile phase TiO2 particles. One important advantage of upconver-
sion nanoparticles over other types of optical nanoparticles is that lanthanides
used in these particles are considered relatively safe and non-toxic [97]. Some
other issues about nanoparticles toxicity and catabolism will be discussed in
Section 5.4.
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1.6 Upconversion
In Section 1.5.2, we discussed different types of nanoparticles for optical molec-
ular imaging. Almost all of these nanoparticles and dyes have excitation and
emission through normal fluorescence in which a high energy (shorter wave-
length, commonly UV-Vis) excitation used to excite the probes followed by
relaxation to ground level and lower energy emission (longer wavelength). Typ-
ical fluorescent imaging has been used for a long time in florescent microscopes.
Introduction of nanoparticles such as QDs improves the resistivity of the probes
to photo-bleaching and increases the sensitivity and specificity of the imaging
by providing a narrow and distinguishable emission signal. But as discussed
earlier, there are two major problems with normal fluorescent imaging: first,
the high energy excitation source leads to an intense autofluorescence from cells
and tissues, which overlaps the signal emitted from nanoparticles or dyes, lead-
ing to a low signal to noise ratio (SNR). Second, UV-Vis excitation has limited
penetration depth, and therefore, limited application for in vivo imaging to sur-
face areas like skin and surface organs.
To overcome these major issues of fluorescent imaging, novel methods use
other optical phenomenon such as two-photon absorption and upconversion.
Figure 1.9 illustrates the schematic of three different optical phenomena, namely
fluorescence (down conversion), two-photon absorption and upconversion. In a
down conversion process, a high energy photon excites the material from the
ground level (G) to E2 energy level, followed by a nonradiative relaxation to
E1 state and an emission with a lower energy. In a two-photon absorption,
the low-energy photons simultaneously excite a sample at a focal point by the
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sum of the energy of both photons (i.e., from G to E2), and therefore, a high
energy photon is emitted. Finally, in an upconversion process, two or more low
energy photons are absorbed by the sample in order to excite the sample to E2
level, by a ladder like energy absorption process, and finally when the electron
reaches the emitting energy level, a higher energy emission signal is produced
[9]. The possibility of using low energy excitation sources in upconversion and
two-photon absorption enables us to avoid autofluorescence in bio imaging with
significant potential for in vivo imaging. The advantage of upconversion over
two-photon microscopy is that for two-photon absorption expensive femtosec-
ond lasers must be used to achieve a small focal point but with upconversion it
is possible to use economical continuous wave laser diodes.
1.6.1 Upconversion Phenomena and Mechanisms
Upconversion is a nonlinear optical phenomenon characterised by conversion
of low energy (long wavelength) radiation, for example near infrared (NIR),
to a high energy (short wavelength) radiation, for instance visible. Although
the concept of upconversion was first introduced in the mid 1960s [8], it has
attracted a high level of interest in the recent years because of their versatile
applications in different fields such as photochemistry, photonics, biophysics,
solid state physics, material science and optical molecular imaging. The key
point in this optical phenomenon is the sequential absorption of photons into
ladder like energy states and therefore lanthanide materials play a crucial role
in the upconversion phenomenon.
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Figure 1.9: Schematics of different optical phenomena and corresponding energy
levels: (A) Normal fluorescence (down-conversion), (B) Two photon absorption
and (C) Upconversion. The dashed/dotted (blue), dashed (green) and full ar-
rows (red) represent photon excitation, non-radiative relaxation and emission
processes, respectively (redrawn using [7, 8]).
Figure 1.10 depicts mechanisms of upconversion phenomenon, where an anti-
stoke lower wavelength emission is resulted from a material excited with a higher
wavelength excitation source, through four different mechanisms: excited state
absorption (ESA), energy transfer upconversion (ETU), photon avalanche (PA)
and energy migration-mediated upconversion (EMU) [9, 98, 10]. The energy of
the emitted photon in all these mechanism is based on a sequential absorption
of at least two photons by one or more metastable excited energy states between
the ground and the emitting states of the ion. In this sense, the upconversion
is different from the other anti-stokes luminescence phenomenon such as multi-
photon absorption and the second harmonic generation, in which simultaneous
absorptions of the photons is required [9, 8]. In contrast to virtual states in
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two-photon absorption and second harmonic phenomena, upconversion emis-
sion happens through physically existing states that are more efficient [19].
Ion 1 Ion 1 Ion 1 Ion 1Ion 2 Ion 2 Ion 2 Ion 3 Ion 4
Sensitizer Activator Sensitizer Sensitizer Activator Activator
ESA ETU PA EMU
Accumulator Migrator
Figure 1.10: Schematic of different upconversion mechanisms excited state ab-
sorption (ESA), energy transfer upconversion (ETU), photon avalanche (PA)
and energy migration-mediated upconversion. The dashed/dotted (blue),
dashed (green) and full arrows (red) represent photon excitation, energy transfer
or relaxation and emission processes, respectively [9, 10].
ESA upconversion mechanism is a single ion mechanism based on a sequen-
tial absorption of two photons. As shown in Figure 1.10, an electron is excited
from a ground state (G) to a metastable intermediate state (E1) during a ground
state absorption (GSA) process. Subsequently, a second photon excites the elec-
tron from the intermediate state to a higher exited state (E2), resulting in an
upconversion emission when electron is transferred from E2 back to G. The two
photons involved in an ESA upconversion can have different energies, which is
different from two photon phenomenon in which the photons should be exactly
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the same. ESA is the simplest upconversion mechanism and is not dependent
on the concentration of rare earth (RE) ions, consequently, this is the most
probable mechanism in samples with low concentration of rare-earth (RE) ions
[9].
ETU mechanism in principle is similar to ESA since it requires at least two
sequential photons, with the difference that in ETU two ions participate in
producing the upconversion emission, as shown in Figure 1.10. The first ion,
sensitizer (energy donor), is responsible for absorption of excitation photons,
and the second ion, activator (energy acceptor), emits the upconversion photon.
First, the sensitizer ion is excited to energy state E1 through a ground state
absorption. Second, the sensitizer ion energizes the activator ion to E1 state
through a nonradiative transfer, while itself relaxes to the ground level. Third,
the excited sensitizer transfers another photon to the activator through a second
nonradiative transfer which excites the activator from E1 to E2. Consequently,
the upconversion emission relaxes the activator ion back to G. The upconver-
sion efficiency in ETU is related to dopant concentration that is related to the
average distance between neighbouring sensitizer and activator ions [9, 99].
The third upconversion mechanism is PA in which an unusual pumping
mechanism that requires excitation intensity above a certain threshold leads to
an upconversion emission. As illustrated in Figure 1.10, a non-resonant weak
GSA populates the excited state E1 of the first ion, which is followed by a
resonant ESA that populates the excited state E2. Next step in PA is the
cross-relaxation between an excited and a neighbour ion at the ground state,
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resulting in the transfer of both ions to their E1 intermediate state. Then, elec-
trons from both ions get promoted to the E2 excited state. Series of further
cross relaxation processes between the two ions will occur after-ward resulting
in an exponentially increasing population of E2 which can produce a strong
upconversion emission [9, 8].
The recently proposed upconversion mechanism, EMU as depicted in Fig-
ure 1.10, is a core-shell engineered upconversion system which enables tuning
upconversion emission wavelength. Lanthanide ions designed to be used in this
system are classified into four classes: sensitizers (Ion 1), accumulators (Ion 2),
migrators (Ion 3) and activators (Ion 4). Like previous mechanisms, the sensi-
tiser is used to harvest pump photons through GSA absorption, which promotes
a neighbouring accumulator ion to an excited state. The accumulator ions re-
ceive electrons from the sensitiser or rarely by absorbing the pump photon to
reach the highest excited level from which energy is transferred to a migrator
ion thorough a non-radiative relaxation. This step is followed by a series of ran-
dom hops of energy between migrator ions until the activator ion receives the
energy thorough a non-radiative transfer from migrator to activator. The final
step is the radiative relaxation of the activator ion resulting in an upconversion
emission. An important features of EMU is that the excitation energy collected
by sensitizer can be amassed in the accumulator ions by successive energy trans-
fers, while enabling one step energy transfer to the activator. Second point is
that EMU provides high conversion efficiency for low energy excitation. And
finally it provides tunable upconversion emission possible by replacing activator
ions with different activator ions [10].
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With respect to the efficiency of the upconversion emission, these mecha-
nisms are distinctly different. The least efficient upconversion mechanism is
ESA, which is favourable only when single ion doping is needed. PA is one of
the most efficient upconversion processes, but it suffers from drawbacks such
as its dependence on the excitation power and the delay in response to excita-
tion (up to several seconds) because of the numerous ESA and cross relaxation
processes. In contrast, ETU is instant and independent of the excitation power
and its upconversion efficiency is at least two orders of magnitude higher than
ESA. EMU is a really efficient method especially for low energy excitation, but
it needs state of the art structural engineering of the particles with core shell
structure. Consequently, ETU is the preferred and practical mechanism for pro-
ducing upconversion with more than one dopant ions [9].
1.6.2 Lanthanide Materials
The lanthanide ions, also called rare-earth, are placed separately from the other
elements at the bottom of the periodic table. They include elements from lan-
thanum with atomic number of 57 through lutetium with atomic number of
71. The first element from lanthanide group first discovered at 1794 by Jo-
hann Gadolin [97], but it took years for scientists to classify them as it is now.
These materials have some unique properties, because of which, they have found
many applications in different technologies including catalysis [100, 101, 102],
batteries [103], optics [104, 105], displays [106] and bioimaging [19, 107, 108, 11].
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Some of the important and unique chemical and optical properties of lan-
thanides can be listed as:
1. They have a wide range of co-ordination numbers (generally 6 – 12, but
numbers of 2, 3 or 4 are known).
2. Their 4f electrons are completely covered by outer 5s and 5p orbitals and
are barely involved in chemical bonding and therefore their spectroscopic,
optical and magnetic characteristics are not affected by ligands and envi-
ronmental effects.
3. The transition between the 4f electrons are parity forbidden, although
they do occur because of the mixing with allowed transitions such as 4f –
5d transitions. When happened, the transitions between the 4f happens
within the above-mentioned shell and therefore they are photostable.
4. As a result of number 2 and 3 the lanthanide ions possess low extinction
coefficients (< 10 M−1cm−1) and long lifetime (up to several milliseconds)
[11].
5. Lanthanide materials have a wide range of electronic [Xe]4f n configura-
tions (n = 0 – 14), and the number of electronic levels is given by
14!
n!(14− n)! (1.18)
and therefore as an example Gd3+ has 3432 energy levels. Figure 1.11
illustrates some of the energy levels of lanthanide ions [11].
6. They prefer anionic ligands with donor atoms of rather high electronega-
tivity (as an example O and F).
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Figure 1.11: Energy level diagram for some of the Ln3+ ions [11].
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7. All lanthanide ions show similar reactivity because of the same valence
electrons.
8. Unlike organic chromophores, lanthanide ions usually have several lumi-
nescent excited states [11].
9. In lanthanide materials, from La to Lu, as the atomic number increases
both atomic and ionic radii decrease, especially at the start of the series,
this is called lanthanide contraction. Because of this effect lanthanide ions
behave very similar in chemical reactions in which the 4f are conserved
although they behave differently in reactions in which 4f electrons are not
conserved [109, 97, 110].
10. All lanthanide ions, except La3+ and Lu3+, have unpaired electrons and
show paramagnetic properties [97].
1.6.3 Structure of Upconversion Systems
An efficient upconversion happens in a system that is composed of a crystalline
host with a low concentration of lanthanide ions. In ETU upconversion, selec-
tion of a proper host, activator and sensitizer is crucial for producing an efficient
upconversion. The proposed theoretical energy transfer of Yb:Er and Yb:Tm
systems excited with 980 nm laser beam is illustrated in Figure 1.12.
The host material plays a crucial role in the upconversion efficiency and
emission profile. An ideal host material is transparent to the wavelength range
of interest, has a low phonon energy, high optical stability and similar lattice
structure to that of the dopant ions. Trivalent rare-earth (RE) ions, alkaline
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earth ions (Ca+2, Sr+2 and Ba+2) and some transition metal ions (Zr+4, Ti+4
and Zn+2) have similar size to RE and can be used as the host material. Another
important feature of a host is a low phonon energy to minimize the nonradiative
energy losses. Heavy halides including chlorides, bromides and iodides exhibit
low phonon energy (less than 300 cm−1). Oxides have high chemical stability
but suffer from relatively high phonon energy (generally more than 500 cm−1)
because of the stretching vibration of the host lattice. In comparison to other
hosts, fluorides show an acceptable chemical stability and a low phonon energy
(≈ 350 cm −1). Another important factor is the compatibility of crystal struc-
ture of the host material to that of the dopant, for example hexagonal-phase
NaYF4:Yb,Er is one order of magnitude more efficient in upconversion emission
than the cubic form with the same dopant concentration. Considering all these
issues the most efficient reported host for upconversion is the hexagonal NaYF4
[9, 19].
Activator dopants, in an upconversion system, should have multiple metastable
states that are available in most lanthanide ions, with the exception of La+3,
Ce+3, Yb+3 and Lu+3. Lanthanide ions such as Er+3, Tm+3 and Ho+3 have
ladder-like energy levels (see Figure 1.12) that are close to their ground levels so
as to facilitate a step-by-step absorption and energy transfer required for the up-
conversion processes. Another important factor is the nonradiative multiphoton
relaxation rate between different energy levels as given by
Knr ∝ exp
(
−β ∆E
hωmax
)
(1.19)
where β is an empirical constant of the host material, ∆E the energy gap be-
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tween the populated energy levels and the next lower energy level of a lanthanide
ion, h the Planck’s constant, and ωmax the highest vibrational mode of the host
lattice. For example, ions such as Er+3 and Tm+3 with relatively large energy
gaps, and thus, low probabilities of nonradiative relaxation are suitable activa-
tors in an upconversion system [9].
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Figure 1.12: Schematic diagram of the proposed energy transfer mechanisms
between Yb+3 as sensitizer and Tm+3 or Er+3 ions as activators. The
dashed/dotted (blue), dashed (green) and full arrows (red) represent photon
excitation, energy transfer or relaxation and emission processes, respectively
(redrawn using [9, 12]).
In ESA mechanism with singly doped crystals, upconversion efficiency is
dependent on the distance between two neighbouring activator ions and the ab-
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sorption cross-section of the ions. The concentration of the activators is low
and carefully adjusted due to the mutual quenching effects of the ions. In order
to take advantage of a highly efficient ETU upconversion mechanism, a sensi-
tizer ion with a sufficient absorption cross-section in the NIR region is often
co-doped with the activators in the host lattice. For example, a trivalent Yb
ion with only one energy level in 4f level of 2F5/2 (as seen in Figure 1.12) has a
large absorption cross-section located at around 980 nm and a good resonance
with f -f transition of activators ions, making it a suitable sensitizer. To get
an efficient upconversion, the concentraion of sensitizer is chosen to be high (20
mol %), in comparison to the low activator content (< 2 mol %) [9].
Figure 1.12 illustrates the schematic of upconversion mechanism by co-
doping Yb+3 with Er+3 or Tm+3. The main emission peaks of Erbium doped
particles are located at 520, 540 and 655 nm corresponding to 2H11/2 →4 I15/2,
4S3/2 →4 I15/2 and 4F9/2 →4 I15/2 transitions, respectively. For Thulium doped
particles typical emission peaks are at 450, 475, 649 and 800 nm associated
with 1D2 →3 H6, 1G4 →3 H6 and 3H4 →3 H6 transitions, respectively. The
blue emissions of the Tm+3 doped particles are 4- and 3- photon processes,
while Er+3 and other Tm+3 emissions are often two-photon processes [9, 12].
1.7 Multimodalities
As described in Section 1.2, different modalities have been applied for the pur-
pose of molecular imaging including nuclear modality, magnetic modality and
55
optical modality. Table 1.1 (Page 7) summarizes advantages, disadvantages and
some other properties of these different modalities. An important point is that
any of these modalities have some unique advantages not provided by other
modalities, which are accompanied by some important limitations. For exam-
ple, optical imaging is a highly sensitive and fast method, while it suffers from
low spatial resolution and poor tissue penetration. On the other hand, mag-
netic resonant imaging provides a high spatial resolution and no tissue penetra-
tion limit, but suffers from relatively low sensitivity and slow image acquisition
time. Therefore, by mixing these two modalities, it is possible to overcome the
limitations of each and achieve more efficient molecular imaging for particular
specimen.
Figure 1.13 demonstrates the concept of multimodality. Different type of
information is retrieved using different imaging modalities. Magnetic resonant
imaging provides comprehensive anatomical images, but it lacks biochemical,
physiological and especially molecular information. Nuclear imaging (e.g., PET)
or optical imaging, on the other hand, are highly sensitive for molecular, bio-
chemical and physiological information, while they lack anatomical information.
Thus, by adopting multimodal systems such as MRI/optical or MRI/PET, it
is possible to have a comprehensive imaging that provides both anatomical and
biochemical information on the subject. Note that for an efficient multimodal
imaging, a modality with a high sensitivity, such as PET or optical, is com-
bined with a modality with a high spatial resolution, for example MRI or CT,
and modalities with similar properties should be avoided as the combined data
may make the analyses and understanding of the result more complex [111, 112].
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Figure 1.13: Schematic of informaiton retrieved from different imaging modal-
ities and how multimodality can be used to cover limitations of each modality
to provide more complete information.
1.8 Potential Targets for Optical Molecular Imag-
ing
The main objectives of molecular imaging, including early disease detection,
better and more accurate screening and diagnosis, targeted therapy and drug
delivery, targeted therapeutic monitoring and treatment follow-ups are never
feasible without proper molecular targets and tags with high affinity and speci-
ficity [20, 22]. Development of target molecules and targeted nanoparticles suit-
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able for molecular imaging is a laborious and multidisciplinary research area. In
this section, before introduction of some possible targets for clinical application,
we look at targeting molecules or tags which can be attached to nanoparticles
through polyethylene glycol (PEG), avidin-biotin and streptavidin.
Antibody molecules are the classical targeting agents in immunohistochem-
istry and also in molecular imaging with nanoparticles. Although novel methods
for production of rodent monoclonal antibodies, rodent recombinant monoclonal
antibodies, and partly humanised antibodies have improved purity and availabil-
ity of these antibodies, the relatively large size (12 nm) and the immunogenicity
of their fragment crystallisable region FC (i.e., the tail of an antibody that inter-
acts with cell surface receptors and complement system and eventually activates
the immune system) have encouraged the development of antibody fragments for
molecular imaging applications [22]. Normal antibodies are approximately 150
kDa in size and therefore are slowly removed from circulation and can accumu-
late in normal tissues. Antibody fragments, in contrast, have molecular weight
of around 25 kDa which better accommodate in vivo requirements. Recently,
synthetic antibody fragments have been produced [113, 114], which eliminate
the need for animals and can increase their production speed.
Oligonucleotides (aptamers), another possible targeting molecules, are small
synthetic nucleic acid molecules, either DNA or RNA, with molecular weight as
low as 5-10 kDa, which can act as ligands for proteins. Advantages of ap-
tamers are rapid and inexpensive synthesis, high homogeneity and stability
over time [115, 116]. Peptides are another class of novel targeting molecules,
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which provide all advantages of aptamers. Examples of peptides targeting
molecules are arginine-glycine-aspartic acid sequence (RGD) to detect integrins
[117, 118, 119], NC-1900 for vasopressin [120] and trans-activating transcrip-
tional activator (TAT) peptides for enhancement of cellular internalization and
mitochondrial detection [121, 122]. Lectins are the last important targeting
groups that have a molecular weight between 12 to 150 kDa and can pass blood-
tissue barriers [22, 123].
There are many possible targets for molecular imaging in clinical applica-
tions and basic biomedical research. Molecular imaging is attractive in many
clinical areas including oncology, cardiovascular disease and neurology. Targets
for detecting cancer in oncology include detecting cancer phenotypes such as in-
creases in metabolism, proliferation, angiogenesis, hypoxia and apoptosis, and
detection of specific protein markers on tumour cells and tumour associated cells,
such as tumour angiogenic vessels and stroma. Some examples of targets for
tumour phenotypes are increases in protein synthesis, glucose transporters and
choline transporters and thymidine uptake in DNA/RNA synthesis (target for
tumour cell proliferation). Examples of tumour specific proteins are integrins,
somatostatin receptors, oestrogen receptors and androgen receptors related to
angiogenesis, neuroendocrine tumours, breast cancer and prostate cancer.
In cardiovascular field there are many examples of readily available targets
with clinical applications. Some important examples are cathepsin K, colla-
gen, elastin, fibrin and VCAM-1 for detecting atherosclerosis, adrenergic neu-
rotransmitters for heart failure and cardiac sympathetic neurones for cardiac
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sympathetic innervations [124, 125]. Neurological imaging is another important
clinical area using molecular imaging and although the blood brain barrier is
a major obstacle to overcome, there are many possibilities in this field that
can have crucial effects on our understanding and treatments of neurological
problems. Examples of useful targets are dopamine receptors, β-amyloid, NK-1
receptors, dopamine transporters and dopamine metabolism with clinical appli-
cation in schizophrenia, Alzheimer’s disease, depression, anxiety and addiction
[126, 127, 128, 129].
Integrins are one of the most important and interesting targets of molecu-
lar imaging for detection of cancer and cardiovascular diseases. Integrins are a
large group of surface receptors with important responsibilities in normal and
pathological cells. Some of the important roles of integrins in tumour cells in-
clude increasing tumour cell migration, invasion proliferation and survival. Also
integrins play an important role in angiogenesis and regulation of tumour cells
by managing crosstalks between growth hormones and tumour cells or tumour-
associated cells. Because of these important roles that integrins have in cancer
physiology, they can be employed as targets for detection and even treatment
of cancers. Different integrins are associated to different tumours: for example,
expression of αvβ3, α5β1 integrins in Melanoma increase lymph node metas-
tasis, in Breast cancer, α6β4 expression enhances tumour size and grade and
decreases patient survival, and αvβ3 causes bone metastasis. Consequently, de-
tection and suppression of integrins can facilitate early detection, better staging
and screening and better treatment. Important integrins in angiogenesis are
αvβ3, α1β1, α2β1, α4β1, α5β1, α6β1, α9β1 and α6β4. Nanoparticles can be
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used for molecular imaging by functionalization with targeting molecules. For
instance, arginine-glycine-aspartate (RGD) peptide can be used to detect αvβ3
integrins [130, 131, 132].
1.9 Conclusion
As described in this chapter, molecular imaging could have revolutionary effect
on biomedical in vivo and in vitro imaging. For an efficient molecular imaging
it is important to choose a desirable modality, apply targetable probes and se-
lect a crucial target. Between all different modalities optical and magnetic are
the safest and most favourable, but because of technological difficulties these
two modalities are the least clinically applied for molecular imaging. As an
example optical modality suffers from lack of penetration depth which limits
its application to superficial targets. This problem could be address by using
the NIR biological window in which absorption and scattering of light in tissues
are limited. On the other hand both optical and magnetic modalities needed
biocompatible, specific, sensitive and stable probes to provide enough signal to
be detected. Nanoparticles, because of their unique properties have the poten-
tial to replace conventional contrasts and enhance the applicability of molecular
imaging. Although in recent years discoveries of novel nanoparticles with unique
properties, such as QDs, overcome many limitations of the conventional imag-
ining contrasts, but these nanoparticles also have some drawbacks that opens
the necessity of discovery of new nanoparticles.
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Upconversion nanoparticles apply non-linear optical phenomenon and there-
fore could be excited by light in near infrared (NIR) portion of spectrum to emit
photons in NIR or visible ranges. NIR excitation not only enable deeper pene-
tration depth but also eliminate autofluorescence problem. Quenching autofluo-
rescence has a significant beneficial effect on the signal-to-noise ratio (SNR) and
can significantly enhance potential for efficient molecular imaging. Other optical
advantages of upconversion nanoprticles are narrow emission, high photostabil-
ity, no bleaching, no blinking and possibility of having multicolour imaging
using same NIR excitation source. On the other hand as lanthanides are the
main building blocks of most upconversion systems and because these elements
are considered biocompatible therefore upconversion nanoparticles are non-toxic
and biocompatible. The other important aspect of upconversion nanoparticles
are their applicability as potential multimodal particles. Many of the rare-
earth materials have paramagnetic properties and therefore theoretically it is
predictable that by using lanthanides as host and dopants for synthesis of up-
conversion nanoparticles it is possible to have multimodal (optical/magnetic)
nanoparticles.
In conclusion, Synthesis of novel upconversion nanoparticles which could be
excited in NIR and emit in NIR and have additional magnetic properties is
necessary for answering to ever-increasing need for a better replacement of con-
ventional imaging contrasts. In this work I tried different synthesis methods and
characterization methods, which will be described in details in the next chapter
in order to examine the possibility of having such an imaging probe.
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Chapter 2
Synthesis and Material
Characterization
As discussed in previous chapter, upconversion nanoparticles have the poten-
tial to play an important role as probes for in vivo and in vitro optical and
multimodal molecular imaging. Although these type of nanoparticles attracted
huge attention in recent years and many different synthesis methods have been
reported by different groups, Section 2.1, but there is still a gap for a practical,
economical and scalable method for synthesis of these kind of nanoparticles.
It is also important to mention that to use the advantages of NIR biological
window for bioimaging, nanoparticles with intense NIR to NIR upconversion is
necessary, and this important requirement rarely been addressed. Therefore the
ultimate goals of this work is to find a practical synthesis method which could
provide a real solution for the above mention problem. Therefore I tried three
different synthesis methods in this work which will be discussed in this chapter.
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The first section of this chapter provides a review of different synthesis meth-
ods reported for upconversion nanoparticles with a discussion of advantages and
disadvantages of each of them. This followed by a comprehensive description of
three different synthesis method experienced in this work and the morphological
and material characterization performed for them.
It is important to mention here that all the synthesis processes performed by
myself in a chemistry lab at The Wolfson Centre in Brunel University. The scan-
ning electron microscopy performed by myself using a Carl Zeiss EVO MA10
SEM located in London Centre for Nanotechnology (UCL). The transmission
electron microscopy performed by a lab technician using a Hitachi H7600 system
located in University of British Columbia (UBC). The dynamic light scattering
experiment (DLS) measurements performed by my self using DynaPro Titan
systems located in University of British Columbia (UBC). The ICP-OES ex-
periments performed by MEDAC ltd and XPS experiments performed by our
collaborator in The University of Birmingham.
2.1 Synthesis of Upconversion Nanoparticles
A vast number of methods including coprecipitation, thermal decomposition, hy-
dro(solvo)thermal synthesis, sol-gel processing, combustion synthesis and urea
homogeneous precipitation have been reported for synthesis of upconversion
nanoparticles [9, 19, 12]. Table 2.1 summarizes common hosts, advantages and
64
disadvantages of each method. In some cases a mixture of two methods are
used for synthesis of specific of nanoparticles. Post synthesis processes are used
as well for development of upconversion nanoparticles with controlled particle
size, chemical composition or surface functionalization.
Table 2.1: Synthesis methods of upconversion nanoparticles and their advan-
tages and disadvantages [9, 19, 12].
Method Example Hosts Advantagess Disadvantages
Coprecipitation LaF3, NaYF4,
LuPO4, YbPO4
Fast growth
No need for costly equipment
Easy procedure
Post-heat treatment required
Ultra-small particles produced
Thermal decompo-
sition
LaF3, NaYF4
GdOF
Narrow size distribution
High quality particles
Monodisperse particles
Expensive precursors
Hydrophobic final product
Toxic by-products
Hydro(solvo)thermal LaF3, NaYF4,
La2(MoO4)3 and
YVO4
Economic precursors
No need for post heat treat-
ment
Excellent control over size and
shape
Autoclave required
Sol-gel preocessing ZrO2, TiO2,
BaTiO3,
Lu3Ga5O12
YVO4
Economic High temperature annealing
required
High aggregation rate
Combustion Y2O3, Gd2O3
La2O2S
Time saving
Easy to perform
Considerable aggregation
Poor morphology control
Flame Synthesis Y2O3 Time saving
Low cost
Sensitive to flame temprature
UBHP Y2O3 Low cost
No specific equipment required
Heat treatment required
Hydrophobic products
Perhaps the easiest and most convenient method for producing ultra-small
particles is co-precipitation, which has been used by several groups for synthe-
sis of nanoparticles (5-10 nm) with a narrow size distribution. While having
no need for costly equipment and complicated procedures, this method has a
fast growth rate and requires post-annealing processes. In a typical process,
solution of lanthanide salts is injected into a solution of the host material. Ex-
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amples of hosts used in this method are LaF3, NaYF4, LuPO4 and YbPO4
[9, 133]. Particle size and growth rate can be regulated by using capping lig-
ands or chelating agents such as polyvinylpyrrolidone (PVP), polyethylenimine
(PEI) or ethylenediaminetetraacetic acid (EDTA) [134]. In particular, PEI pro-
vides a good platform for direct surface functionalization of nanoparticles with
bioligands [135]. A heat treatment step is required as post processing, which is
one of the disadvantages of this method.
Thermal decomposition is another synthetic method that produces highly
monodispersed particles with no need for post-annealing processes. In a typical
procedure, metal precursors, mostly trifluoroacetat, are thermolysed together
with oleic acid and octadecene. Oleic acid acts as the primary solvent that
prevents agglomeration of particles and octadecene acts as the high boiling sol-
vent (350 ◦C). The advantages of oleate-based synthesis include narrow particle
size distribution, high luminescence efficiency and the high phase purity of the
particles. Although this method produces high quality particles, it requires ex-
pensive air sensitive precursors, results in mostly hydrophobic particles and has
toxic by-products [44, 54] . Examples of the reported hosts for this method are
LaF3, NaYF4 and GdOF [11, 53, 136].
The hydro(solvo)thermal method is a good method for preparation of highly
crystalline materials at much lower temperature and with no need for post an-
nealing. The process is performed in an autoclave reaction vessel that maintains
the required temperature and pressure for a desired period of time. By keeping
solvents in temperatures and pressure above their critical point, the autoclave
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enhances the solubility of solid and increase the reaction rate between solids.
Since the reaction happens in a closed cylinder, growth monitoring is virtually
impossible. Particle size and morphology can be manipulated in this method
by using polyol- or micelle-mediation. Some of the popular hosts reported for
this method include LaF3, NaYF4, La2(MoO4)3 and YVO4 [137, 138].
Another synthesis method used for production of upconversion materials
especially for thin-film coating is sol-gel process. This method is based on
hydrolysis and polycondensation of metal alkoxide or acetate precursors. To
enhance the quality of crystal formation of the particles post synthesis high
temperature annealing is required. Particles derived from sol-gel method are
not suitable for bio-purposes due to the tendency of the crystals to aggregate
[7, 57]. This method has been reported for different hosts such as ZrO2, TiO2,
BaTiO3, Lu3Ga5O12 and YVO4 [9, 139].
In contrast to time consuming sol-gel and solvo(hydro)thermal methods,
combustion synthesis is fast and provides oxide particles by exothermic chemi-
cal reaction (temperatures ranging between 500 ◦C and 3000 ◦C) which spreads
through the reaction material in an autonomous way. Draw backs of combustion
synthesis include substantial particle aggregation and formation of amorphous
particles. The particles size and shapes depend on the reaction temperature
which is governed by the ratio of the metal ions to chemical fuel ratio. In a
typical combustion synthesis, hydrazine or glycine are used as fuel or reduc-
ing agents. Examples of reported hosts include Y2O3, Gd2O3 and La2O2S
[140, 141, 142].
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Another fast and time-saving synthesis method reported is flame synthesis.
Flame synthesis is a one-step and continuous method for low-cost synthesis of
nanomaterials. The typical host for this method is Y2O3 and its main draw-
back is the sensitivity of the particle size, morphology and photoluminescence
intensity to the flame temperature [143].
Finally, the urea homogeneous precipitation method is a fast and low cost
method with no need for expensive equipments. This method will be described
in details in the following section. The drawbacks of this method is the require-
ment of heat treatment and the hydrophobic nature of the final products. The
typical host used for this method is Y2O3 [144].
2.2 Urea Homogeneous Precipitation Method
Urea homogeneous precipitation (UHP) method is used for synthesis of several
metal oxide complexes. This method was first reported by Tang et al. in 1937
[145] for synthesis of near monodispersed aluminium sulfate particles. The first
report of synthesis of metal oxide nanoparticles using UHP was by Salutsky and
Quill in 1950 [146]. Owing to its low cost and low processing temperature and
the possibility of getting finer particles in comparison to the other methods,
many groups investigated synthesis of metal oxides including rare-earth oxides
using UPH [147, 148, 149, 150]. Recently, UHP method has been used for syn-
thesis of mixed lanthanide oxide nanoparticles [151, 144, 152]. In general, UHP
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takes advantage of a slow release of anions (mainly OH− and CO32−) from urea
decomposition at temperatures above 83 ◦C. The release of anions in a solu-
tion containing metal cations form precipitation through nucleation and growth
mechanisms explained by La Mer model [153]. The La Mer model emphasises
that a single burst of nucleation happens above the point of supersaturation of
reaction solution, which is then followed by a slow progressive growth, therefore
defining a strict separation between nucleation and growth steps. This model
does not hold for all cases as it is reported that aggregation of fine particles can
produce structures with different size and morphology by varying the synthesis
condition [150, 144].
The proposed reaction mechanism for synthesis of Gd2O3 particles is as-
sumed to have two steps [150], namely:
1. Urea Decompostion:
(NH2)2CO → NH+4 +OCN− (2.1)
OCN− + 2H2O → CO2−3 +NH+4 (2.2)
CO2−3 +H2O → HCO−3 +OH− (2.3)
HCO−3 +H2O → H2CO3 +OH− (2.4)
H2CO3 → CO2(g) +H2O (2.5)
2. Precipitation:
Gd3+ +OH− + CO2−3 + 1.5H2O → Gd(OH)CO3 · 1.5H2O (2.6)
Therefore, the overall reaction can be summarized as
Gd3+ + 1.5(NH2)2CO+ 5H2O → Y (OH)CO3 · 1.5H2O+ 3NH+4 + 1/2CO2(g)
(2.7)
69
The important factor in any chemical precipitation is the supersaturation
degree S, given by [144]
S = aAaB/Ksp (2.8)
where aA and aB are the activity of the partially hydrolyzed cation ([Ln(OH)x(H2O)y]
3−x,
x+ y=6, Ln=any Lanthanide atom) and anion (CO3
2−), respectively, and Ksp
the solubility product constant. The nucleation starts only if S reaches the crit-
ical supersaturation S∗ and as the aqueous solubility of a lanthanide complex
increases with decreasing ionic radii of Ln33+. As a result of the lanthanide
contraction law, i.e., a lanthanide with a smaller ionic radii has larger Ksp (for
example, Y has a larger Ksp than Gd), the possibility of a stable precipitation is
higher for Gd than for Y [144]. In a mixed-lanthanide synthesis process, the av-
erage ionic radii and concentration of the ions define the supersaturation value.
The homogeneous nucleation rate, RN , is another important factor related
to supersaturation S∗ via
RN = A exp
( −16piσslv2
3k3T 3 ln2 S
)
(2.9)
where RN is the number of nuclei formed per unit time per unit volume, σsl the
surface tension at the liquid solid interface, v the atomic volume of the solute, k
the Boltzmann constant and T temperature [151]. Consequently, if all synthe-
sis parameters are kept constant, a lanthanide with a larger ionic radii is more
likely to precipitate through nucleation than through growth and therefore it
produces smaller and denser particles.
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In a practical sense, factors that will significantly affect size and shape of
the Y2O3 particles in UHP method are [150, 151, 144]:
1. Concentration of the rare-earth solution: This can dramatically change
the particle size, varying from 65 to 140 nm in concentration range between 0.005
and 0.025 M by increasing nucleation rate. But the lanthanide concentration can
also increase the growth rate and therefore concentrations higher than 0.025 M
cause severe agglomeration of the particles. At concentrations lower than 0.02
M the zeta potential is about 13 mV, but as concentration increases the zeta
potential drops dramatically and saturates to a value of 2-3 mV. The reduced
zeta potential implies rapid agglomeration of the precipitated particles. As a
result, the lanthanide concentration has to be between 0.005 and 0.02 M and
the solution needs to be subjected to forced dispersion to increase critical upper
concentration in order to get homogeneous monosipersed particles.
2. Urea concentration: By increasing urea concentration from 0.04 to 4 M
particle size decreases from 220 to 100 nm. The underlying mechanism is the
increase in concentration of anions such as CO3
2− and OH− in more concen-
trate urea solution, leading to higher nucleation and less subsequent growth
due to lower concentration of cations. Extremely high urea concentration can
cause rapid precipitation and inter-particle aggregation. The precipitation rate
increases with urea concentration increases of up to 3 M and saturates beyond
this value.
3. Reaction temperature has significant effect on precipitation rate, but has
minimal effect on the size and shape of the particles.
4. Solution pH is a controlling factor for the particle morphology as severe
coagulation occurs at pH < 2. By increasing the reaction pH to more than 3, it
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is possible to produce well-separated monodispersed particles. The precipitation
rate is low at low pH, increases with pH and reaches a plateau at pH > 3.
2.2.1 Synthesis of Gd2O3:Yb
3+/Er3+, Gd2O3: Yb
3+/Tm3+,
Y2O3:Yb
+3/Er3+ and Y2O3:Yb
3+/Tm3+
As illustrated in Figure 2.1 in a typical synthesis process, 10 mmol of Gd(NO3)3,
3 mmol of Yb(NO3)3 and 0.25 mmol of Er(NO3)3 are dissolved in 150 ml of dis-
tilled (DI) water in a 500 ml flask. Another flask is used to make a 2 molar
aqueous solution of urea. Both solutions are placed in an ultrasonic bath and
ultrasonicated at room temperature for 30 minutes to get homogeneous and
clear solutions. The rare-earth solution is then heated in a water bath to 60◦C
followed by adding 150 ml of 2 M urea solution. The reaction temprature is
raised to 88◦C and maintained for about 20 minutes in which the color of the
solution changes from clear to bluish tint and finally to milky white. The total
reaction time including the time for the solution to reach the reaction temper-
ature is 40 minutes. The milky mixture is then crash cooled using an ice bath
and stored at room temperature for 48 hours. The sedimented white nanopar-
ticles are separated by centrifugation at 8000 rpm for 10 minutes. Then, the
supernatant liquid is decanted off and nanoparticles are further purified by cen-
trfugation wash with DI water twice, isopropyl alcohol (IPA) once and again
with DI water. Finally, the nanoparticle precipitates are dried in a vacuum oven
at 100◦C for 3 hours, followed by a final heat annealing step at 900◦C for one
hour in a furnace. The white powder is cooled down to room temperature and
used in characterization experiments.
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Table 2.2: Synthesis molar ratio of Gd2O3: Yb
3+, Tm3+ samples.
T1 T2 T3 T4 T5 T6
Gd (mmol) 10 10 10 10 10 10
Yb (mmol) 0.6 3 0.6 0.6 3 3
Tm (mmol) 0.1 0.25 0.1 0.25 0.1 0.25
urea (M) 1 1 2 2 2 2
Table 2.3: Synthesis molar ratio of Gd2O3: Yb
3+, Er3+ samples.
E1 E2 E3 E4 E5 E6
Gd (mmol) 10 10 10 10 10 10
Yb (mmol) 0.6 3 0.6 0.6 3 3
Er (mmol) 0.1 0.25 0.1 0.25 0.1 0.25
urea (M) 1 1 2 2 2 2
For synthesis of Tm3+ doped nanoparticles Tm(NO3)3 is used instead of
Er(NO3)3. Similar process is used for making different molar ratio of Gd2O3:Yb
3+/Er3+
and Gd2O3:Yb
3+/Tm3+ by changing the molar ratio of the precursors used in
the synthesis. We synthesise samples with 1 molar urea solution to examine
the effect of urea concentration on synthesis of nanoparticles. Similar methods
are also used for synthesis of Y2O3: Yb
+3/Er3+ and Y2O3: Yb
+3/Tm3+ by re-
placing Gd(NO3)3 with Y(NO3)3. Tables 2.2 and 2.3 summarize different molar
ratio of dopants and urea used for synthesis of different samples prepared in this
work.
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Gd(NO3)3 (10mmol)
+
Yb(NO3)3 (3mmol)
+
+
Er(NO3)3 (0.25mmol)
DI Water (150 ml)
Ultrasonication (30 Min)
Room Temprature
Dry in vaccum oven 
at 100°C for 
3 hours
Age at room
temprature for
48 hours 
Resulting Powder 
Annealed at 900°C
 for 1 Hour
Urea (2 Molar)
 +
DI Water (150 ml)
Heat in water bath 
until the solution 
reach to 60°C
Ultrasonication (30 Min)
Room Temprature
Mix together and heat in water
 bath to 88°C and age for 20
minutes as soona s visible
blue tint appears
Cool Suddenly in ice bath
Wash and centrifuge 
(8000 rpm for 10 minutes)
three times with DI water 
and 
once with IPA 
Figure 2.1: Synthesis flowchart of upconversion nanoparticles using urea homo-
geneous precipitation method.
2.2.2 Electron Microscopy Results
Figure 2.2 and the left part of Figure 2.4 illustrate the scanning electron micro-
scope (SEM) photomicrographs and the size distribution of Gd2O3:Yb
3+/Er3+
samples (E1-E6) synthesized using urea method. Sample E1 and E2 are syn-
thesized using 1 molar urea stock and have different concentration of dopants.
E1 is doped with 0.6 mmol of Yb3+ and 0.1 mmol of Er3+ ions, while E2 is
doped with 3 mmol of Yb3+ and 0.25 mmol of Er3+. The other samples E3,
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E4, E5 and E6 are synthesized with 2 molar urea solutions. The pre-synthesise
dopant (Yb:Er) molar ratios are 0.6:0.1, 0.6:0.25, 3:0.1 and 3:0.25 for E3, E4, E5
and E6, respectively. As seen in the size distribution figure in addition to SEM
micrographs, the Er doped particles are spherical and monodispersed and the
size distribution of the particles are between 60 nm to 200 nm, depending on
the precursor and urea concentration, as other synthesis parameters including
reaction pH, temperature, time and annealing process are kept constant for all
of them. For the sample E1, the size distribution are between 100 and 180 nm
with an average particle size of 160 nm, while for the sample E2 particles have
narrower size distribution (80 to 100 nm) with an average size located around
80 nm. The smallest particle size in this set of samples belongs to sample E6
with size range of 60-100 and the average particle size of 80 nm. Sample E4
has the widest size distribution between 80 and 200 nm with the average size
at 120-140 nm.
Figure 2.3 and the right side of Figure 2.4 demonstrate the SEM photomicro-
graph and the size distribution of Tm3+ doped Gd2O3:Yb
3+ samples. Sample
T1 is doped with 0.6 mmol of Yb3+ and 0.1 mmol of Tm3+ ions, while T2 is
doped with 3 mmol of Yb3+ and 0.25 mmol of Tm3+, but both synthesised us-
ing a 1 molar urea solution. Sample T3, T4, T5 and T6 are synthesised with 2
molar urea solution with dopant molar ratio (Yb:Tm) of 0.6:0.1, 0.6:0.25, 3:0.1
and 3:0.25, respectively. Similarly to Er doped samples, Tm doped samples are
spherical and monodisperse with size range of 60 to 180 nm. sample T1 have
the largest particles with an average size of 160 nm and the widest size distri-
bution, while sample T6 has the smallest particles with an average size of 70 nm.
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E4
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200 nm 200 nm
E6
Figure 2.2: SEM photomicrographs of Gd2O3:Yb
3+, Er3+ samples synthesized
using UHP method. Samples E1 (10:0.6:0.1 mmol) and E2 (10:3:0.25 mmol)
are synthesized using 1 M urea solution, while samples E3 (10:0.6:0.1 mmol),
E4(10:0.5:0.25 mmol), E5 (10:3:0.1 mmol) and E6 (10:3:0.25 mmol) are synthe-
sized using 2 M urea solution.
The transmission electron microscopy (TEM) images of sample E4 is illus-
trated in Figure 2.5. TEM photomicrographs confirm spherical monodispersed
nanoparticles with rough surfaces and size of 100 nm attached to the TEM
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T1
200 nm 200 nm
T2
200 nm
T3
200 nm
T4
200 nm
T5 T6
200 nm
Figure 2.3: SEM photomicrographs of Gd2O3:Yb
3+, Tm3+ samples synthesized
using UHP method. Molar ratios of Gd:Yb:Er / Urea are 10:0.6:0.1 mM / 1 M
for T1, 10:3:0.25 mM / 1 M for T2, 10:0.6:0.1 mM / 2 M for T3, 10:0.6:0.25 mM
/ 2 M for T4, 10:3:0.1 mM / 2 M for T5 and 10:3:0.25 mM / 2 M for T6.
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Figure 2.4: Size distribution diagram for Tm3+ and Er3+ doped Gd2O3 samples
produced from analysis of typical SEM photomicrographs of samples E1-E6 and
T1-T6.
grid. The high resolution TEM (HR-TEM) images show a crystal lattice for
sample E4, Gd2O3:Yb
3+, Er3+ (10:0.6:0.25) with a lattice plane constant of
4.6 A˚. Figure 2.6 illustrates TEM and HR-TEM photomicrographs of samples
T5, Gd2O3:Yb
3+, Tm3+ (10:3:0.1), showing ovoid particles with size of 60 nm.
T5 nanoparticles are smaller than E4 particles in TEM photomicrographs but
sample E4 are more monodisperse. The HR-TEM image of T5 sample is also
depicted in Figure 2.6, showing a crystal lattice constant of about 4.1 A˚.
Considering the sample based nature of particle size and agglomoration anal-
ysis based on SEM and TEM photomicrographs, size distribution analysis is
performed on dispersion of particles in aqueous solution using dynamic light
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100 nm
10 nm
4.6Å
Figure 2.5: TEM photomicrograph of sample E4 Gd2O3:Yb
3+,Er3+
(10:0.6:0.25), showing spherical particles with size range of about 100 nm and
the HR-TEM photomicrograph showing the crystal structure of a particle.
scattering (DLS) using a DynaPro Titan system on samples E3, E4, T5 and T6,
as shown in Figure 2.7. These samples are selected as they have the highest
upconversion emission intensity and performance. Scattering of light by small
particles in a solution, described in details in Section 1.3.1, is the basis priniciple
for DLS measurements. A small particle in a solution scatters incident light in
all directions according to Rayleigh scattering. The time-dependent fluctuations
of scattered light intensity is measured and related to particle size, distribution
and the monodispersity of the particles. Due to the sensitivity of DLS measure-
ments, preparation of a dilute, well-dispersed and dust-free solution is critical.
DLS samples are prepared by mixing 1 mg of each sample in 5 ml filtered DI
water. The mixtures undergo an intensive ultra-sonication using Sonic Ultra-
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Figure 2.6: TEM photomicrograph of sample T5 Gd2O3:Yb
3+,Tm3+ (10:3:0.1),
showing spherical particles with size range of about 60 nm and the HR-TEM
photomicrograph showing the crystal structure of a particle.
sonicator VX750 for 10 minutes to prepare a well-dispersed and homogeneous
solution. The solution were then diluted 10 times and filtered again for DLS
measurements. Figure 2.7 illustrates the size distribution results for selected
samples. Tm3+ doped samples T5 and T6 provide very similar distribution
graph with a size range of 50 to 500 nm although the main peaks are at around
100 and 125 nm. Samples E3 and E4 show smaller particles in comparison to
T5 and T6 with the highest peak for particles with diameter of less than 100 nm
for sample E3 and at around 100 nm for sample E4. Er3+ doped samples show
a narrower size distribution with not many peaks located more than 300 nm in
comparison to samples T5 and T6 that demonstrate an exponential decrease in
the number of particles as the diameter increases from 150 to 500 nm. These
results signify that the particles have acceptable aqueous dispersibility that
is important for bioimaging applications. To reduce agglomeration issues for
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Figure 2.7: Size distribution diagram for sample T5, T6, E3 and E4 measured
using dynamic light scattering.
bioimaging, surface modification methods such as those reported by Zako et al.
[154] can be used.
In our experiments, we also tried Y2O3 as host to synthesise upconversion
nanoparticles using UHP method. Figure 2.8 illustrates the SEM photomicro-
graphs form the Y2O3:Yb
3+,Tm3+ and Y2O3:Yb
3+,Er3+. Both samples are
synthesized using 1 M urea stock and molar ratio of 10:0.6:0.1 for Gd:Yb:Tm
or Gd:Yb:Er, respectively. The particles are spherical with similar morphology
and size of Gd2O3 nanoparticles described previously. The issue with using
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Y2O3 as the host for upconversion nanoparticles is that the emission is far less
intense as compared to Gd2O3 particles, and the Tm doped Y2O3 do not emit
in the range detectable by our detectors.
200 nm 200 nm
Y2O3:Yb
3+,Tm3+
(10:0.6:0.1)
Urea 1 M
Y2O3:Yb
3+,Er3+
(10:0.6:0.1)
Urea 1 M
Figure 2.8: SEM photomicrograph of Y2O3:Yb
3+, Tm3+ and Y2O3:Yb
3+, Er3+
samples synthesized using UHP method. Molar ratio for both samples are
10:0.6:0.1 with 1M urea, showing similar particle shape as that of Gd2O3 sam-
ples.
2.2.3 ICP Spectroscopy
Inductively coupled plasma optical emission spectrometry (ICP-OES) can pro-
vide important information regarding the elemental composition of our samples.
ICP is performed on all samples using a Varian Vista MPX ICP-OES system
(Medac Ltd). ICP-OES is one of the most commonly used sensitive elemental
analysis tools for determining trace concentrations of elements of a sample by
using electromagnetic (light) radiation emitted from or absorbed by atoms of a
sample. Every element has its own characteristic set of electronic energy levels
and therefore its own unique set of absorption and emission wavelengths. In
optical emission spectrometry (OES), the sample is subjected to high temper-
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Figure 2.9: Schematic of the major components of a typical ICP-OES spec-
troscopy system (adapted from [13]).
atures that lead to excitation and ionization of atoms in the sample. Excited
atoms decay to lower energy states through non-radiative or radiative energy
emission. In OES, the intensity and spectrum of the emitted energy is used
to determine the concentrations of the elements of interest [13]. Figure 2.9 il-
lustrates the schematic of major components of a typical ICP-OES instrument.
One of the most important advantages of ICP-OES over other spectroscopy and
elemental methods is that the thermal excitation can populate a large number of
different energy levels for different elements at the same time. All of the excited
atoms and ions can emit their characteristic radiation at nearly the same time,
enabling selection of different emission wavelengths for an element and simulta-
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neous measurement of emission from different elements.The detection limits for
different elements are generally given by µg/L (ppb) range [13].
Table 2.4: ICP spectroscopy results and calculated elemental atomic ratio of
Gd2O3: Yb
3+, Er3+ samples.
E1 E2 E3 E4 E5 E6
ICP
Results
(%)
Gd 70.97 74.74 78.91 76.42 60.6 66.02
Yb 10.28 6.13 5.25 6.42 23.89 15.24
Er 1.76 1.9 0.68 1.78 0.6 0.89
O 16.99 17.23 15.16 15.38 14.91 17.85
C < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1
H < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1
N < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1
Calculated
Atomic
Ratio
Gd 0.45 0.47 0.501 0.485 0.385 0.42
Yb 0.059 0.035 0.03 0.037 0.138 0.088
Er 0.01 0.011 0.004 0.01 0.003 0.005
O 1.06 1.077 0.948 0.961 0.932 1.116
The results of the ICP-OES spectroscopy for Gd2O3: Yb
3+, Tm3+ and
Gd2O3: Yb
3+, Er3+ synthesised with different concentration of dopants and
urea are summarized in Tables 2.4 and 2.5, respectively. The ICP results shows
the concentration of each element in each samples while the calculated atomic
ratio are calculated considering atomic mass of each element. We have tested C,
H and N elements in order to assure that the purification and annealing steps
removed these elements from the samples and only Gd2O3 doped with other
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lanthanide dopants remain in our samples. The reported concentration of C, H
and N are less than 0.1 and could be considered as the detection limit of the
system.
Table 2.5: ICP spectroscopy result and calculated elemental atomic ratio of
Gd2O3: Yb
3+, Tm3+ samples.
T1 T2 T3 T4 T5 T6
ICP
Result
(%)
Gd 70.28 74.79 72.54 73.82 55.29 66.17
Yb 12.02 9.58 9.66 8.37 29.06 15.63
Tm 2.55 0.79 1.85 2.85 0.86 1.02
O 15.5 14.84 15.95 14.96 14.79 17.18
C < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1
H < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1
N < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1
Calculated
Atomic
Ratio
Gd 0.44 0.475 0.461 0.469 0.351 0.42
Yb 0.069 0.055 0.055 0.048 0.167 0.09
Er 0.015 0.004 0.01 0.016 0.005 0.006
O 0.947 0.928 0.997 0.935 0.924 1.07
As seen from the results of Table 2.4 for Er3+ doped Gd2O3: Yb
3+ samples,
samples synthesised using 2 M urea solution has improved chance for getting ap-
propriate dopant concentrations reflecting the initial ratio of the precursors used
in comparison to samples synthesised using 1 M urea (E1 and E2). For example,
by comparing samples E3 and E6, a gradual increase in dopant concentration of
E6 is observed than that of E3, accompanied by a decrease in Gd concentration.
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Table 2.5 provides the elemental analysis results for Tm3+ doped samples.
The results show a higher dopant concentration for samples T6 in comparison
to T3 that has similar molar ratio of the dopants, signifying the capability of
UHP method in successful incorporation of dopants in the final product. Al-
though the initial Gd3+ concentration of all Tm3+ or Er3+ doped samples are
at 10 mmol, the concentration of Gd is lower for samples doped with higher
concentration of Yb3+, Er3+ or Tm3+. This reduction can be attributed to the
replacement of Gd3+ in the crystal structure with respective dopant ions. Ad-
ditionally, the use of a 2 M urea solution increases the incorporation of dopants
in the final product and subsequently decreases Gd3+ concentration.
2.2.4 X-Ray Photoelectron Spectroscopy Results
The X-ray photoelectron spectroscopy (XPS) is based on photoelectronic effect
discovered by Hertz in 1887 [14]. When photons from a light source hit a solid
sample, they can eject electrons from the valance band. In XPS, high energy
X-ray photons are used to interact with core level electrons from any orbital of
the sample. Figure 2.10 shows the different parts of an XPS system, consisting
of X-ray source, the spectrometer and a high vacuum chamber. The measured
energy Esp of the ejected electron at the XPS spectrometer is related to the
biding energy Eb and the Fermi energy EF according to
Eb = hν − Esp − qφsp, (2.10)
where hν is the energy of the primary X-ray photon and φsp the work function
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of the spectrometer (3 to 4 eV). As Eb depends on the X-ray energy, it is impor-
tant to provide a monochromatic X-ray excitation for XPS measurement, often
sourcing from a narrow band X-ray sources such as Al or Mg. Since XPS is a
surface analysis method, the emitted photoelectrons originate from the upper
0.5 to 5 nm surface of the sample. The depth of XPS measurements is related
to the electron escape depth or electron mean free path [155].
e-
X-ray
Gun
Argon
Gun
Sample
Electron 
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Figure 2.10: Schematic different components of a typical XPS system (adapted
from [14].
In our experiments we performed XPS measurements on selected samples
(T5,T6, E3 and E4) with the highest upconversion emission for both Tm3+ and
Er3+ doped Gd2O3:Yb
3+ samples. Figure 2.11 shows the binding energy spec-
trum for sample T5. The Gd 4d and O 1s peaks can be observed clearly in the
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spectrum as shown in the figure. There are observed overlaps between the Gd
4p and C 1s peaks and between Yb and Tm peaks (Yb 4d with Tm 4d and Yb
4s with Tm 4s) due to similarity of the binding energy for these orbitals. An
important point is the appearance of C in XPS measurements of all our samples
while we did not detect any carbon in ICP-OES experiments reported in Section
2.2.3. We believe this is due to the long delay between the ICP-OES and XPS
measurements and possible gradual surface absorption of CO2 from atmosphere
during this time, this is in accordance with some recently published results [156].
Figure 2.11: XPS result of sample T5 showing Gd 4d and O 1s peaks while there
are some overlaps between Gd 4p and C 1s and also between Yb and Tm 4d
peaks. The similarity and low intensity of Yb and Tm signals makes it difficult
to quantify them.
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Table 2.6: Atomic percentages of elements in sample T5 and T6 based on peak
areas in XPS wide scan.
Gd 4d
Atomic (%)
Yb 4d
Atomic (%)
O 1s
Atomic (%)
C 1s
Atomic (%)
T5
16.91 9.115 51.65 22.32
18.19 9.027 53.18 19.43
17.48 9.914 55.22 18.38
T6
16.96 4.452 46.01 32.58
15.79 5.371 46.13 32.71
14.16 3.752 42.58 39.5
Table 2.6 shows the atomic percentage of elements estimated from the peak
areas of XPS wide scan results for samples T5 and T6. Due to small concentra-
tion of Tm dopants in these samples (0.1 mmol for T5 and 0.25 mmol for T6)
and the overlap between Yb 4d and Tm 4d peaks, it is not possible to accurately
quantify the atomic percent of Tm in these samples. While the XPS results gen-
erally corroborates those of the ICP-OES results (Table 2.2), some differences
are observed. The average atomic percentage of Gd derived from XPS peaks
is 17.52 % and 15.63 % for samples T5 and T6, repsectively. The ICP results
show much higher concentration of Gd of 55.29 % and 66.17 % for samples
T5 and T6, respectively. The difference in the concentrations extracted from
these two experiments can be attributed to the inaccuracy of the XPS based
concentrations due to the overlap between Gd 4d and C 1s peaks. Thus, Gd
concentrations estimated by XPS can be significantly underestimated. More
importantantly XPS measurement results provide information on the surface
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composition of the particles, while ICP better represent the mass composition
of the entire sample, thus the observed difference can be partly attributed to the
structural differences between surface and core of the particles, as seen in the
HR-TEM photomicrographs. As described in Section 2.2, during UHP method,
a Gd core nucleation is followed by growth that forms the spherical particles,
thus the concentration Gd is expected to decrease from core to surface. In ad-
dition, the surface is more vulnerable to absorption of CO2 from atmosphere,
affecting the Gd percentage. The atomic percentage of Oxygen in sample T5
and T6 is also higher than the estimated O2 percentage from ICP measurements.
Table 2.7: Atomic percentages of elements in sample E3 and E4 based on peak
areas in XPS wide scan.
Gd 4d
Atomic (%)
Yb 4d
Atomic (%)
Er 4d
Atomic (%)
O 1s
Atomic (%)
C 1s
Atomic (%)
E3
21.3 1.07 4.26 50.44 22.93
20.82 1.43 2.72 53.20 21.83
23.51 1.11 3.91 51.18 20.29
E4
22.75 0.51 3.95 53.84 18.94
23.14 0.78 3.44 53.67 18.97
23.67 0.92 3.54 51.78 20.09
Table 2.7 illustrates the atomic ratio of samples E3 and E4 estimated from
peak areas in XPS wide scan. The average Gd percentage detected is 21.87 %
for E3 and 23.18 % for sample E4, which are higher than the Gd percentage
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detected by XPS for Tm doped samples (although similar molar ratios are used
for Gd for both cases), but still smaller than the percentage derived from ICP
results. This differences can also be attributed to the underestimation of XPS
due to the overlaps between Gd 4d and C 1s. Unlike the Tm doped samples,
the atomic percentage of Er dopants can be estimated at 3.63 % for E3 and 3.64
% for E4 due to better visibility of the peaks. We have detected smaller Yb
atomic ratio in E3 and E4 as compared to Tm doped samples, which reflects
higher Yb precursor for E3 and E4 of 0.6 mmol in comparison to 3 mmol for T5
and T6. The average atomic ratio of oxygen in sample E3 and E4 derived from
XPS results is 51.6 % and 53.09 % which is much higher than the oxygen atomic
percentage measured by ICP. This can be attributed to having more oxygen on
the surface of the particles and also because of CO2 absorption on the surface
of the particles and overlaps between Gd 4p and C 1s peaks.
2.2.5 X-Ray Diffraction Results
X-ray diffraction (XRD) is one of the most frequently used technique for analysis
of crystal structure of materials. Principally, XRD is based on Bragg’s law of
diffraction for an incicent X-ray beam from crystal planes with spacing d to give
a constructive inteference when
2d sin θ = nλ, (2.11)
where θ is the angle of incident X-ray to the surface, λ the X-ray wavelength,
and n the order number of reflection. Figure 2.12 shows a schematic of X-ray
diffraction system.
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Figure 2.12: Schematic of X-ray diffraction system.
Figure 2.13 depicts the XRD results for selected Tm3+ doped (T1, T6) or
Er3+ doped (E1, E6) Gd2O3:Yb
3+ samples, showing peaks for crystalline Gd2O3
core of the particles [157, 158].
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Figure 2.13: XRD results from selected Gd2O3:Yb
3+ samples doped with Tm3+
(T1 and T6) or Er3+ (E1 and E6).
2.3 Organic Solvothermal Method
2.3.1 Synthesis of Y2O3:Yb
3+/Er3+, Y2O3:Yb
3+/Tm3+ and
ZnO:Li+/ Er3+ Using Rare-Earth Co-ordination
The novel solvothermal method is used for synthesis of Y2O3:Yb
3+/Er3+, Y2O3:Yb
3+/Tm3+
and ZnO:Li+/ Er3+. Tetramethyl heptanedionato (TMHD) rare-earth co-ordination
complexes are used as metal precursors. The rare-earth co-ordination complexes
are chosen because they form clear homogeneous solutions in organic solvents
such as IPA. By adding ammonia to the homogeneous solution the solution
becomes alkaline and therefore the organic precursours form metal hydroxides,
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which subsequently convert to metal oxides during heat treatment. The pro-
posed synthesis reactions are
Y (TMHD)3 + Y b(TMHD)3 + Er(TMHD)
NH4OH−−−−−→
Y (OH)3 + Y b(OH)3 + Er(OH)3 + [TMHD] (2.12)
and
Y (OH)3 + Y b(OH)3 + Er(OH)3 + [TMHD]
Heating−−−−−→
YxY byErzOp +H2O +NO2 + CO2. (2.13)
The synthesis process is similar to the synthesis method described in the
Figure 2.14, the only difference is that no surfactants are used here. In a typ-
ical synthesis 10 mmol of Y(TMHD)3, 3mmol of Yb(TMHD)3 and 0.25 mmol
of Er(TMHD)3 are mixed in 50 ml IPA in separate flasks. The solutions are
vigrously stirred, heated and refluxed in an oil bath at 100◦C until they become
homogeneous and clear in about 30 minutes. Then all solutions are mixed in a
three-necked flask and the mixture is stirred and heated at the same tempera-
ture for 1 hour, following by adding a mixture of ammonia/DI water (150/50ml)
drop-wise while monitoring pH. The pH of the solution before adding any am-
monia is usually about 8.10 which increases by adding ammonia and white
precipitates form when pH reaches to about 12.5, at which time the sample is
cooled gradually to room temperature. The big clusters and impurities are then
removed using a vacuum filter and the organic solvents are removed using a
rotary evaporator. Nanoparticles are then separated by centrifugation at 4000
rpm for 20 minutes. Samples are then annealed in a furnace at 800◦C for 2
hours and the resulting white powder used for characterization experiments.
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The same process is used for making Y2O3:Yb
3+/Tm3+ by replacing Er(TMHD)3
with Tm(TMHD)3. Also for producing ZnO:Li
+/ Er3+, Y(TMHD)3 is replaced
with Zn(TMHD)2 and Yb(TMHD)3 replaced with Li(TMHD). Other synthesis
steps remain the same for all synthesised samples.
2.3.2 Synthesis of Y2O3:Yb
3+, Er3+ and Y2O3:Yb
3+, Tm3+
with Different Surfactants (PVA, PAA, PEG)
Figure 2.14 is the flowchart of the synthesis of Y2O3:Yb
3+, Er3+ and Y2O3:Yb
3+,
Tm3+ by using different surfactants including polyvinyl alcohol (PVA), poly-
acrylic acid (PAA) and polyethylene glycol (PEG) to manipulate size and mor-
phology of the particles. The proposed reaction is the same as reaction 2.12 and
2.13 and the surfactant role is to cover the crystal seeds in order to limit further
outgrowth of the nanostructures. Synthesis steps are similar to those used for
samples with no surfactants.
2.3.3 Electron Microscopy Results
SEM photomicrographs for Y2O3:Yb
3+,Er3+ and Y2O3:Yb
3+,Tm3+ samples
synthesised using rare-earth co-ordination precursors with no surfactant are il-
lustrated in Figure 2.15. Both Er3+ doped (right) and Tm3+ doped (left) sam-
ples are semi-spherical microparticles with size distribution of 1 µm to 4 µm,
showing much larger particles in comparison to UHP method.
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Figure 2.14: Synthesis flowchart of upconversion nanoparticles using rare-earth
co-ordination as precursors with surfactants.
As described in Section 2.3.2, we have examined the effect of using surfac-
tants to manipulate morphology and size of the nanoparticles using solvother-
mal method. Figure 2.16 depicts SEM photomicrographs of Y2O3:Yb
3+,Er3+
and Y2O3:Yb
3+,Tm3+ nanoparticles synthesised using several surfactants PAA,
PVA and PEG, respectively, from top to bottom. Comparing these images with
those for samples produced without surfactants shown in Figure 2.15, it is evi-
dent that surfactants dramatically reduce the size of the particles. The samples
synthesised using PAA and PVA have similar morphology, consisting of clusters
of particles in the size range of less than 50 nm. Samples synthesized using
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Y2O3:Yb
3+,Er3+
(10:3:0.25 mmol)
2 μm
Y2O3:Yb
3+,Tm3+
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Figure 2.15: SEM photomicrograph of Y2O3:Yb
3+, Er3+ and Y2O3:Yb
3+,
Tm3+ synthesized by rare-earth co-ordination precursors with no surfactants.
PEG surfactant, however, consist of far more homogeneous and monodispersed
spherical and oval particles.
Figure 2.17 demonstrates SEM photomicrographs of ZnO:Er3+,Li+ samples
synthesized using organic solvothermal method. For synthesis of these samples
similar process to that described in Section 2.3.1 is used. But unlike spherical mi-
croparticles produced for Y2O3:Yb
3+,Er3+ and Y2O3:Yb
3+,Tm3+ shown in Fig-
ure 2.15, ZnO:Er3+,Li+ samples shows clusters of rod shape nanostructures with
some morphological changes for different molar ratios. The ZnO:Er3+,Li+ with
molar ratio of 10:0.2:0.1 mmol provides spike shape nanostructures, whereas
ZnO:Er3+,Li+ with same molar ratio of Zn2+ and Li+ but doped with 0.5
mmol of Er3+ provide columnar rods. Figure 2.14 also display Y2O3 doped
with Yb3+,Er3+ or Yb3+,Tm3+ demonstrating rods with diameter of about 50
to100 nm and length of more than 200 nm.
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Figure 2.16: SEM photomicrograph of Y2O3:Yb
3+, Er3+ and Y2O3:Yb
3+,
Tm3+ synthesized by rare-earth co-ordination precursors and different surfac-
tants PVA, PAA and PEG for controlling size and shape of particles.
2.4 Combustion Method
2.4.1 Synthesis of Y2O3:Yb
3+,Er3+, ZnO:Yb3+,Er3+ Using
Inorganic Precursors
Synthesis of upconversion nanoparticles are performed using combustion meth-
ods similar to what has been reported in literature [141, 140]. We synthesised
a series of samples using ZnO and Y2O3 as the host for the nanoparticles.
As dopant, we have investigated different molar concentrations and different
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200 nm
ZnO:Er3+,Li+
(10:0.2:0.1 mmol)
200 nm
ZnO:Er3+,Li+
(10:0.5:0.1 mmol)
Figure 2.17: SEM photomicrographs of ZnO:Er3+,Li+ synthesized with rare-
earth co-ordination precursors.
dopant combinations such as ZnO:Yb3+,Er3+ and Y2O3:Yb
3+,Er3+. Two mo-
lar ratios of precursor materials for ZnO:Yb3+:Er3+ are 10:1.8:0.2 mmol and
10:3:0.25 mmol and for Y2O3:Yb
3+,Er3+ are 10:3:0.3 and 10:3:3. The flowchart
of synthesis is illustrated in Figure 2.18.
In a typical procedure, Y(NO3)3 (10 mmol), Er(NO3)3 (0.25 mmol) and
Yb(NO3)3 (3 mmol) are mixed with 10 ml DI water in a flask. The mixture
is magnetically stirred at room temperature for 30 minutes to form a homoge-
nous solution. Then appropriate amounts of hydrazine or glycine is mixed with
the dispersion and stirred at room temperature for an hour for Zn and Y host
materials. The solvent is removed using a rotary evaporator, and the product
transferred into a crucible and heated at 200◦C for about 30 minutes in a fur-
nace to remove the remaining water. Combustion occurs when the temperature
is increased to 290◦C in a matter of seconds. The fluffy powder that remains
after the combustion is heated further to 800◦C for an hour.
For the combustion synthesis of M2O3 samples, we use a metal nitrate (oxi-
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dizer) and an organic fuel such as glycine, where M = Y, Yb or Er. The reaction
is exothermic corresponding to stoichiometric reaction
6M(NO3)3 + 10NH2CH2COOH + 18O2 →
3M2O3 + 5N2 + 18NO2 + 20CO2 + 25H2O. (2.14)
The molar ratio of glycine to metal nitrate compounds is 1.2:1, as suggested by
literature to yield the best molar ratio for upconversion nanopowders [141]. In
the case of ZnO, the synthesis conditions are kept the same, but the glycine is
replaced with hydrazine as the reducing agent. The possible reaction is
1Zn(NO3)2 + 3N2H4 +O2 → 1ZnO + 6H2O + 4N2 (2.15)
and the same reaction is used for other dopants including Er and Yb to produce
the doped ZnO samples.
Y(NO3)3 (10mmol)
+
Yb(NO3)3 (3mmol)
+
+
Er(NO3)3 (0.25mmol)
DI Water (10ml)
Stir (30 Min)
Room Temprature
+
Glycine (16 mmol)
or
Hydrazine (2ml)
Stir (1 Hour)
Room
 Tem
prature
Solvent evaporation
by Rotary Evaporator
Dry in Furnace at
200°C for 30 Minute 
Increase Temprature to 
290°C for 2-3 Minutes to
Ignite Combustion
Resulting Powder 
Annealed at 800°C for 
1 Hour
Figure 2.18: Flowchart of combustion synthesis method.
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2.4.2 Electron Microscopy Results
Figure 2.19 depicts SEM photomicrographs for Y2O3:Yb
3+,Er3+, ZnO:Yb3+,Er3+
nanoparticles produced using combustion method. Both Y2O3:Yb
3+,Er3+, ZnO:Yb3+,Er3+
demonstrate clusters of bead-shaped nanoparticles with the average size of
around 50 nm. From the images, it is safe to say that Y2O3:Yb
3+, Er3+ sample
have smaller and finer nanoparticles in comparison to ZnO:Yb3+,Er3+ particles.
While the combustion method is an easy and fastest method, the resultant par-
ticles suffer from severe aggregation in comparison to other methods.
200 nm 200 nm
Y2O3:Yb
3+,Er3+
(10:3:0.25 mmol)
ZnO:Yb3+,Er3+
(10:3:0.25 mmol)
Figure 2.19: SEM photomicrographs of Y2O3:Yb
3+,Er3+, ZnO:Yb3+,Er3+ sam-
ples synthesized using combustion method and inorganic precursors.
2.5 Conclusion
A good synthesis method has to be easy to apply, efficient, controllable and eco-
nomic. In this work I tried three different synthesis methods including urea ho-
mogenous precipitation (UHP), organic solvothermal and combustion method,
in order to find the best possible way, considering synthesis equipment available.
It is important to mention here that as described in Section 2.1, one of the most
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common synthesis method applied for synthesis of upconversion nanoparticles
by many groups recently, is hydrothermal method which have advantages such
as excellent morphological control of the nanoparticles, economic process and no
need for post heat treatment. The most important drawbacks of hydrothermal
method is that it requires specific high pressure autoclave reactor, it is not pos-
sible to monitor synthesis process and it is not a scalable method. Because of
these disadvantages and also as I did not have access to equipments required for
hydrothermal method, I focused my investigation in this work on other methods
described in this chapter.
UHP method is applied for synthesis of Gd2O3:Yb
3+,Er3+, Gd2O3:Yb
3+,Tm3+,
Y2O3:Yb
3+,Er3+ and Y2O3:Yb
3+,Tm3+. The morphological and elemental
analysis performed for these samples proved that UHP method is a reliable
method for producing high crystalline, monodisperse spherical nanoparticles
with good correlation between dopants molar ratio in precursors and resultant
particles. There were no noticeable morphological differences between sam-
ples synthesized using Gd2O3 or Y2O3 as host. Therefore, because Gd2O3
samples provide better optical and magnetic properties, which is discussed in
the following chapters, I focused my work on synthesis of Gd2O3:Yb
3+,Er3+,
Gd2O3:Yb
3+,Tm3+ samples. UHP synthesis method provides several advan-
tages such as it does not demand any fancy equipment and it uses economic
precursors and water as the reaction medium, so it is an affordable, easy to
apply and scalable method. The main disadvantages of this method are that
it requires post heating step and the final products are hydrophobic. Thus, for
bioapplications synthesized particles need to go through a surface modification
102
step as well.
The other method that been tried in this work was novel organic solvother-
mal method. The idea behind this method, that to our best of knowledge
is reported for the first time, is that the rare-earth co-ordinations such as
TMHD complexes are easily soluble in organic solvents such as IPA and hav-
ing a homogenous mixture of dopants and host ions enhance the possibility of
getting dopants in favourable places in host lattice. Using this method I syn-
thesized different samples including Y2O3:Yb
3+,Er3+, Y2O3:Yb
3+,Tm3+ and
ZnO:Li+,Er3+ with different molar ratios. The synthesized particles have spher-
ical shape with size range between 1 µm to 4 µm, with strong upconversion
emission in case of Y2O3:Yb
3+,Er3+. As the resultant particles were larger that
could be applied for bioapplications, surfactants have been tried for morpho-
logical manipulation of particles synthesized using this method. In conclusion
we manage to get nanoparticles using organic solvothermal method, but as will
be discussed in 3 this morphological changes also altered the optical properties
of these particles. This method have advantages such as there is no need for
specific equipments and the synthesis process is easy to perform. The disadvan-
tages of this method could be named as expensive precursors, large particle size
and difficulty in controlling the morphology of the particles.
Finally, I also tried combustion method for synthesis of Y2O3:Yb
3+,Er3+
and ZnO:Yb3+,Er3+. This conventional method is a very fast method which re-
quired inexpensive precursors and no reaction vessel. The main disadvantages
of combustion method are severe aggregation and low upconversion emission.
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In conclusion, considering all the advantages and disadvantages of the three
different synthesis methods experienced in this work, UHP method is the most
practical method with the best morphological, optical and magnetic properties
for resultant nanoparticles. Morphologically, nanoparticles synthesized using
UHP method are homogeneous, with acceptable narrow size distribution and
good monodispersity compare with the two other methods. UHP method also
is a scalable method, as reaction happened in aqueous solution, the reaction tem-
perature is not high ( 83◦C and there is no need for high pressure reaction condi-
tion, therefore it could be a promising method for large scale synthesis as well.
At the end it is important to mention that interestingly, Gd2O3:Yb
3+,Tm3+
samples synthesized using UHP method is the only sample synthesized in this
work with pure NIR to NIR upconversion, while Tm3+ doped samples produced
using other methods did not have detectable upconversion emission in NIR spec-
tral region.
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Chapter 3
Optical Characterization of
Upconversion Nanoparticles
Optical characterization of the synthesised nanoparticles are presented in this
chapter to evaluate their performance for molecular imaging in biologically sig-
nificant window. As mentioned in Chapter 1 when an excitation photon is
absorbed by a material, the absorbed energy takes it to an excited state,this is
followed by a radiative, nonradiative or mixed relaxation process. In a radiative
process, a photon is emitted during the relaxation of an electron from anThe
excited to the ground state, on the other hand, in a nonradiative process is
dissipated as heat generation or a chemical reaction. The radiative and nonra-
diative emission response of a material to optical excitation is determined by
the structure and composition of materials. As a result, optical characterisa-
tion provides critical information on electronic and material properties of the
synthesized materials.
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In this thesis, I have described two different methods for measurement of
upconversion photoluminescence in Sections 3.1 and 3.2. Measurement results
for time-resolved luminescence decay are presented in Section 3.3, providing a
better understanding of the optical response of the sample to pulsed excitation.
Finally, upconversion multiphoton microscopy is demonstrated for synthesized
samples to prove the applicability of the synthesized nanoparticles for spatially-
resolved molecular imaging, as summarized in Section 3.5.
It is important to mention here that all the optical characterization experi-
ments described in this chapter performed by my self. The FTIR system used
for upconversion photoluminescence measurements was located in London Cen-
tre for Nanotechnology (LCN) while the other photoluminescence experiment
setup was in electrical engineering department of University College London
(UCL). The decay measurement performed using an optical set up in chemistry
department of University of British Columbia (UBC) and finally the multipho-
ton microscopy setup was in Simon Fraser University (SFU).
3.1 FTIR System for Measurements of Upcon-
version Photoluminescence
As upconversion is an anti-Stokes phenomena many of conventional characteri-
sation systems are not applicable for measurements of upconversion photolumi-
nescence, especially, for accurate measurement of low intensity emissions. Al-
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most all commercially available spectrophotometers employ monochromators to
provide spectral data. And although it is possible to get high resolution photo-
luminescence using specific configurations such as double pass and double grat-
ings, It is really difficult to get a high quality and high resolution upconversion
photoluminescence data using conventional spectrophotometers. To overcome
this problem in measurement of upconversion nanoparticles, we have introduced
a novel photoluminescence setup for our experiments using a modified Bruker
VERTEX 80v Fourier transform infrared (FTIR) and visible spectrometer.
In FTIR systems, a Michelson interferometer [7] is used instead of a dis-
persive element, such as a prism or diffraction grating, to resolve the wave-
length spectrum of emitted light. In a Michelson interferometer, photons from
a broad-band source is divided into two part using a beam splitter, with one
beam heading toward a moving mirror and the other toward a fixed mirror.
The interference of the two beams reflected from the two mirrors is constructive
or destructive depending on the position of the moving mirror to produce an
interfrogram for different frequencies, which can be related to the light intensity
using Fourier transform. Generally, Using FTIR system for this purpose has
three main advantages:
1. Fellgett’s advantage – All wavelengths/frequencies are measured simulta-
neously, so a complete spectrum can be recorded very rapidly and many
scans can be averaged in the time taken for a single scan of a dispersive
spectrometer.
2. Jacquinot advantage – For the same resolution, the energy throughput in
an interferometer can be higher than in a dispersive spectrometer, where
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it is restricted by the slits. which provide ability to achieve the same
signal-to-noise ratio as a dispersive instrument in a much shorter time.
3. Connes advantage – The wavenumber scale of an interferometer is derived
from a HeNe (helium neon) laser, λ = 632.8 nm, that acts as an internal
reference for each scan. The wavenumber of this laser is known very
accurately and is very stable. As a result, the wavenumber calibration
of interferometers is much more accurate and has much better long term
stability than the calibration of dispersive instruments.
3.1.1 Optical Setup
Figure 3.1 illustrates the schematic of FTIR optical setup used for measure-
ment of upconversion photoluminescence. A conventional fibre-coupled contin-
uous wave (CW) semiconductor laser diode (NT55-373 Edmond Optics) with
an emission centred at a wavelength of 975 nm and a nominal output power of
450 mW was used as the excitation light source. The collimated laser beam is
reflected and focused on the sample that is placed on a sample holder in front of
a FTIR system. Emissions from the sample is then collected by the objectives of
the FTIR system and guided through the beam splitter. From the beam split-
ter beams propagate toward the mirrors and the reflected beams are reunited
to produce a single beam. Two short pass filters with cutting wavelengths of
950nm and 900nm are used to prevent the excitation laser from reaching the
detector that is a normal commercial silicon photodiode.
108
Figure 3.1: FTIR spectrometer optical setup used for accurate measurement of
upconversion photoluminescence.
3.1.2 Results and Discussion
Upconversion photoluminescence of all Gd2O3 samples doped with Tm
3+ and
Er3+ is measured using the optical setup described in the previous section. Fig-
ure 3.2 illustrates the photoluminescence spectrum of Tm doped samples T1,
T2, T3 and T6. Samples T1 and T2 are synthesised using 1 M urea solution,
whereas samples T3 and T6 are synthesised using 2 M urea. Samples T1 and
T3 are doped with 0.6 mmol of Yb3+ and 0.1 mmol of Tm3+, whereas sam-
ples T2 and T6 are doped with 3 mmol Yb3+ and 0.25 mmol of Tm3+. When
excited with the 980 nm CW laser diode, all Tm3+ doped samples show pure
near infrared to near infrared (NIR-to-NIR) upconversion emissions with a wide
double peak in the range of 760 to 840 nm with the highest peaks located at
around 810 nm, as seen in the figure. The lowest emission intensity belong to
sample T1 that contains a low dopant concentration and synthesised using a
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Figure 3.2: Upconversion photoluminescence from Tm doped samples T1, T2,
T3 and T6, excited with a 980 nm CW laser diode. This diagram signifies the
effect of changing urea and dopant concentrations on emission intensity. The
peak emission of all samples is at 810 nm. HeNe laser of the spectroscope is
marked in blue.
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1 M urea. In contrast, the highest intensity is for sample T6 with a high dopant
concentration and a 2 M urea. Sample T2 and T3 shows similar upconversion
intensities, although sample T3 is doped with a lower concentration of dopants.
These results shows that increasing the urea concentration during synthesis en-
hances the upconversion intensity of samples.
Figure 3.3 shows the upconversion photoluminescence of samples T3, T4,
T5 and T6. All these samples are synthesised using a 2 M urea solution with dif-
ferent dopant molar ratios. All samples emit pure upconversion with a gradual
increase of intensity from T3 to T6, which can be attributed to the increased
dopant concentration. The intensities detected from samples T5 and T6 are
similar. Both T5 and T6 are doped with 3 mmol Yb3+, but have different con-
centrations of Tm3+, which are 0.1 mmol for T5 and 0.25 mmol for T6. As seen
in this figure, for Tm3+ doped Gd2O3 samples it is necessary to have 3 mmol
Yb3+ to get an intense upconversion emission, and for this Yb3+ concentra-
tion, the emission intensity changes negligibly when Tm3+ dopant concentration
changes from 0.1 to 0.25 mmol for T5 and T6, respectively, possibly due to self
quenching of activator Tm3+ dopants by nonradiative relaxation.
For Er doped Gd2O3 samples, photoluminescence upconversion is demon-
strated in Figure 3.4 and Figure 3.5. Similar to Tm doped samples the up-
conversion measurments are performed using a 980 nm excitation from a CW
laser diode with 450 mW power. Figure 3.4 illustrates the effect of concetra-
tion of urea solution on the photoluminescence intenisty of Er3+ doped samples.
Samples E1 and E3 are doped with 0.6 mmol of Yb3+ and 0.1 mmol of Er3+,
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Figure 3.3: Effect of dopant cocentrations on upconversion photoluminescence
of Tm3+ doped samples. Samples doped with 3 mmol Yb3+ have the most
intense emission that is not changed significantly by changing the concentration
of Tm3+ dopants. The peak emission of all samples is at 810 nm. HeNe laser
of the spectroscope is marked in blue.
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Figure 3.4: Effect of urea concentration on upconversion photoluminescence
from Er3+ doped samples.
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Figure 3.5: Effect of dopant concentration on upconversion emission from Er3+
doped samples. The most intense emission is detected from sample E4 with 0.6
mmol of Yb3+ and 0.25 mmol of Er3+.
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but E1 is synthesised using a 1 M urea solution, while a 2 M urea is used for
synthesis of sample E3. Upconversion emission from sample E3 is strong and
centred in the red region of spectrum at around 661 nm. Sample E3 shows a
similar peak in the red region, but also emits in the green and near infrared
regions the spectrum, as shown in the figure. Sample E6 and E2 have similar
dopant concentrations, which are Yb3+ 3 mmol and Er3+ 0.25 mmol. Sample
E6 is synthesised with a 2 M urea solution, while for sample E2 1‘M urea is
used. Comparing the photoluminescence of these samples shows that increas-
ing the urea concentration from 1 M to 2 M enhances the intensity for the
main emission peaks in the red region at around 661 nm. Note that similar to
sample E3, sample E6 have some small peaks in green region and near infrared
region, although these peaks have been suppressed in comparison to those of E3.
Figure 3.5 illustrates the effect of dopant concentration on upconversion
emission of Gd2O3 doped with Yb
3+ and Er3+. Unlike Tm doped samples ex-
plained earlier, for the Er3+ doped samples the highest emission intensity is
detected for samples synthesised using a 2 M urea solution. The most intense
emission detected from sample E4 that is doped with 0.6 mmol of Yb3+ and
0.25 mmol of Er3+. The second intense upconversion emission is observed for
sample E3 that is doped with 0.6 mmol of Yb 3+ and 0.1 mmol of Er3+. Sam-
ples E5 and E6 are doped with larger concentration of dopants Yb:Er of 3:0.1
and 3:0.25, respectively, but the upconversion emission of these samples are less
intense than samples E3 and E4. The main emission from all samples is mea-
sured in the red region of the spectrum with the highest peak located at 661
nm. Samples E4 and E3 display emission peaks in the green region with the
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highest peak at around 560 nm. In addition, small near infrared emissions are
detected in samples E3 and E5 at around 810 nm.
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Figure 3.6: Upconversion photoluminescence of Y2O3:Yb
3+, Er3+ microparti-
cles synthesized using rare-earth co-ordination precursors. Strong upconversion
detected in the red and green regions of spectrum.
In addition to Gd2O3, we have investigated the upconversion emission from
Y2O3:Yb
3+, Er3+ samples synthesized using organic solvothermal method us-
ing the FTIR setup. Figure 3.6 shows the emission spectrum of Y2O3:Yb
3+,
Er3+ with molar ratios of 10:3:0.25. The upconversion emissions from these
samples are strong with two range of peaks in the red and the green regions of
spectrum. The highest peak is in the red region located at around 670 nm and
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there are two other peaks in this region centred at 655 nm and 648 nm. The
highest peak in the green region is located at 544 nm. I also tried other molar
ratios for the organic Y2O3:Yb
3+, Er3+ samples but the most intense emission
is detected from the molar ratio of 10:3:0.25. It is important to mention that I
did not detect any upconversion emission from Y2O3:Yb
3+, Tm3+ synthesized
using the organic solvothermal method.
3.1.3 Effects of Urea and Dopant Concentrations
As described earlier, several synthesis parameters affect the optical properties of
resultant particles synthesised by UHP method, including host material, dopants
concentration, urea concentration, reaction pH, reaction temperature and re-
action time. In this work, the effects of urea and dopant concentrations on
the morphological and especially the upconversion photoluminescence of the
nanoparticles are investigated.
I have not detected any significant effect on the morphology of the parti-
cles by changing the urea and dopants concentrations. Although it has been
reported that increasing urea concentration from 0.04 to 4 M decreases the par-
ticle size from 220 to 100 nm in case of synthesis of Y2O3 nanoparticles [150],
but in this work, I have shown that for different amount of urea 1 and 2 M, the
morphology of the particles does not change significantly. In contrast, by using
a higher concentration of urea 2 M the photoluminescence intensity increases
significantly, signifying the effect of urea concentration on the incorporation of
dopants in the host Gd2O3 crystal lattice. I observed that the reaction and
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ageing times affect the morphology and size of the particles more significantly.
The reaction time for all our samples is kept at around 20 minutes. We observed
that for a shorter reaction time of around 5 minutes no observable crystalline
particle is formed and no upconversion photoluminescence is detected. By run-
ning the reaction for more than 1 hour, particles become massively large and
form large aggregates and sediments in the reaction flask. We have not detected
any upconversion photoluminescence from aged samples as well. Therefore, best
results for upconversion emission was achieved for a urea concentration of 2 M
which provides good nucleation and crystallinity in the samples over a controlled
reaction time.
The other critical factor for upconversion emission is the dopants concentra-
tion. The sensitiser (Yb3+) and activator (Tm3+ or Er3+) concentrations are
crucial factors for having an intense upconversion emission, since low concentra-
tion of dopants decreases the energy transfer efficiency and excess concentration
of dopants leads to emission quenching effects by increasing the non-radiative
relaxation between ions inside the host lattice. For ETU upconversion systems,
other researchers suggest that the sensitiser concentration should be high (∼
20 mol %) and the activator content should be relatively low (∼ 2 mol %) [9]
unrelated to the type of activator or sensitiser ions.
In this work, I have tried different concentrations of both sensitiser and
activator as described in Tables 2.2 and 2.3. Similar to urea, the dopants con-
centration does not play a crucial role in particles morphology and their size
which could be justified by the fact that rare-earth materials and especailly Yb,
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Tm and Er act in a similar way in the chemical reactions and therefore changing
their relative concentrations should not have crucial effect on the morphology of
the particles. On the other hand effect of the dopants concentration on upcon-
version photoluminescence is crucial and is related to the type of the dopants.
In case of Gd2O3:Yb
3+, Tm3+ the highest luminescence intensity is detected
for sample T5 doped with 3 mmol of Yb3+ and 0.1 mmol of Tm3+, which is
comparable to the suggested ratios in the literature and shows the crucial role
that Yb3+ plays in energy transfer of this optical system. The luminescence
intensity decreases when I tried higher or lower dopants concentrations because
of non-radiatiove relaxation and non-efective energy transfer mechanisms, re-
spectively.
Gd2O3:Yb
3+, Er3+ samples shows the highest upconversion intensity with
0.6 mmol Yb3+ and 0.25 mmol Er3+ (sample E4). The upconversion lumines-
cence of the Er3+ doped samples, unlike the Tm3+ doped samples, decreases by
increasing Yb3+ concentration, signifying the less critical role of Yb3+ in energy
transfer of Er3+ doped samples in comparison to the Tm3+ samples. The energy
transfer mechanisms of these samples will be described in Section 3.4.
3.2 Photoluminescence Measurement for Organic
and Combustion Samples
Most commercial spectrophotometers [7] use monochromators in order to pro-
vide the spectrum of the emission coming from a sample under test. These
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systems also use a monochromator for generation of different excitation wave-
lengths. A monochromator separates a narrow band of wavelengths ∆λ from
a radiation source using constructive diffraction of the incoming light from a
fine grating (typically 4000 to 20000 lines per cm). Two slits (entrance and
exit) are used as well to achieve narrower band of wavelengths, but inevitably
suppress the amount of light reaching the detector. The typical light source of
a spectrophotometer is a tungsten filament lamp with an emission in the range
of 350 – 2500 nm.
As discussed earlier, there are several issues related to the use of a con-
ventional spectrophotometer for upconversion photoluminescence measurement.
First, for upconversion a laser excitation is required and it is not possible to get
an emission using the normal tungsten lamp used for monochromators. To over-
come this issue, we have coupled a laser to a conventional spectrophotometer
setup and bypassed the main light source and the first monochromator, which
are not that easy to perform on most spectrophotometers. Second, due to the
sharp emission peaks form the rare-earth based upconversion, it is necessary to
have a very narrow wavelength resolution, which implies a smaller slit and finer
grating and consequently an extremely low intensity light reaching the detector
if a monochromator is used. Finally, as the signal is very low intensity, the
measurements accuracy and repeatability is not good when a monochromator
is used.
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Figure 3.7: Optical setup, using a monochromator and a photomultiplier tube
(PMT) to measure upconversion photoluminescence of samples synthesised by
organic and combustion methods.
3.2.1 Optical Setup
Due to the limitations and issues of conventional spectrophotometers, discussed
previously, I have set up a hand made spectrophotometer suitable for mea-
surement of upconversion photoluminescence. Figure 3.7 depicts a schematic
diagram of the optical setup used for the measurement of upconversion pho-
toluminescence of samples derived mainly from organic solvothermal method
and combustion method. A collimated 980 nm CW laser diode is used as the
excitation source that is focused on the sample located on a sample holder. The
upconversion emission guided through lenses and other objectives including two
sets of shortpass filters with cutting edges of 900 nm and 950 nm in order to
eliminate the excitation and prevent saturation of the detector. The filtered
emission signal enters a monochromator that is connected to a photomultiplier
tube (PMT) detector. The recorded data from the PMT to a computer for the
analysis.
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3.2.2 Results and Discussion
The optical setup described in Section 3.2.1 is used to measure low intensity
upconversion emission from samples synthesized based on organic slovothermal
method with surfactant and combustion method. The upconversion emissions
of Y2O3:Yb
3+, Er3+ samples syhtnesized with different surfactants including
PVA, PAA and PEG are displayed in Figure 3.8. The molar ratios of the host,
dopants and also the surfactants used in the synthesis are kept unchanged in
all samples. Interestingly the upconversion emission spectrums of the PVA and
PEG samples are similar, while that of the PAA samples shows emission peaks
in the green region of the spectrum. The highest peaks for all samples are lo-
cated in the red region at around 670 nm.
It is important to mention that due to low intensity of emission from these
samples it is hard to compare the emission intensities quantitatively. But the
emission intensity of the organic solvothermal samples decreases dramatically
when surfactants are used in synthesis. This can be due to the critical mor-
phological changes when the surfactants are used, which affect the crystal and
lattice formation and decrease the energy transfer in samples.
Another important issue is that by using a monochromator in the output
decreases the sensitivity of the measurements. Comparison of the spectra de-
rived using FTIR (Figure 3.6) setup and this setup (Figure 3.8) demonstrates
the difference in accuracy of the two setups.
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Figure 3.8: Upconversion photoluminescence of samples synthesized using rare-
earth co-ordination with different surfactants.
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Figure 3.9: Upconversion photoluminescence of ZnO and Y2O3 samples syn-
thesized using the combustion method. Photoluminescence of annealed ZnO
samples decreases the emission intensity but sharpens the emission peaks.
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Figure 3.9 illustrates the upconversion photoluminescence measurement re-
sults for Y2O3:Yb
3+,Er3+ and ZnO:Yb3+,Er3+ samples synthesized using com-
bustion method and measured with the setup described in Figure 3.7. Both
Y2O3 and ZnO samples have emissions in the red region with the highest
peaks located at around 660 nm with comparable intensities. We have tried
a 24-hour annealing for the ZnO samples, as reported to increase the intensity
of the upconversion emission [159], but as shown in Figure 3.8, annealing of
ZnO:Yb3+,Er3+ samples for 24 hours at 900◦C decreases the emission intensity
by at least three orders of magnitude.
3.3 Time Resolved Photoluminescence Measure-
ments
Mainly, there are three different methods for time resolved photoluminescence
measurements:
1. Decay of Emission to Obtain Lifetime. A pulsed laser is used as the
excitation source and the emission decay is monitored.
2. Real-time Monitoring of Forster Resonance Energy Transfer (FRET). A
pulsed laser is used to excite an energy donor molecule and the emission
of an energy acceptor molecule is studied as a function of time.
3. Transient Spectroscopy. A pulsed laser is used to obtain absorption, emis-
sion or Raman spectra of a sample.
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After a pulsed excitation, the photoluminescence intensity I often decays
through an exponential fluorescence decay involving a decay rate k, as given by
I = I0e
−kt = I0e−t/τ , (3.1)
where I0 is the initial photoluminescence intensity at t = 0 when the excitation
pulse is turned off and τ the characteristic lifetime of the emission. This be-
haviour is referred to as a single exponential decay. The decay rate k represents
both a radiative decay rate kr and a nonradiative decay rate knr. Considering
the radiative and nonradiative lifetimes, τr and τnr, respectively, we have
k = kr + knr =
1
τr
+
1
τnr
=
1
τ
. (3.2)
We have performed upconversion photoluminescence decay measurements
on Gd2O3:Yb
3+,Er3+ (sample E4) and Gd2O3:Yb
3+,Tm3+ (sample T5), which
are selected in view of their intense upconversion emissions among all samples
synthesised using UHP method. The optical set up used for this measurement
described in the following.
3.3.1 Optical Setup
Figure 3.10 and 3.11presents the optical setup used for upconversion decay mea-
surements. A 980 nm pulsed laser with a 5 ns pulse width and 3 mJ energy is
used as the excitation source. A 500 nm longpass (LP) filter is placed between
the laser and the sample in order to eliminate the second hormonic of the laser
source. An optical powermeter is used next to the LP filter to monitor the re-
flectance and scattering of the laser and its harmonics. Samples are sandwiched
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Figure 3.10: Optical setup for measurement of upconversion photoluminescence
decay.
Figure 3.11: Schematic fiagram of Optical setup for measurement of upconver-
sion photoluminescence decay. Short pass and OD filters mounted in front of
PMT.
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between two peaces of thin quartz and placed on a sample holder. The emis-
sion from the sample is guided to a fast PMT detector through two shortpass
filters with cutting wavelengths of 950 and 900 nm in order to remove the laser
excitation beam. Dark glass walls are used to make a dark room for the sam-
ple compartment to prevent the ambient light from reaching the detector. The
detector is connected to a computer to record data.
3.3.2 Results and Discussion
Figure 3.12 depicts the decay measurement results for the sample E4, i.e.,
Gd2O3:Yb
3+,Er3+ with molar ratio of 10:0.6:0.25, using the optical setup de-
scribed in 3.3.1. The top part of Figure 3.12 demonstrates the decay results
of sample E4 without any filter and with a 0.3 OD and 1 OD neutral density
filters. The idea behind using these neutral density filters is to ruled out the
effect of high intensity excitation beam on the decay results for the emission
from the sample. The decay curves show a rapid decay with a lifetime of about
10 µs and a then a gradual decay lasting for about 35 µs. The lower part of
Figure 3.12 illustrates the logarithmic scale of the decay measurement results
for sample E4 with green straight lines fitted to curve. We have calculated the
decay time constant τ from the slope of the fitted lines using:
τ =
dt
dI
log1 0e, (3.3)
where dI is the amount of decay in the intensity in the time interval dt. The
decay graph without an OD filter shows a double exponential behaviour with
a decay time constant τ1=5 and τ2=7.79 µs for the first and second fittings,
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Figure 3.12: Decay measurement of upconversion emission from sample E4 in
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close time constants) without using OD filters. The emission becomes a single
exponential decay when a 1 OD filter is used.
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respectively. Calculated decay time constants with a 0.3 OD filter is τ1=6.15
and τ2=8.68 µs. Finally, the decay time constant calculated for the only fitting
line of 10 OD filter is τ=7.16 µs. Therefore, although decay graphs without fil-
ter and with a 0.3 OD filter show double exponential behaviour, since the time
constants of the two fittings of the graphs are very close, the double exponential
behaviour can be attributed to the intense photon flux coming from the exci-
tation source, and the decay behaviour of E4 sample should be considered as a
single exponential with a time constant of τ=7.16 µs as found for measurement
with a 1 OD filter.
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Figure 3.13: Upconversion luminescence decay measurements of sample T5,
showing a fast decay followed by a long tail.
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The decay measurements are also performed on sample T5, i.e., Gd2O3:Yb
3+,
Tm3+ with molar ratios of 10:3:0.1, as illustrated in Figure 3.13. The decay
measurement shows a rapid decay with a lifetime of about 75 ns followed by a
long tail of gradual decay with a lifetime of 1.6 µs. The calculated decay time
constants for sample T5 using Equation 3.3 is τ1=1 ns and τ2=130 ns for the
rapid and slow decays, respectively. These results signify the distinctly different
photoluminescence decay characteristics of sample T5 showing a clear double
exponential decay in comparison to sample E4.
Differences between energy levels and energy transfer in Tm3+ doped and
Er3+ doped Gd2O3:Yb
3+ is the main underlying reason for the observed dif-
ferences in the decay measurement of these two samples. As it will be discuss
in Section 3.4, the main emission from sample E4 (Gd2O3:Yb
3+, Er3+) is due
to the radiative relaxation of 4F9/2→ 4I15/2. Although, we have detected some
peaks in the green region of the spectrum as well, the main emission is from
this energy transfer in the red area (661 nm), consequently leading to a longer
lifetime and single exponentional for the photoluminescence decay (as seen in
Figure 3.12). For sample T5 (Gd2O3:Yb
3+, Tm3+), however, the emission is
only coming form the radiative energy relaxation of 3H4→ 3H6 (810 nm), but
Tm3+ is famous as a blue emitter and it has a ladder like energy levels to reach
to 1D2 energy and emit in blue. In our system the structural formation of the
ions force most of the electrons to reach to 3H4 and emit at 810 nm which
produce the fast decay peak, but there exist some electrons populated at other
energy levels that reach higher energy levels of Tm3+ such as 1D2 and
1G4 and
the relaxation of these electrons produce a very long but low intensity tail as
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observed in Figure 3.13.
3.4 Energy Levels and Energy Transfer
Methods
Understanding of how energy transfer happens in the synthesized samples is one
of the most important steps in optical and material characterization. Upconver-
sion photoluminescence and decay measurements described in previous sections
provide essential data necessary for decoding complicated energy levels and en-
ergy transfer mechanisms. In this section I provide a brief review of quantum
mechanic basics of energy levels and energy transfer in rare-earth materials,
followed by comprehensive discussion of proposed energy transfer mechanisms
for Gd2O3:Yb
3+, Er3+ and Gd2O3:Yb
3+, Tm3+ Systems.
3.4.1 Quantum Mechanic Basics of Energy Level
Structures in RE materials
During the last century, discoveries in the field of quantum mechanics have
revolutionised our understanding of the structure of matter. Here is a brief
overview of fundamentals of electronic structure of materials especially Lan-
thanides, based on details provided by Jean-Claude G. Bu¨nzli in [160], Guokui
Liu in [161] and Michel J. F. Digonnet in [162]. Basically, the Schro¨dinger
equation defines the interaction of electrons and nucleus in an atom as
HΨn = EnΨn (3.4)
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where H is the time-dependent Hamiltonian operator describing the sum of
kinetic and potential energies in the system. Ψn is the wavefunction and related
to the movement of the particles and its square, (Ψn)
2, gives the probability
that the particle will be found in a position given by the coordinates; the set of
all probabilities for a given Ψn is called an orbital. En is the quantified energy
associated with a specific wavefunction and is independent of the coordinates.
In case of hydrogen the Hamiltonian simply consist of Coulombo’s attraction
between electron and nucleus and the kinetic energy named as H0. Each wave-
function, or orbialts, calculated from the equation 3.4 defined by four quantum
numbers, showing the two motions of the electrons including angular momentum
~l and the spin ~s. The principal quantum number n is an integer and represent
radial expansion of the orbital. The angular quantum number l varies from 0
to (n-1) and depicts the shape of the orbital, letters: s, p, d, f, g,... for l= 0,
1, 2, 3, 4,... respectively. on the other hand ml is the projection of the ~l into z
axis and its values different from -l and +l. Finally, ms is the projection of ~s
and have values of ± 12 .
The energy levels of heavy atoms such as RE3+ free ions are determined by
Hamiltonian operator given as,
H = H0 +HC +HSO (3.5)
Where H0 is the central field approximation, HC is the electrostatic interac-
tion and HSO is the spin orbit coupling. The central field approximation is the
main contributor, in which each electron is assumed to move independently in a
spherically symmetric potential formed by the nucleus and the average potential
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of all the other electrons. Both HC and HSO are small compare to central field
approximation and treated as perturbation. Using the central field approxima-
tion, the 4F
N electron configuration has a single specific energy unrelated to the
orbital and spin angular momentum. This single energy level is lifted by the
HC and HSO, which splits the configuration into multiple energy levels. In this
aspect for all 4f orbitals, each f electron contributes an orbital quantum num-
ber of 3 and spin of 12 . The LS coupling, or Russell-Saunders coupling, defines
the energy states of rare-earth materials. L and S are added vectorially to form
the total angular momentum J and the energy states are labelled as 2S+1LJ .
Here 2S+1, with S as the overall spin quantum number, represents the spin
multiplicity. When S=0 , 2S+1=1, it represent a singlet state, while for S=1,
2S+1=3, represents a triple state. L represents the total angular momentum.
The overall total angular momentum J is then obtained by coupling both L and
S together such as J= (L-S), (L-S)+1, ..., (L+S).
Figure 3.14 shows an example of energy level splitting diagram of rare-earth
materials. In this model the degeneracy of the electron configuration, defined
by central field approximation, first lifted by the electrostatic interactions to
produce the first splitting. This followed by the weaker spin-orbit coupling
splits those levels into sub-levels. This coupling model is more accurate for light
elements and for heavy elements such as lanthanides the free ion Hamiltonian
is simplified into terms of effective operators based on the type of rare-earth.
When a rare-earth is doped into a host and chemically bonds the electrostatic
interaction change the spherical free ion model, but as the 4F
N electrons are
shielded this interactions are week and is considered as a perturbation HCF to
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Figure 3.14: Energy diagram showing splittings resulting from electron-electron
and electron-host interactions [162]
the previously described free ion model. HCF lifts the angular momentum J,
splitting each 2S+1LJ into number of levels. For example, 2J+1 states created
if the RE3+ ion has even number of f electrons. The manifolds split from J
levels are responsible for the spectroscopic properties of lanthanides including
absorption and emission.
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3.4.2 Energy Transfer Mechanisms for Gd2O3:Yb
3+, Er3+
and Gd2O3:Yb
3+, Tm3+ Systems.
As mentioned before, lanthanide ions are the best choice for making upcon-
version materials due to their ladder like energy levels (Figure 1.11). We have
also discussed the possible theoretical energy transfer mechanisms in systems
which use Yb3+ as a sensitiser and Tm3+ or Er3+ as an activator, as shown
in Section 1.6.3 (Figure 1.12). The optical characterisation not only provides
the emission wavelength and spectrum for different samples but also leads to an
understanding of the energy transfer mechanism of the observed photolumines-
cence emission.
Figure 3.15 depicts the photoluminescence of Gd2O3:Yb
3+, Er3+ samples
(E1 to E6) in one graph from which it is possible to claim that in all Er3+
doped samples the main emission peaks are centred at 661 nm, which can be
attributed to the 4F9/2→ 4I15/2 energy transfer mechanism. There are also two
other peaks in some of the Er3+ doped samples: the first is in the green region
at 562 nm and the second in the NIR region centred at 811 nm (detected in
samples E3 and E5). These two peaks are correlated to the energy transfer of
4S3/2→ 4I15/2 and 4I9/2→ 4I15/2, respectively.
The mechanism leading to upconversion in Er3+ doped samples can be sum-
marized as follows. The Yb3+ absorbs 975 nm photon in the 2F7/2→ 2F5/2
transition. Electrons are then easily transferred from the Yb3+ 2F5/2 level to
the Er3+ 4I11/2 level because of the alignment of the respective energies, as
schematically illustrated in Figure 3.16. The Er3+ also absorbs photons from
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Figure 3.15: Upconversion photoluminescence of Gd2O3:Yb
3+, Er3+ samples
with different synthesis condition, showing different peaks and corresponding to
the proposed energy transfer mechanisms.
975 nm laser in the 4I15/2→ 4I11/2 energy transfer. Therefore, the Er3+ 4I11/2
populated by absorbing photons directly by Er3+ or by transfer from Yb3+ to
Er3+. From there, another 975 nm photon can be absorbed or transferred from
Yb3+, taking the electron to Er3+ 4F7/2. The electron then makes its way to
4F9/2 thorough a non-radiative relaxation. From this energy level, a
4F9/2→
4I15/2 transition gives rise to a 661 nm unconverted visible red emission.
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Figure 3.16: Left: Stark level scheme showing energy transfer between Yb3+
and Tm3+ ions for an 810 nm emission. Right: Similar level scheme showing
energy transfer between Yb3+ and Er3+ ions for a 660 nm emission. The y-axis
is wavenumber, and the position of the Stark levels are taken from Kaminskii’s
definitive work [15].
The energy transfer for a green emission (562nm) from Er3+ doped sam-
ple also starts from absorbing a 975 nm photons from the laser excitation by
Yb3+ and Er3+ as described above, which ends in populating Er3+ 4F7/2. From
there, absorption or transfer of another photon takes the electrons to Er3+
2H11/2 from which electrons are relaxed by a non-radiative relaxation to reach
Er3+ 4S3/2. Finally, the electron transition
4S3/2→ 4I15/2 produces the observed
green emission. In the case of Er3+ doped samples (E3 and E5) the low intensity
NIR upconversion emission is centred at 810 nm. This rarely possible energy
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transfer happens by series of non-radiative relaxations between Er3+ 4F7/2 and
Er3+ 4I9/2 from which electrons radiatively relax to emit the NIR emission. As
it is more likely for electrons to relax through higher energy levels such as 4F9/2,
the NIR emission from Er3+ doped samples is not statisitcally favoured.
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Figure 3.17: Upconversion photoluminescence of Gd2O3:Yb
3+, Tm3+ samples
with different synthesis conditions, showing different peaks and corresponding
proposed energy transfers.
Figure 3.17 depicts the photoluminescence of Gd2O3:Yb
3+, Tm3+ for sam-
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ples T1 to T6. These samples show almost pure NIR-to-NIR upconversion
emission centred at 810 nm corresponding to the 3H4→ 3H6 transition. The
traces of two other emissions that appear in some samples, namely the 661 and
488 nm emissions can be attributed to the 1G4→ 3F4 and 1G4→ 3H6 transi-
tions, respectively.
Figure 3.16 demonstrates the suggested Stark manifold levels for upconver-
sion mechanisms observed for the Yb3+ and Tm3+ ions adjacent to each other
and highlights the importance of the Yb3+ sensitiser in facilitating the upconver-
sion emission. The 2F7/2→ 2F5/2 transition in Yb3+ resonates with the photon
energy of the 975 nm pump laser excitation. From the Yb3+ 2F5/2 level, an
electron can transfer to the Tm3+ 3F4 level by losing some energy, whereupon
another 975 nm photon can excite it into the 3F2 level. From there, the electron
makes its way to the 3H4 where it undergoes the
3H4→ 3H6 transition giving
rise to the 810 nm upconverted near infrared emission. Another alternative path
sees electrons from Yb3+ 2F5/2 level excited to the Tm
3+ 1G4 level through the
so-called diagonal transition. This is followed by the non-radiative relaxation
from Tm3+ 1G4 to Tm
3+ 3H4 and the radiative relaxation
3H4→ 3H6 that leads
to emission of the 810 nm photon.
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3.5 Upconversion Imaging by Multiphoton
Microscopy
Upconversion is a multiphoton phenomenon and therefore multiphoton micro-
scopes are used for in vitro applications of upconversion nanoparticles. In mul-
tiphoton microscopy, absorption of series of photons excites a fluorophore such
as upconversion nanoparticle to an excited state followed by upconversion emis-
sion which is used to obtain an image. Most of the practical applications of
multiphoton microscopes for upconversion nanoparticles use a two-photon ab-
sorption mechanism since a three-photon absorption requires an excitation laser
with an extremely high peak intensity [7].
Since a normal two-photon microscope requires simultaneous absorption of
two laser photons from a pulsed source, it is necessary to use high power laser
as the probability for this absorption is proportional to the square of light inten-
sity. Typically, a Ti:Sapphire laser that produces a very short (∼ 100 fs) pulses
centered around 800 nm with a very large peak power (50 kW) is needed. Please
note that theoretically upconversion excitation can occur even without simulta-
neous excitation and therefore high laser femtosecond lasers are not necessary.
To prove the applicability of the Gd2O3 upconversion nanoparticles synthesised
in this work for in vitro bioimaging, we have performed microscopy imaging
using a Leica TCS SPII confocal and multiphoton microscope. The next two
sections will describe the optical setups and the results of the experiments.
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Figure 3.18: Schematic of Leica TCS SPII spectrophotometer detection system
using a prism, 2 sliders and 4 PMTs to detect the region of interest of the
spectrum [16].
3.5.1 Optical Setup
The Leica TCS SPII confocal and multiphoton microscope is used for charac-
terization of upconversion nanparticles. In addition to UV and visible laser
sources, the system has a tunable IR source. The excitation from the laser is
passing through a series of objectives and mirrors, which produce a collimated
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beam that reaches the sample through the microscope objective lens. Emission
from the sample goes exactly the same way as the excitation and reaches a beam
splitter that sends the emission signal trough filters and in case of the confocal
microscopy through a pin hole. The filters and beam splitter are used to control
the amount light heading toward the detector. The specific detector system
of Leica system is shown in Figure 3.18. The emission light passes thorough
a prism that stretch the light to separate the spectrum that can be redirected
onto the opening window of different PMTs. There are four PMTs available in
this system with slits that narrow down or widen the spectrum of the incoming
light, as shown in the figure. The advantage of using such a system is possibility
to adjust the imaging band according to the dye used, the possibility of multi-
spectral imaging using all four different PMTs and the possibility of performing
emission spectra via wavelength scan [16].
3.5.2 Results and Discussion
To demonstrate the potential of using the synthesised upconversion nanoparti-
cles for in vitro bioimaging applications, we have used the Leica multiphoton
microscope. Sample E4, with the most intense upconversion emission is selected
for this experiment. Unfortunately the highest sensitivity of the PMT detectors
of the microscope was at 795 nm and therefore even this unique set up is not
suitable for Tm3+ doped samples. Upconversion nanoparticles from sample E4
are dissolved in DI water and stirred to get a homogeneous milky mixture. One
drop of the solution is sandwiched between two pieces of microscope film for the
experiment.
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Brightfield Upconversion Overlay
910 nm excitation
950 nm excitation
980 nm excitation
Figure 3.19: Brightfield, upconversion luminescence and the overlap image of
clusters of nanoparticles from sample E4 under a two photon micrsocope. Dif-
ferent excitation wavelength has been tried and images are produced with all
different excitations.
The excitation light source used in this experiment was a tunable NIR laser
and we have tried different wavelength excitation from 850 to 1000 nm. Fig-
ure 3.19 illustrates the photomicrographs of the same sample exposed to differ-
ent excitation wavelength of 910 (top), 950 (middle) and 980 nm (bottom).
The micrograph from left to right are bright field microscope image of the
nanoparticles, upconversion luminescence detected from the same sample us-
ing the corresponding excitation in the dark, and the overlay image of these
pictures. The middle column of pictures shows a strong upconversion emission
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Figure 3.20: The intensity versus λ from Sample E4 (Gd2O3:Yb
3+, Er3+) with
different excitation wavelength, derived from microscopy imaging, showing the
corresponding peaks in the red and green regions of spectrum.
from the clusters of particles for all excitation wavelengths used. The overlap
pictures signify that the observed emissions accurately correlate to the location
of the nanoparticles under the microscope. The spot size for the emitted sig-
nal is defined by the size of nanoparticle aggregates on the sample and for our
detector is around 1µ m. This signifies the potential for high spatial resolution
provided by these nanoparticles. We did not detect upconversion emission with
excitation wavelengths smaller than 900 nm and larger than 1000 nm, but the
145
intensity of emission remain unchanged for the accuracy of our detector for the
range of 910 – 980 nm, indicating the possibility of using these upconversion
nanoparticles with 910 nm excitation, a preferred wavelength for bioimaging as
water absorption coefficient is minimal at 910 nm in comparison to that for 980
nm [163].
Figure 3.20 depicts the photoluminescence intensity from sample E4 (Gd2O3:Yb
3+,
Er3+) measured by multiphoton microscope. Three different excitation wave-
lengths are examined for this sample, including 910, 950 and 980 nm. All
wavelengths produce photoluminescence intensity spectrum with two peaks lo-
cated at green (570 nm) and red (661 nm) regions of spectrum, demonstrating
the efficiency of these nanoparticles for stable upconversion for a range of exci-
tations.
3.6 Challenges and Opportunities in Optical
Characterization of NIR-to-NIR
Upconversion Nanoparticles
As described in this chapter, optical characterization of upconversion nanoparti-
cles is performed using different methods and approaches so as to provide a com-
prehensive understanding of the optical properties of the synthesised nanopar-
ticles. One of the most important challenges for optical characterization of up-
conversion nanoparticles, especially for the biologically important NIR-to-NIR
conversion, is the lack of commercially available optical setup for precise and
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quantifiable experiments. Due to this problem, performing NIR-to-NIR charac-
terization a commercial optical setup needs to be radically modified or a new
setup needs to be assembled. The reason for this problem is rooted in that al-
most all optical systems are built for Stoke’s shift conversion or down conversion
such as fluorescence. As an example, the most convenient way to do photolumi-
nescence experiments is to use a spectrophotometer, such as Horiba’s FluoroLog,
but these devices usually use a tungsten light source with a monochromator to
provide excitation beam in the required spectrum and for upconversion these
light sources do not have the required intensity. This issue can be addressed by
accommodation of a NIR fibre-coupled laser.
Second issue for the characterization of NIR-to-NIR upconversion samples
is related to the confocal or multiphoton microscopes. Most typical confocal
microscopes are not equipped with a NIR laser sources and their filter sets need
to be changed for upconversion microscopic imaging use. Using multiphoton
microscopes is a more convenient replacement as they have a tunable NIR laser
by default. Though, the problem with multiphoton microscopes is their detec-
tors and filters. For instance, the PMTs of Leica multiphoton that we used in
this work has the maximum edge of sensitivity at 780 nm, and consequently, not
suitable for microscopy imaging of Tm3+ doped particles with 810 nm emission
while we manage to use the system sucessfully for Er3+ doped samples with an
emission centred at 661 nm. It is important to note that since a compatible
PMT for this type of microscope is still not available commercially by the man-
ufacturer, the only possible way to do microcopy on these sample is setting up
a hand made multiphoton microscope with the desired characteristics.
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The above-mentioned problems limit the experimental methods that can be
used for optical charaterization of NIR-to-NIR upconverison nanoparticles, but
novel method such as using FTIR spectroscope for this purpose as demonstrated
here can be a significant opportunity for future systems providing a high reso-
lution full spectrum measurement even at low emission intensities.
3.7 Conclusion
Optical characterization is one of the most important steps in understanding op-
tical, electronic and material properties of upconversion nanoparticles. There-
fore, I tried different methods and approaches in this work to provide a com-
prehensive understanding of optical behaviour of synthesized nanoparticles.
Upconversion photoluminescence of Gd2O3:Yb
3+, Tm3+ and Gd2O3:Yb
3+,
Er3+, synthesized by UHP method, performed using novel FTIR setup reported
in this chapter. Strong NIR to NIR upconversion detected from Gd2O3:Yb
3+,
Tm3+ centred at 810 nm. This kind of pure NIR to NIR upconversion to the
best of our knowledge has not been reported before for this type of upcon-
version nanoparticles. Same optical set up used for Gd2O3:Yb
3+, Er3+ which
shows upconversion emission centred in red spectral region (661 nm). By ap-
plying upconversion photoluminescence measurements for samples synthesized
using different dopants and urea concentration, this work also provide a better
understanding of optimized synthesis recipe and energy transfer mechanisms
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in this type of nanoparticles. Unrelated to the type of dopants used in these
materials keeping urea concentration at 2 M provides good nucleation and crys-
tallinity in samples leading for more intense upconversion emission. The effect
of dopants concentration is different for different kind of lanthanide used as
activator ion. The energy transfer and upconversion emission of Gd2O3:Yb
3+,
Tm3+ are more Yb3+ dependent compare with samples doped with Er3+ as
activator. Therefore the most intense emission from Tm3+ doped samples are
detected from samples doped with 3 mmol of Yb3+ and only 0.1 mmol of Tm3+
(sample T5), while in Er3+ doped samples most intense emission detected from
sample doped with only 0.6 mmol of Yb3+ and 0.25 mmol of Er3+. Although
it is suggested that for ETU upconversion systems the sensitiser concentration
should be high (∼ 20 mol %) and the activator content should be relatively low
(∼ 2 mol %) [9] unrelated to the type of activator or sensitiser ions, in this
work I found out that, at least for samples with Gd2O3 as host, to get the most
intense upconversion emission the sensitiser, in this case Yb3+, concentration
should be adjusted depending on what element used as activator.
Upconversion photoluminescence also measured for samples synthesized through
other methods tried in this work. For Y2O3:Yb
3+, Er3+ samples synthesized
using novel organic solvothermal method FTIR setup applied and intense up-
conversion detected from these samples. While for samples synthesized with
organic solvothermal method by employing surfactants and also from combus-
tion synthesis method, different optical setup applied using monochromator and
PMT. These measurements not only provide crucial information about the op-
tical properties of the synthesized samples but also provide an opportunity to
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compare two different photoluminescence methods described in this chapter.
In conclusion FTIR is a faster and easier to apply method, with much better
resolution and possibility of getting whole spectrum data compare to the other
method.
Decay measurements also performed for Gd2O3:Yb
3+, Tm3+ and Gd2O3:Yb
3+,
Er3+ using the optical setup described in this chapter. There is a fundamental
difference between decay results of Gd2O3:Yb
3+ doped with Tm3+ and Er3+,
related to the different energy transfer mechanism of these two systems. The
Er3+ doped samples exhibited a single exponential decay behaviour, while Tm3+
doped samples had a double exponential behaviour consist of a fast decay re-
lated to radiative relaxation from Tm3+ 3H4 resulting in 810 nm upconversion
emission, while some of the absorbed electrons populated at other energy levels
of Tm3+ such as 1D2 and
1G4 relaxed in a non-radiative way to produce a long
tail decay. It is important to mention here that to the best of out knowledge no
prior work exists on upconversion photoluminescence decay of nanophosphors
based on Gd2O3 doped with Yb
3+, Tm3+ or Yb3+, Er3+.
Another optical experiment that I performed in this work and described
in this chapter was testing Gd2O3:Yb
3+, Er3+ nanoparticles with a commercial
two photon microscope. This specific experiment shows the applicability of these
type of nanoparticles synthesized in this work for in vitro applications. As the
microscope equipped with a tunable laser I also tried different excitation wave-
lengths and it was proved that the intensity of emission remained unchanged for
the range of 910-980 nm within the experimental error, which indicates the pos-
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sibility of using these upconversion particles for 910 nm excitation, a preferred
wavelength for bioimaging as water absorption coefficient is lower at 910 nm in
comparison to that for 980 nm.
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Chapter 4
Magnetic Characterization
of Gd2O3 Upconversion
Nanoparticles
A motivation for using Gd2O3 as host for optically-active upconversion nanopar-
ticles is the possibility for using its magnetic properties in bimodal bioimaging.
Gd complexes have proven to be a powerful alternative contrast agents for MRI
[164, 165, 30], with advantage of providing a rise to positive contrast (bright
signal) on T1-weighted images because of their paramagnetic properties. This
is in contrast to the superparamagnetic nanoparticles that only enhance the
negative signal in MRI images, which is difficult to be distinguished in a weak
MRI signal. In order to characterise the magnetic properties of the synthe-
sised Gd2O3:Yb
3+, Tm3+ and Gd2O3:Yb
3+, Er3+ upconversion nanoparticles
we used Superconducting Quantum Interference Device (SQUID) as one of the
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most sensitive magnetometers and Magnetic Force Microscopy (MFM) as one
of the most novel methods reported.
All SQUID and zero-field-cooled/field-cooled (ZFC/FC) measurements are
performed by MPMS-XL Quantum Design magnetometer located in The Royal
Institution of Great Britain and their technician helped me for these measure-
ments. The MFM and AFM measurement performed by myself using a Veeco
Dimension 3100 Atomic force microscopy located in London Centre for Nan-
otechnology (LCN). The following sections will describe basics of SQUID and
MFM measurement and results of the magnetic characterisation of nanoparti-
cles.
4.1 SQUID Measurements
Superconducting quantum interference devices (SQUID) is a very sensitive mag-
netometer, designed to detect very small magnetic fields. SQUID provides ad-
vantages such as high sensitivity (≈ 10− 100 fT Hz− 12 ), wide bandwidth (from
DC to 10 kHz), broad dynamic range (> 80 dB), its quantitative nature and
reasonable costs [166]. The great sensitivity of SQUID magnetometers is asso-
ciated to the properties of superconductive materials and Josephson junctions.
Superconductive materials conduct current with zero resistivity when cooled
down to temperatures below a critical temperature Tc. The maximum cur-
rent that a superconductive material can conduct with zero resistance is the
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critical current Ic. A superconductive ring will have a quantized magnetic
flux that is integer products of the quantum magnetic flux φ0 = h/2e ∼=
2.067833758(46)×10−15 Wb, where h is Planck’s constant and e the elementary
charge and weber (Wb) the SI unit of magnetic flux. A Josephson junction is
formed by two superconductive material separated by a thin insulator layer or
a weak link.
A SQUID measurement system is a superconducting loop containing two
Josephson junctions, which provide a weakly connected superconducting loops.
Thus, a change in the magnetic flux applied to the loop φA will cause the current
to move in opposite way in order to oppose this change and ignite a phase dif-
ference in the junction. Most novel SQUID systems use a pick-up coil to collect
data, in order to avoid exposing the bare SQUID to the magnetic field of interest.
The schematic of a typical SQUID system is presented in Figure 4.1. The
SQUIDs are located inside a small magnetic shield (for example superconduct-
ing niobium). The superconducting pick-up coils are located at the bottom of
the Dewar, the electronic devices are at room temperature and the magnetic
objects are beneath the instrument. The samples is placed inside a gelatine
capsule and kept in the SQUID part of the system and placed inside the liquid
helium. A resistor attached to the SQUID holder is used to heat the sample
during the experiment.
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Figure 4.1: Cross sectional schematic diagram of a simple SQUID system (re-
drawn from Ref. [17]).
4.1.1 SQUID Results and discussion
The SQUID measurements performed by a MPMS-XL Quantum Design magne-
tometer. Magnetic moment versus applied magnetic field (MH) measurements
performed at 5 K and 300 K with a maximum applied magnetic field of 70 kOe
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for all samples except sample E4 which measured at maximum 50 kOe. The
weight of materials used for the experiments are 7.5 , 8.8, 10.8, 17.8 and 10.2 mg
for samples T6, T5, E6, E5, E4, respectively, and all the results are normalised to
the weight of the sample. Temperature dependent ZFC and FC magnetization
measurements were obtained with the same system for a range of temperature
between < 2 K and 300 K with an applied magnetic field of 100 Oe.
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Figure 4.2: MH curve of Er+3 and Tm+3 doped samples at 5 K. All samples
show similar behaviour with a curvature without absolute saturation and no ob-
servable hystresis. Samples T5 (red) and E5 (dark blue) show less susceptibility
and higher curvature than other samples.
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Figure 4.2 illustrates the measured MH curves of nanoparticles doped with
Er+3 and Tm+3 at 5 K temperature for samples T5, T6, E5, E6 and E4, demon-
strating similar magnetisation behaviour for all samples. Although none of
the samples reach saturation and there is no hysteresis at this temperature,
a curvature is observed in the MH curves, indicating a saturation at around
105 emu g−1. The curvature of the sample T6, E6 and E4 is completely identi-
cal, while it is slightly higher for samples E5 and T5 and the curves approach
the saturation point faster. The observed MH results for samples T5 and E5
can be justified by the lower Gd percentage reported as compared to samples
T6, E6 and E4 in ICP spectroscopy results. The percentage of Gd appeared in
samples T5 and E5 is 55.29% and 60.6%, respectively, whereas this is 66.17%,
66.02% and 76.42% for samples T6, E6 and E4, respectively. From this graph
a magnetic mass susceptibility χ of 2.5 × 10−3 emu/Oe.g at 5 K is extracted
from the slope of the curves in the linear central region using Equation 1.13.
As illustrated in Figure 4.3 the MH curves of Gd2O3 samples doped with
Yb+3:Er+3 or Yb+3:Tm+3 at room temperature (300 K) shows no curvature,
an indication for a typical paramagnetic materials [5, 167]. From this figure,
the magnetic mass susceptibility can be extracted as 1.33× 10−4 emu/Oe.g at
room temperature. Sample E4 shows slightly higher susceptibility possibly due
to the smaller dopant concentration in sample E4 (10:0.6:0.25) and the higher
Gd percentage in the final synthesized sample measured by ICP spectroscopy
as 76.42%.
Figure 4.4 illustrates the zero-field-cooled (ZFC)/ field-cooled (FC) curves
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Figure 4.3: Magnetic behaviour of Tm3+ and Er3+ doped samples at 300 K.
All samples shows linear pattern which is a typical behaviour of paramagnetic
material. Sample E4 (light blue) show the highest magnetic mass susceptibility.
of the samples as a function of temperature. All samples show similar behaviour
which is a clear evidence of the paramagnetic behaviour obtained from all sam-
ples, not affected with dopant concentration or different types of lanthanide used
as dopants. The ZFC/FC results shows the typical signature 1/T behaviour for
paramagnetic materials, which corroborates with the absence of blocking tem-
perature and splitting between FC and ZFC [164]. The lack of hysteresis and
absolute saturation in MH graphs and lack of splitting in ZFC-FC rules out
the possibility of superparamagnetic behaviour and this is in accordance to the
size range of the particles synthesised as the superparamagnetic behaviour is
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reported in ultra small Gd2O3 nanoparticles with size range of around 3 nm
[164].
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Figure 4.4: zero-field-cooled (ZFC) field-cooled (FC) measurements of Tm3+
and Er3+ doped samples. No blocking temperature and splitting suggest the
paramagnetic properties of the samples.
4.2 Magnetic Force Microscopy
Magnetic force microscopy (MFM) belongs to atomic force microscopy (AFM)
family of measurements and is based on the interaction between a magnetised
cantilever tip with surface of a sample. A flexible cantilever with typical size of
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around 200 µm long, 30 µm wide and 3 µm thick with a sharp magnetic tip is
used as a force sensor. The force on the cantilever is measured by measuring
changes on the reflection of a laser beam focused on the tip of the cantilever.
When a small force Fz = F0 cos(ωt) at a frequency ω interacts with the cantilever
causes the tip to oscillate with a displacement z given by
z = z0 cos(ωt+ φ(ω)), (4.1)
where φ is the phase difference between oscillations of the tip and external force
[168]. The amplitude z0 of the oscillations is given by
z0 =
F0
m
√
(ω20 − ω2)2 + (ω0ωQ )2
, (4.2)
where m is the mass of the tip, Q the quality factor representing the ratio of
energy stored in the cantilever to the energy lost per cycle, ω0 =
√
(k/m) the
natural oscillation frequency of the cantilever and k the spring constant of the
tip. The phase shift φ reads
φ = tan−1
(
ωω0
Q(ω20 − ω2)
)
. (4.3)
The force on the magnetic tip increases as it approaches the magnetic sample,
leading to a change in the resonance frequency ∆ω given by
∆ω = −ω0
2k
∂Fz
∂z
. (4.4)
The above equation signifies that when a force attracts the cantilever, the reso-
nance frequency of the cantilever decreases and for forces pushing the cantilever
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away the resonance frequency of the cantilever increases [168].
When using a magnetized tip, the energy of the cantilever tip/sample U can
be written as
U = −µ0
∫
tip
~Mtip ~HsampledVtip, (4.5)
where µ0 is the magnetic permeability of vacuum, ~Mtip is the magnetization of
the cantilever tip and ~Hsample is the magnetic field of the sample. The force is
thus derived by
~F = −∇U = µ0( ~Mtip · ~∇) ~Hsample. (4.6)
One of the most important issues in MFM measurement is distinguishing
between magnetic forces interact with cantilever and other forces such as vibra-
tional or electrostatic forces. In order to achieve this goal, we use the tapping
mode and lifting mode to carry out MFM experiments. Figure 4.5 shows a
schematic of the idea of the two-pass experiment. In a two-pass experiment, the
sample is first topologically assessed by using the tapping mode, meaning that
the cantilever oscillates with a certain frequency while moving and scanning the
sample. After the first scan cantilever is lifted from the sample to a required
height ∆z to avoid the surface electrostatic forces and measurement is done only
for the long-range magnetic forces [18, 169].
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Figure 4.5: Schematic of a two-pass scanning magnetic force microscopy (MFM).
First scan is the topographic tapping mode for morphological characterization
followed by second scan which is the lift mode to measure the magnetic inter-
actions (redrawn using [18]).
4.2.1 Experimental Method
We have performed magnetic force microscopy (MFM) on sample E4 (Gd2O3:Yb
3+,
Er3+) as it has the most intense upconversion emission as illustrated in Figure
3.15 and also it has the highest magnetic susceptibility between the synthesised
samples, as shown in Figure 4.3. We have tried the same experiment on com-
mercial nickel nanoparticles as well, so as to compare behaviour of ferromagnetic
nickel with paramagnetic Gd2O3 nanoparticles. The experiment are carried out
by a Veeco Dimension 3000 AFM by using commercially available Veeco MFM
cantilevers with 225 micron length and with a resonant frequency f0 between
60 and 100 kHz. The tip is a conducting antimony doped silicon coated with
chrome and cobalt and then magnetized to a Coercivity of ∼ 400 Oe and a
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spring constant in the order of 1 – 5 N/m.
To get high quality AFM and MFM images, a delicate sample prepara-
tion is required as particles need to rigidly adhere to the substrate that has
a roughness less than the size of the nanoparticles. A sliced silicon wafer is
used as a substrate, which is washed first with isopropyl alcohol (IPA) during
a 30 minute ultrasonication. The substrate is then placed in an aminopropy-
ltriethoxy silane (APTES) saturated desiccator for 24 hours in order to get a
very thin film layer of APTES on the surface of silicon to enhance adhesion of
nanoparticles. Meanwhile, 10 mg of Gd2O3:Yb
3+, Er3+ or nickel nanopowder is
diluted in 10 ml DI water and subjected to 30 minutes ultrasonication to get a
homogeneous dispersion of the nanoparticles. The dispersions are then diluted
with DI water 5 times. A drop of the diluted nanoparticle dispersions is placed
on the APTES modified substrate and dried at room temperature under nitro-
gen. The prepared samples is then used in MFM and AFM measurements [170].
AFM imaging performed using the tapping mode by the above-mentioned
magnetised tip to get the morphological image of the particles. Then, the tip
is lifted away from the sample by 90 nm, at which distance the surface forces
such as Van der Waals and the electrostatic forces are negligible and only the
magnetic interaction of the particles and magnetised tip is recorded. The result
of AFM and MFM experiments will be discussed in the following section.
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Figure 4.6: Atomic force microscopy (A) and magnetic force microscopy (B)
measurement results with corresponding phase shift graphs of sample E4
(Gd2O3:Yb
3+, Er3+) on the illustrated scan lines.
4.2.2 Magnetic Force Microscopy Results and Discussion
Figure 4.6 illustrates the AFM and MFM photomicrgraphs and their corre-
sponding phase diagrams for nanoparticles from sample E4 (Gd2O3:Yb
3+, Er3+).
As illustrated, the AFM micrograph (A) illustrates clusters of spherical particles
with a size range of around 100 – 200 nm diameter and 1 µm height. The graph
on the right of the AFM micrgraph shows the cantilever amplitude related to
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the topography measurement of particles on the shown scan line. MFM micro-
graph (B) shows the MFM image derived by repeating the experiment by lifting
the cantilever by 90 nm and shows the magnetic interaction of magnetized tip
with the paramagnetic field of Gd2O3:Yb
3+, Er3+ nanoparticles induced by the
magnetic field of the tip during the AFM scan. A small negative phase shift
is detected when the tip reaches the surface of the particles followed by sharp
spikes, indicating oscillation of the tip due to the magnetic its interaction with
the particle magnetic field.
We have perform similar AFM and MFM imaging on commercial nickel
nanoparticles. Figure 4.7 demonstrates the result for this experiment. In part
(A) the topography image of a cluster of nickel nanoparticles with 200 nm di-
ameter and approximately 700 nm height. Part (B) illustrates the MFM image
from the same cluster while the cantilever is lifted by 90 nm from the sample.
The cluster of nanoparticle is disappeared in this image, signifying that the
cantilever does not have interaction with the magnetic field of the nickel parti-
cles at this height. The graph next to picture (B) shows the phase shift of the
cantilever while imaging the nanoparticles cluster and it illustrates no obvious
phase shift related to detection of the particles.
Comparing results from ferromagnetic nickel nanoparticles (Figure 4.7) and
paramagnetic Gd2O3:Yb
3+, Er3+ (Figure 4.6), it is arguable that although the
AFM images, part (A) in both figures, shows similar topography of the particles
with different size range, but the recorded MFM micrographs, part (B) in both
figures, are completely different. By lifting the cantilever by 90 nm from the
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Figure 4.7: Atomic force microscopy (A) and magnetic force microscopy (B)
results with corresponding phase shift graphs of nickel nanoparticles.
surface of the samples, in case of nickel nanoparticle there is no obvious phase
shift while for the Gd2O3:Yb
3+, Er3+ a sharp and strong phase shift is detected
especially at the surface of the particles. This result can be justified by keeping
in mind that nickel nanoparticles are ferromagnetic and therefore the magnetic
field of the particles is unrelated to the magenetization of the tip and therefore
by lifting the cantilever to 90 nm from the sample no oscilating interaction will
be caused. While, the Gd2O3:Yb
3+, Er3+ nanoparticles are paramagnetic and
166
the magnetic field of the particles is induced by the magnetic field of the tip,
therefore when the very similar but opposite field from the tip and particles
interact with each other, a strong oscilating interaction occurs.
4.3 Conclusion
In this chapter, magnetic characterization of the synthesized Gd2O3:Yb
3+, Er3+
and Gd2O3:Yb
3+, Tm3+ samples have been described. These nanoparticles ex-
hibit paramagnetic behaviour and therefore have a strong potential application
as a positive MRI contrast. The SQUID measurements not only proved the
paramagnetic behaviour of the particles, but also showed that the magnetic
properties of these nanoparticles are not affected by the kind of dopants and
concentration of the dopants. Thus, the most important factor affecting the
magnetic properties of the particles is host material, in this case Gd, which pro-
vides a constant and stable magnetic behaviour for these nanoparticles. This is
an important point because it means that it is possible to dope Gd2O3 nanopar-
ticles with different elements in order to get different upconversion emission
colour with higher intensity and better efficiency without altering the magnetic
behaviour of the particles.
I have also performed magnetic force microscopy that shows the possibility
of magnetic characterization on single nanoparticle. The comparison of MFM
results of commercially available nickel nanoparticles with Gd2O3:Yb
3+, Er3+
nanoparticles synthesized in this work illustrated a completely different reaction
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between the MFM cantilever and magnetic field of the particles. In case of the
paramagnetic Gd2O3:Yb
3+, Er3+ the interaction of the magnetized tip and the
induced magnetic field of the particles produce a strong oscillation. This reac-
tion did not happen for ferromagnetic nickel nanoparticles.
Testing properties of these nanoparticles in MRI experiments is an interest-
ing future work that requires customizable MRI test systems. Another interest-
ing experiment is to perform MFM experiments on a single particle with both
magnetized and normal tip and comparing the effect of the magnetized tip on
single particles. The main challenge for this experiment is bringing back the tip
to exactly the same particle on the sample.
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Chapter 5
Potential for Multi-Modal
In Vitro and In Vivo
Bio-Imaging
5.1 In Vitro Optical Imaging and Use of Up-
conversion Nanoparticles
Upconversion nanoparticles provide unique optical properties, described in Sec-
tion 1.6.2, such as sharp, blinking-free and long lifetime luminescence, high
photostability, possibility for using low power continuous wave lasers as excita-
tion source and tunable emission. Because of these, there exists a huge interest
for their applications in bioimaging and biological experimentation. The first
potential field that upconversion nanoparticles can play an important role is in
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vitro bioimaging.
:αvβ3 Integrinαvβ3
Cancer
Cell
Cancer
Cell
Normal
Cell
:Upconversion nanoparticle
:RGD ligand
αvβ3
RGD
UCN
UCN
RGD
αvβ3
RGD
UCN αvβ3
RGD
UCN
αvβ3
RGD
UCN
αvβ3
RGD
UCN
NIR NIR NIR
Figure 5.1: Schematic of how RGD modified upconversion nanoparticles dis-
tinguish between a normal cell without specific integrin αvβ3 expression and a
cancer cell with integrin on its cell surface.
First in vitro application of upconversion nanoparticles is using them for
targeted detection of normal cells and pathological cells such as cancer cells.
The idea is to attach a ligand that can specifically detect a target, so as to
detect for example a cancer cell from a normal cell. A famous example of a
clinically useful ligand is arginine–glycine–asparatic acid (RGD) peptide. RGD
can be attached to integrin αvβ3 specifically and as these integrins are expressed
in some cancer cells but not in normal cells, it is possible to distinguish these
two types of cells by doing an optical image. Figure 5.1 shows a schematic of
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how RGD modified upconversion nanoparticles can be immobilizer on a can-
cer cell with integrin expression but not on the surface of a normal cell. This
type of targeted detection reported recently by different groups and prove the
applicability of upconversion nanoparticles [171, 172]. There are many other
clinically important targets with their specific targets that could be developed
in the same way for in vitro bioimaging. Although the in vitro detection of two
different cells is far from a real clinical application but it is possible to think
that by developing specific ligands for specific targets it is possible to increase
the specificity and selectivity of clinical pathology by using nanoparticles for in
vitro bioimaging.
Second example is the application of upconversion nanoparticles for hetero-
geneous bioassays. In this application, a substrate is covered with molecules
that can capture and immobilize specific analyte molecules in a test sample
or solution to give a quantitative measure of the amount of analytes. Figure
5.2 illustrates a schematic of a heterogeneous assay system using upconversion
nanoparticles. In a competitive assay, free analytes in a sample compete with
analytes modified by upconversion nanoparticles for immobilization on the sur-
face molecules. The setup is washed after letting the system to settle to remove
unattached analytes or nanoparticles. The substrate is then excited by a NIR
excitation beam and the emission from the immobilized nanoparticle-modified
analytes is detected. In this case the amount of analyte is inversely propor-
tional to the emission intensity. In a non-competitive assay, probes modified
by upconversion nanoparticles are captured on top of analytes immobilized on
the capture molecule in a sandwich structure. After washing the substrate the
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remaining particles are subjected to NIR excitation. In this case, the intensity
of upconversion luminescence is directly proportional to the concentration of
analytes [19].
Although for in vitro applications even µm size particles can be suitable,
but smaller particles lead to better target-to-reporter ratio and higher qual-
ity results. One advantage of using upconversion nanoparticles for in vitro
bio-applications is the lack of autofluorescence in the samples due to the low
energy NIR laser as excitation source. Limited or no autofluorescence means
higher signal to noise ratio (SNR) that results in higher image resolution and
more sensitive quantitative results. It is important to keep in mind that, unlike
quantum dots (QDs), emission wavelength of upconversion nanoparticles is not
related to their size but defined by the type of activator used in the particles.
This means that it is possible to get different emission colours from very similar
particles and with the same NIR excitation source. This is a massive advantage
as it provides possibility of simultaneous multicolour imaging and multicolour
assays for different targets.
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Figure 5.2: Mechanism of heterogeneous bioassays with upconversion nanopar-
ticles. (A) A competitive assay, in which free analytes compete with analytes
modified with nanoparticles, (B) A non-competitive assay in which analytes
are sandwiched between probe and capture molecule. After being washed the
amount of analytes can be quantified by the emitted signal from nanoparticles
excited with NIR beam (redrawn from [19]).
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5.2 In Vivo Bio-Imaging with Upconversion
Nanoparticles: Animal Scans and
Intra Operation Imaging
Recently, in view of the progress in development of high quality and efficiency
upconversion nanoparticles, these nanoparticles have started to play an impor-
tant role as an alternative for conventional dyes used for molecular imaging
[173, 174]. Upconversion nanoparticles have some important advantages over
other nanoparticles and imaging probes especially for in vivo applications. First
advantage of upconversion nanoparticles is the use of NIR sources, as discussed
in Section 1.3.3, resulting in less autoflourescence emission from bio-samples
and higher signal to noise ratio and better image quality [107]. In addition,
NIR excitations enable a deeper tissue penetration [175, 176]. Another advan-
tage of upconversion nanoparticles for in vivo applications is the possibility for
multicolour emission depending on the type of dopants used in synthesis of the
nanoparticles using a single NIR excitation source. The emission from these
nanoparticles are sharp with unique signature, without any overlap with exci-
tation source which improves the imaging sensitivity.
To use the NIR-biological window, which enables deeper tissue penetration,
upconversion by default has the excitation beam in the NIR region, but it is
hard to get the emission in NIR region as well. Although recently pure or semi
pure NIR to NIR upconversion nanoparticles are reported [53, 163], there is still
a need to develop particles with high conversion efficiency and pure NIR-to-NIR
upconversion. In this work, we have demonstrated pure NIR-to-NIR upconver-
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sion nanoparticles. These particles are excited with different wavelength in the
range of 900 to 1000 nm and emit pure upconversion centred at 810 nm. This
will open huge potential application for in vivo imaging using upconversion
nanoparticles.
There are two important factors involve in efficient application of nanoprti-
cles for in vivo including size and the surface condition of nanoparticles. Parti-
cles need to be small enough to be able to pass biological barriers such as cell
walls, endothelial layer and blood brain barrier and also to be able to avoid the
reticuloendothelial system (RES) including lymph nodes, spleen and liver. On
the other hand the very small particles can be filtered away rapidly in kidney.
There are some contradictory reports about the effective particle size [22, 5],
but it is possible to say that an ideal size is in the range between 10 – 100 nm
depends on the in vivo application. The other important factor is the surface
condition of the particles, generally speaking particles need to be covered with a
layer of biocompatible material in order to be stealth from the immune system
and RES, the most popular way of doing this is to cover particle with polyethy-
lene glycol in a process referred to as PEGylation. Surface modified particles
can resist the RES system and their blood circulation half-life increases by sev-
eral orders of magnitude [22].
Pathological tissues especially tumour tissues have structural differences as
compared to normal tissues. Examples of these differences include presence of
angiogenic blood vessels and expression of specific target molecules. These diff-
ferences can be employed for active and passive targeting of cancer cells and
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pathologic tissues. In comparison to normal tissues tumour tissues have higher
permeability because of endothelial pores with sizes varying from 10 to 1000 nm
[177]. Also the lymphatic derange system is not working in tumorous tissues,
and as a result, nanoparticles can easily get into the tumour tissues, are not
easily removed, leading to accumulation in the tumour. Detection of the accu-
mulated nanoparticles can indicate a tumour tissue in a passive mechanism that
is referred to as the enhanced permeability and retention effect (EPR) [178], en-
abling passive targeting.
As the passive targeting is limited by structure of a tumour such as degree
of tumour vasculature (related to the type of tumour) or pressure of solid tu-
mours, the application of this type of targeting is limited. To overcome this
issue, active targeting has been introduced, by using specifically activated and
functionalized nanoparticles. An example for this type of targeting is the use of
functionalized particles with RGD ligands, described in Section 5.1, and since
integrin αvβ3 is expressed on the endothelial cells of some tumours, nanoparti-
cles are immobilized and accumulated selectively on these targets to provide an
intense emission for a sensitive detection.
Other groups recently have demonstrated the application of upconversion
nanoparticles for in vivo imaging, especially in animal models [179, 163]. This
is a novel subject of research, and for example to the best of our knowledge,
there is no report for in vivo application of pure NIR-to-NIR upconversion
nanoparticles, although there are some reports about using these type of parti-
cles in phantom tissues to illustrate deeper imaging penetration depth for this
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nanoparticles. An example for application to animal models is to test the ef-
fect of new medical treatments on a particular cancer or other pathologies by
targeted imaging of the targets related to that cancer. By trying these imag-
ing techniques over time and comparing the presence of the target the effect of
the medical treatment can be studied more effectively. This method can have
significant, transformative effect on the laborious, time consuming process of
discovering new medicines. As it is mentioned in Section 3.6, design and instru-
mentation of novel upconversion imaging systems are a novel field and there is
no commercial system available for this type of imaging. Recently, Mahmood
et. al. [180] reported a system for small animal upconversion imaging, which is
a basic design for this type of imagers and signifies the opportunity for design
and developing better and more practical imaging systems in this field.
An important example of clinical in vivo applications of nanoparticles is the
detection of sentinel lymph node during surgery. The sentinel lymph node is the
first lymph node or group of nodes infected by metastasizing cancer cells from
a primary tumour. Use of nuclear modality (e.g., PET) has become the typical
method for detection of sentinel lymph node in clinic. But this is limited due to
danger of radiation from the nuclear contrasts, low quality images and cost of
these imaging systems. Recently, there have been some reports about applica-
tions of magnetic nanoparticle for this purpose. Upconversion nanoparticles can
play an important role, as the excitation source for these type of nanoparticles is
a low cost conventional CW laser without adverse radiation effects. An impor-
tant point is that optical modality suffers from low penetration depth, a problem
that can be severely reduced by using NIR-to-NIR upconverison nanoparticles,
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but in the case of surgery the tissues are exposed and therefore the limited
penetration depth is not a major problem while the high sensitivity of optical
modality could be used for an accurate detection of the sentinel lymph nodes.
The synthesized Gd2O3 based upconversion nanoparticles synthesized in this
work are multimodal particles with optical and magnetic properties. This im-
portant property enables the possibility of using these type of nanoparticles as
multimodal probe for biomedical imaging. The advantages of multimodality for
in vivo application is the ability to use advantages of the two modalities to im-
prove the effectiveness of imaging technique. For example, by using these type
of particles for sentinel lymph nodes, it is possible to use the paramagnetic be-
haviour of the particles to get high quality anatomical MRI images overlapped
with sensitive detection of the targets using optical imaging. And as both these
two important and comprehensive diagnosis tools are performed by same par-
ticle it is much safer and more biocompatible than applying different contrasts
for obtaining different images.
Although theoretically and to some extent practically it has been demon-
strated that by using NIR biological window, it is possible to increase the
penetration depth of the optical modality, it is important to mention that
different tissues in the body have different anatomical, physiological and bio-
physicochemical properties and these properties can affect the accessibility and
efficiency of the tissues for in vivo molecular imaging. For example, blood brain
barrier (BBB) tissues have a barrier that separate brain from the general blood
circulation in the body and therefore it is difficult and tricky to detect a target
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inside the brain. Or for example, bones do not have a very dynamic circulation
so it is not possible to use the circulation force for transferring imaging probes
to the targets located in them. And also some tissues are located in some places
in the body that is not possible to access them through skin, while some other
tissues such as breast, skin, prostate, lymph nodes, and liver are more accessible
thorough circulation and located in positions that could be easier for using the
optical imaging. Although as will be discussed it is possible to use endsocopy
techniques, as described in Section 5.3, but targets should be selected accord-
ing to the properties of the tissue, their accessibility and the possibility to be
imaged using the available modality.
5.3 In Vivo Endoscopic Use of Bio-Imaging
Nanoparticles
Introduction of endoscopic imaging to medicine is one of the most important
breakthroughs both for the diagnosis and treatment of illnesses, as it helps
medics and surgeons to have access to tissues and organs in vivo. In recent
years, the introduction of new technologies such as wide-field endoscopy, aut-
ofluorescence endoscopy, scanning fiber endoscopy, confocal endomicroscopy and
two-photon endomicrsocopy has opened a new era in potentials of endoscopy for
clinical diagnosis and treatments. Especially, the development of confocal and
two-photon endomicroscopy can have revolutionary effects on molecular imaging
using endoscopy. In confocal endomicroscopy, a single photon usually in the vis-
ible range is used to excite tissues and the emitted fluorescence beam is detected
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by using the core of single mode optical fiber which acts as a filter to reject the
scattered light except the light coming from the interested focal point. Using
this method information form cancer cells have been detected in tissues as deep
as 500 µm below the surface. On the other hand, in two-photon endomicroscopy,
two NIR excitation beams excite the tissue simultaneously to produce a visible
emission from the target of interest. Two-photon endomicroscopy brings some
advantages such as less scattering in tissues, limited photo-bleaching and deeper
depth penetration because of NIR excitation [181].
In all of the above-mentioned endomicroscopic methods, usage of targeted
nanoparticles can enhance their sensitivity and selectivity. Applying upcon-
version nanoparticles as targeted probes can be a real opportunity to improve
optical molecular imaging using endomicroscopy [182]. One important advan-
tage of upconversion to even two-photon endoscopy is the possibility to couple
a NIR continuous wave laser diode in an endoscope easily and there is no need
for simultaneous excitation. On the other hand, another fiber optic with filters
designed for the emission wavelength could be used for detection and as the
emission coming from particles in the case of upconversion is sharp it is easy
to detect the signal form any background emission that increases the sensitivity
of images. Finally, possibility to get NIR-to-NIR upconversion nanoparticles as
shown in this work, implies deeper penetration depth for both excitation and
emission without minimal autofluorescence from background tissues.
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5.4 Toxicology and Catabolism of Nanoparticles
Nanotechnology has attracted attention in the recent years as a technology that
can play a crucial role in the future of medicine and bioscience. But like any
other novel technology it also ignites questions about the acute and chronic ef-
fects of nanoparticles and nanostrsuctures on cells and tissues in vitro and in
vivo. Traditionally, toxicology of materials is dose related, which means that
medicines and chemicals can have different effects with different doses and can be
toxic in certain dosages. This approach to toxicology changes to some extend in
the case of nonmaterials as chemical and physical properties of material change
in nano-scale. Because of this, for nanomaterial not only the dosage but also
their type, size, shape, surface, charge, coating, dispersion, agglomeration and
aggregation can play an important role in their toxic effect and their catabolism
[183]. Another important point is that the surface layer of nanoparticles are
much more important for their reactivity, and consequently, their toxicity, and
this surface attracts biomaterial to form strong or weak bonds as soon as the
nanoparticles enter a bio-matrix. The surface of a nanoparticles after being
covered with biomaterial is called corona [184]. So not only the type of material
that nanoparticles are built from is important, but the environment where the
nanoparticles are going to be used in and thus the corona surface of the particles
should be studied in toxicology studies.
In vitro toxic effects of nanoparticles on cells can be chemical or physical.
The chemical mechanisms include production of reactive oxygen species (ROS),
release of toxic ions, disturbance on cell membrane transport activity and oxida-
tion damages. The physical mechanisms are also important and related to the
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size and morphology of particles. These mechanisms include membrane activity
disruption, blocking transport processes, disruption in protein synthesis mech-
anisms and aggregation of particles [183]. Adding all these mechanisms, the
first organelle being affected is the cell membrane, which can be manipulated
by surface modification of the particles, but particles can potentially disrupt
normal functions of the cell membrane. Other vulnerable organelles in cells are
mitochondria and lysosomes. There are some reports that carbon nanotubes
can reach mitochondria and disrupt its function as the cell engine. Lysosomes
are responsible for metabolism inside the cells and the observed disruption is be-
lieved to be generally due to accumulation of nanoparticles, but the catabolism
process of nanoparticles inside lysosomes are not well understood yet [185, 183].
The in vivo toxicology and catabolism of nanoparticles is even more com-
plicated and less revealed yet. The biodistribution studies of nanoparticles in
animal models have shown that unrelated to how particles enter the body, traces
of nanoparticles are detected in liver, spleen, heart and even brain [183]. It is
even reported that silica nanoparticles and titanium dioxide particles in the size
range of 35 to 70 nm cause pregnancy problems such as smaller fetus and pres-
ence of particles in fetus liver and brain [186]. Therefore, there is an urgent need
for a comprehensive study of in vivo toxicological properties of nanoparticles.
Upconversion nanoparticles are not excepted to suffer extensively from the
mentioned toxicology issues. Although rare-earth material are generally consid-
ered as non-toxic and bio-compatible [97], and there are some reports available
on the in vitro and in vivo applications of these nanoparticles without any
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acute toxic problems [187], but the longterm effects of these type of particles
are not well understood. While Gd complexes is an FDA approved MRI con-
trast agent, but these type of material can cause heavy metal toxicity if used in
high dosages or accumulated in tissues during longterm usage. In conclusion,
although upconversion nanoparticles are far safer and biocompatible than other
nanoparticles including QDs, but their catabolism and more importantly their
longterm effects is still unknown, which requires significant attention.
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Chapter 6
Conclusions
Upconversion Gd2O3:Yb
3+, Tm3+ and Gd2O3:Yb
3+, Er3+ nanoparticles have
been synthesized using urea homogeneous precipitation (UHP) method. Tm3+
doped samples demonstrate pure near infrared to near infrared (NIR–to–NIR)
upconversion emission centred at around 810 nm (associated to the 3H4→ 3H6
energy transfer of Tm3+), when excited with a low cost 975 nm continuous
wave excitation laser in photoluminescence experiments. This places both exci-
tation and emission wavelength in the biologically important window that has
the highest penentration depth and minimal tissue autoflourescence, leading to
increased image quality and signal to noise ratio. For Er3+ doped samples,
upconversion emission mainly falls in the visible red region centred at 661 nm
(attributed to the 4F9/2→ 4I15/2 energy transfer of Er3+), when excited with
the same infra red laser excitation. Effect of molar ratio of dopants and urea
concentration used in the synthesis is systematically investigated for finding the
best recipes for these particles. Morphological characterization, including scan-
ning electron microscopy (SEM) and transmission electron microscopy (TEM)
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shows spherical and oval monodispersed particles with a rough surface and a size
distribution in the range of 50 to 150 nm. The size distribution and monodis-
persity tests using dynamic light scattering (DLS) approve the size distribution
of the particles and demonstrate formation of acceptable aqueous dispersions
and point out agglomeration challenges especially for bioimaging applications.
The HR-TEM tests show a lattice distance of 4.1 A˚for Gd2O3:Yb
3+, Tm3+ and
4.6 A˚for Gd2O3:Yb
3+, Er3+ nanoparticles. The elemental analyses including in-
ductively coupled plasma optical emission spectrometry (ICP-OES) and X-ray
photoelectron spectroscopy demonstrate correlation between the starting molar
ratios of the host and dopants and final concentrations of the ions in the re-
sultant particles. XPS results also suggested that particles tend to absorb CO2
from atmosphere but this has no effect on the particles optical and magnetic
properties.
For sensitive optical characterization of the synthesized nanoparticles, we
have developed a novel method for upconversion photoluminescence measure-
ment using fourier transform infrared (FTIR) and visible spectrometer by which
it is possible to get accurate and high resolution data with possibility of scan-
ning whole spectrum without limitations of a conventional spectrophotometers
for NIR-to-NIR applications. The most intense NIR-to-NIR emission is de-
tected from the samples synthesized with 2 M of urea solution and doped with
3 mmol Yb3+ and 0.1 or 0.25 mmol Tm3+. The highest upconversion intensity
in the case of Er3+ doped samples belongs to samples doped with 0.6 mmol of
Yb3+ and 0.25 mmol of Er3+ and syhthesized with 2 M urea stock solution.
The photoluminescence decay measurements illustrate a single exponential de-
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cay behaviour for Er3+ doped samples with a time constant of τ = 7.16 µs. The
Tm3+ doped samples, in contrast, demonstrate a distinguishable double expo-
nential decay behaviour with a decay constant of τ1 = 0.001 µs and τ2 = 0.13
µs for the rapid and long tail decays, respectively. The photoluminescence and
decay measurements suggest different energy transfer mechanisms responsible
for the Tm3+ and Er3+ doped samples. The Tm3+ samples are more depen-
dent on Yb3+ sensitisers, thus requiring a high (3 mmol) Yb3+ concentration
for the most intense emission and a low activator concentration to prevent self
quenching effects. In contrast, in Er3+ doped samples, Yb3+ dopant plays a
much less critical role, since Er3+ also absorbs the excitation in addition to
acting as an activator. Microscopic images of the nanoparticles illustrate the
potential for using these upconversion nanoparticles in in vitro bioimaging. The
emission detected from particles excited with a 980 nm is accurately correlated
to the location of the particle clusters in the bright field image, illustrating a
spatial resolution down to a micron. Other excitation wavelengths in the range
of 900–1000 nm show similar upconversion emission.
Multimodal behaviour of Gd2O3:Yb
3+, Tm3+ and Gd2O3:Yb
3+, Er3+ up-
conversion nanoparticles is demonstrated by magnetic characterization of the
synthesized nanoparticles. Superconducting quantum interference devices (SQUID)
show no saturation and no hysteresis for MH measurements carried out at 5 K,
but a curvature is present in the MH behaviour. A magnetic mass susceptibility
χ of 2.5 × 10−3 emu/Oe.g at 5 K. MH curves of Gd2O3 samples doped with
Er+3 or Tm+3 at room temperature (300 K) demonstrate no curvature, an indi-
cation for a typical paramagnetic materials and a magnetic mass susceptibility
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of 1.33× 10−4 emu/Oe. Zero-field-cooled (ZFC)/ field-cooled (FC) curves pro-
vide evidence of paramagnetic behaviour including the typical signature 1/T
behaviour, absence of blocking temperature and lack of splitting between FC
and ZFC. Magnetic force microscopy (MFM) show that synthesized nanoparti-
cles produce positive phase difference on a magentized tip even at a lift height
of 90 nm, whereas nickel nanoparticles do not show such a behaviour when the
tip is lifted from the sample.
In addition to the above nanoparticles, we have synthesized Y2O3:Yb
3+,
Er3+ and Y2O3:Yb
3+, Er3+ upconversion nanoparticles using similar UHP
method, and we observed that Gd2O3 is a better host for upconversion nanopar-
ticles in comparison to Y2O3 for providing a stronger emission. We investigated
novel thermal decomposition method for synthesis of upconversion phosphors us-
ing organic co-ordination complexes as precursors. The synthesized Y2O3:Yb
3+,
Er3+ particles have a size in the micrometer range with spherical shape and show
strong upconversion emission in the red (661 nm) and green (560 nm) regions of
the spectrum. Surfatants such as PEG, PVA and PAA have been used to control
the morphology and size of the particles, and Y2O3:Yb
3+, Er3+ nanoparticles
with diameters of 150 nm are demonstrated using PEG surfactants. We have
also presented synthesis of upconversion nanoparticles using the combustion
method for both Y2O3:Yb
3+, Er3+ and ZnO:Yb3+, Er3+ but the upconversion
emission from these samples are extremely low intensity and not comparable to
the samples synthesiszed with other methods. We examined the effect of long
term annealing on the combustion samples, showing a decrease in the emission
intensity for at least three order of magnitude.
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The results of this work for synthesis and characterization of multimodal
magnetic and optical nanoparticles opens significant opportunities for novel in
vitro and in vivo bioimaging applications. As mentioned in the next section,
these results provide the foundation for significant improvements in the field of
optical molecular and multimodal imaging with direct implications for better
diagnosis and clinical applications.
6.1 Future Works
The future works that can be directly founded on the contributions of this thesis
include:
1. Progress in synthesis of upconversion nanoparticles. Although in this work
we have demonstrated fine and monodispersed Gd2O3 nanoparticles with
pure NIR-to-NIR upconversion for particles doped with Tm3+ and NIR
to visible for those doped with Er3+, there exist many opportunities for
novel synthesis routes. Using other lanthanide ions as dopants and using
core-shell structures [10] can improve both the morphological and opti-
cal properties of the nanoparticles. We have tried synthesis using organic
precursors and reported dramatic change in the morphology of the synthe-
sized particles using surfactants. Applying surfactants on the fine particles
synthesized with UBHP method is another idea worth trying to improve
size and surface conditions of the particles.
2. Surface modification and functionalization of the particles. As mentioned
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before to increase the efficiency of particles for bioimaging, especially for
in vivo applications, surface modifications are required. For example, the
surface modifications used for Y2O3 particles in literature [154] can be eas-
ily used for Gd2O3 particles and commercial availability of functionalized
PEG makes the design of experiments for in vitro and in vivo bioimaging
applications easier.
3. Designing upconversion set-up both for in vitro and in vivo imaging. As
mentioned before, the lack of a standard setup for upconversion imaging is
an important problem for sensitive optical and microscopy imaging exper-
iments. This poses as a great experimental and commercial opportunity
for development of next generation upconversion microscopy and clinical
tools. An experimental setup can be arranged using commercially avail-
able multiphoton microscopes for in vitro experiments and designing flex-
ible setups for animal experiments and other in vivo imaging applications.
4. Performing in vitro and in vivo experiments. In vitro and in vitro ex-
periments are possible to perform with upconversion nanoparticles with
different types of dopants that enable having multiple targets with mul-
ticolour tagging capability. Another opportunity is to try both MRI and
optical imaging simultaneously to use advantages of both methods and
enhance the possible clinical application of these particles.
5. Toxicology and longterm safety experiments of upconversion nanoparticles.
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As mentioned, an important missing piece of the puzzle for application of
nanoparticles for clinical applications is better understanding of toxicol-
ogy, catabolism and longterm effects of nanoparticles. Designing experi-
ments to overcome these issues is one of the most important future works
in nanopaticle research area.
6. Finding new targets with high specificity and selectivity for clinical applica-
tions. We have briefly mentioned possible targets for clinical applications
in this thesis. Development of new targets for specific in vitro and in vivo
diagnosis and test applications is the key for connecting these nanoparti-
cles to new applications in nanomedicine. Extensive research and collabo-
ration with different research groups in basic medical science and clinical
areas is one of the most important strategies to improve this novel field of
science and technology.
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